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Résumé 
Les grilles de calcul sont une nouvelle Technologie de l’Information permettant la collecte et 
le partage de l’information, la mise en réseau d’experts et la mobilisation de ressources en 
routine ou en urgence. Elles ouvrent de nouvelles perspectives de réduction des coûts et 
d’accélération de la recherche in silico de médicaments contre les maladies négligées et 
émergentes. Dans ce contexte, la première partie de la thèse a porté sur la conception de 
services bio-informatiques sur grille. Ils facilitent le déploiement et la mise à jour sur la grille 
RUGBI de logiciels et de bases de données. La seconde partie a vu le déploiement 
d’expériences de criblage virtuel à haut débit sur l’infrastructure de grille EGEE. Les 
expériences ont démontré que les grilles collaboratives ont la capacité à mobiliser 
d’importantes ressources de calcul dans des buts bien définis pendant une période de temps 
significative, et qu’elles produisent des résultats biologiques pertinents. 
 
Mots clefs: grille de calcul, recherche de medicaments in silico, maladies négligées, 
maladies émergentes, services bio-informatiques, deploiement de logiciels et de bases de 
données, mise à jour de bases de données, criblage virtuel à haut débit. 
Summary 
Computing grids are a new Information Technology offering unprecedented opportunities for 
collecting and sharing information, networking experts and mobilizing resources routinely or 
in an emergency. Grids open new perspectives to in silico drug discovery for the reduction of 
costs and the acceleration of research against neglected and emerging infectious diseases. In 
this context, the first part of the thesis focuses on the conception of bio-informatics services in 
the framework of the RUGBI grid which carry out the software and database deployment and 
update on grid resources. The second part focuses on the deployment of high throughput 
virtual screening by docking in the framework of the EGEE grid. The experiments 
demonstrated how collaborative grids have a tremendous capacity to mobilize very large CPU 
resources for well targeted goals during a significant period of time and that they can be used 
for producing relevant biological results in the drug discovery process. 
 
Keywords: computing grids, in silico drug discovery, neglected diseases, emerging 
infectious diseases, bioinformatics services, software and database deployment, database 
update, high throughput virtual screening 
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General introduction 
Malaria is a major health problem for Burkina Faso’s population. It is the leading cause 
of morbidity, hospitalization and mortality. Children under five years old and pregnant 
women are most at risk. In 2001, 45% of deaths for children under five years old in Burkina 
Faso were induced by malaria. Malaria is called a neglected disease because it affects the poor 
population of least developed countries and treatments are often not locally available for the 
population. 
Avian influenza is a growing threat to world public health. Possible scenarios for the first 
influenza pandemic of the 21st century painted a grim picture for human health the world 
over, the survival of existing development projects, and the health of the global economy, 
with losses expected to reach around US$ 800 billion during the first year of a pandemic. 
Avian influenza is called an emerging infectious disease because it has existed previously but 
is rapidly increasing in incidence and in geographical range. 
Both neglected and emerging infectious diseases are major public health concerns in the 
beginning of the 21Pst P century. They demand international collaboration for early detection, 
epidemiological watch, prevention, and a constant search for drugs and vaccines. New drugs 
are constantly needed to anticipate the emergence of drug resistance as well as to cure new 
diseases. Actions are undertaken worldwide to fight these diseases. 
Information Technologies increase the impact of these actions. Information Technology, 
or Information and Communication Technology, is the technology required for information 
managing and processing, especially in large organizations. In particular it deals with the use 
of electronic computers and computer software to convert, store, protect, process, transmit, 
and retrieve information from anywhere, anytime. Grids are a new Information Technology 
offering unprecedented opportunities for collecting and sharing information, networking 
experts and mobilizing resources routinely or in an emergency.  
 In silico drug discovery is one of the most promising strategies to speed-up the drug 
discovery process and to reduce its cost. Grids open new perspectives to in silico drug 
discovery for the reduction of costs for research and development against neglected diseases 
and the acceleration of research and development against emerging infectious diseases. The 
objective of this thesis was to explore the grid impact on the in silico drug discovery against 
these neglected and emerging infectious diseases. 
In this context, two areas were investigated:  
• The first area was the conception of services for grid-enabled protein structure 
prediction in the framework of the RUGBI grid. 
• The second area was the deployment of high throughput virtual screening by virtual 
docking in the framework of the EGEE, AuverGrid and TWGrid grids. 
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Beginning in January 2003 and ending in December 2005, the goal of the French national 
RUGBI project was to design and deploy on the basis of free technologies and existing 
infrastructures a computing grid offering a set of services to analyze proteins. Today, these 
grid-enabled services are available through a web portal and aim to support academic 
biologists and small and medium life science enterprises. In this framework, two grid-enabled 
services to deploy and update protein structure prediction software and databases were 
developed to help life science scientists to access the grid. Services were developed for a 
broad range of bioinformatics applications but are particularly relevant for protein structure 
prediction in the perspective of in silico drug discovery. 
The objective of the software and database deployment service is to allow registration, 
installation, modification and consultation of any biological software and database in a grid 
environment. The objective of the database update service is to make available the last version 
of a flat file database on the grid for the jobs launched. The result gives access to a ready-to-
use software and updated database on the RUGBI grid. 
I led the workpackage responsible for deploying bioinformatics services on the RUGBI 
grid infrastructure. Partners of the work package were Corpuscular Physics Laboratory of 
Clermont-Ferrand (CNRS-IN2P3), Communication and Systèmes company, Computing 
Center of IN2P3 (IN2P3) and Institut de Biologie et Chimie des Protéines (CNRS). After 
analyzing the requirements of the life science industrial partners involved in the project, I 
designed the grid-enabled bioinformatics services for academic and industrial end-users. I 
defined the use cases, the functional specifications and the information system. Developments 
were made in collaboration with the Communication & Systems company and research 
engineers from the Corpuscular Physics Laboratory of Clermont-Ferrand. For this reason, 
they are only summarized in this document. 
 
Initiated in 2004, WISDOM is an international initiative to enable a virtual screening 
pipeline on a grid infrastructure against neglected and emerging infectious diseases. Virtual 
screening is about selecting and ranking in silico the best candidate drugs, i.e. the molecules 
which could impact the target biochemical activity. In this framework, two high throughput 
virtual docking experiments were deployed on public cluster grid infrastructures. They tested 
large chemicals libraries for their ability to interact with the target. Given the very large 
amount of data involved in the computation, such a large scale deployment is a stressful 
experiment for the grid infrastructure, which is called a data challenge.  
The first large scale docking experiment ran on the EGEE grid production service in July 
and August 2005 against targets relevant to research on malaria. The objective was the 
deployment of a CPU consuming virtual docking application generating large data flows to 
test the grid operation and services. The second large scale docking experiment ran on the 
EGEE, Auvergrid and TWGrid grid production services in April and May 2006 against 
targets relevant to research on avian influenza. The objective was to improve the performance 
of the in silico high throughput screening environment in less than three months and to test 
another environment, the DIANE production system, which enables users to have efficient 
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and interactive control of the massive molecular dockings on the grid. These achievements 
demonstrated the relevance of grids for the drug discovery process against neglected and 
emerging infectious diseases and in enabling world-wide and multidisciplinary collaboration. 
I led the grid deployment of the two WISDOM experiments. Docking experiment 
preparation and output analysis were leaded by Fraunhofer Institute SCAI for the first 
experiment against malaria, and by Genomics Research Center (Academia Sinica of Taiwan) 
and Institute for Biomedical Technologies (CNR) for the second experiment against avian 
influenza. The first step of the deployment was the design of the WISDOM experiment from 
the docking application requirements. Then I developed the WISDOM production system for 
installing, testing and deploying the application on large scale grids. The third step was the 
deployment: it required to manage an international grid expert staff (the Biomedical Task 
Force) for controlling the deployment and to interact with the different actors of the grid 
infrastructures (user support, grid system administrators, middleware developers, etc.). The 
last step was the deployment statistics analysis to report the deployment and the faults, and to 
improve the WISDOM production system for the next experiments. In the second experiment 
against avian influenza, the DIANE production system was deployed and used in parallel to 
the WISDOM production system by Computing Center of Academia Sinica and CERN. They 
analyzed the DIANE deployment statistics and the tools comparison was done jointly. For this 
reason, the DIANE development and deployment are only summarized in this document. 
 
Chapter 1 introduces the present challenges raised by neglected and emerging infectious 
diseases. It focuses specifically on malaria and on the influenza A virus subtype H5N1. Then 
it discusses how Information Technologies can help to develop new strategies against them. It 
will focus on one of these strategies, in silico drug discovery, and it will highlight its 
relevance for neglected and emerging infectious diseases. Finally, it describes how one new 
Information Technology, the grid, can greatly improve the in silico drug discovery process. 
 
Chapter 2 proposes several definitions for a grid. Then it focuses on the most widespread 
grids, the desktop and cluster grids in order to compare them. The aim is to identify the best 
grid environments to be used to develop in silico drug discovery services against neglected 
and emerging infectious diseases. Finally the infrastructures and the technologies of the grids 
used will be justified and described. They are the EGEE, Auvergrid, TWGrid and RUGBI 
grids.  
 
After a summary of related works, chapter 3 presents the two grid-enabled services to 
deploy and update protein structure prediction software and databases in the RUGBI 
framework. The objectives, architecture, results, limitations and perspectives are presented. 
Services were made for a broad range of bioinformatics applications but are useful for protein 
structure prediction in the perspective of in silico drug discovery. 
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Chapter 4 introduces the requirements for a large scale deployment on the public cluster 
grid infrastructure EGEE. Then different grid-enabled initiatives to deploy large scale virtual 
screening or particle physics experiments are reported. The chapter continues with a 
description of the bioinformatics components of a docking experiment in order to understand 
how to build an efficient WISDOM production system. Finally the design of the WISDOM 
production system is presented. Specific issues, preparatory steps on the AuverGrid 
infrastructure, production system design, license management and accounting data 
management are detailed. 
 
Chapter 5 describes in detail the three objectives of the first data challenge having used 
the WISDOM production system described in the previous chapter. Then an analysis of the 
large scale deployment is proposed, followed by a description of achievements in terms of 
scale. It reports issues related to the deployment and the monitoring of the in silico docking 
experiment as well as experience with grid operation and services. Perspectives about the 
biological results from the deployment, the grid-enabled virtual screening against malaria and 
a new data challenge against neglected diseases are finally presented.  
 
Chapter 6 describes in detail the three objectives of the second data challenge. Then 
deployment strategy improvements for the WISDOM production system and the DIANE 
framework are presented. An analysis of the large scale deployment is proposed, followed by 
a description of achievements in terms of scale, focused on the comparisons of the WISDOM 
and DIANE production systems. It reports the effects of the deployment and the monitoring of 
improvements of the WISDOM production system concerning deployment stability. 
Perspectives stemming from the biological results from the deployment and a grid-enabled 
high throughput virtual screening service are presented. 
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Chapter 1. In silico drug discovery against 
neglected and emerging infectious diseases 
1.1. Introduction 
Neglected and emerging infectious diseases concern mainly the poor population. The 
number of deaths and clinical incidences impact world-wide opinion. Beyond the dramatic 
individual circumstances, these diseases affect significantly the development of the least 
developed countries. 
Drug discovery is a major piece of the global puzzle to reduce the influence of disease 
and consequently the human and economic costs. New drugs are constantly needed to 
anticipate the emergence of drug resistance as well as to cure new diseases. In silico drug 
discovery offers a new alternative to reduce the cost of drug development and to speed-up the 
discovery process. 
Information Technologies also open perspectives for the sharing of information between 
all the actors of the drug development process. A knowledge environment integrating and 
sharing tools, data, computing power and storage space is necessary to better exploit the 
different steps of the in silico pipeline, like protein structure prediction, or the virtual 
screening of large databases of molecules. 
Grid technology can contribute to building such environment sharing resources and 
providing real-time services for urgent needs. A grid is a new Information Technology 
proposing a collaborative environment, based on an infrastructure of interconnected 
resources. 
The aim of this chapter is to introduce the present challenges raised by the neglected and 
emerging infectious diseases, and to discuss how Information Technologies can help to 
develop new strategies again them. We will then focus on one of these strategies, in silico 
drug discovery and on one new Information Technology, the grid. 
The chapter is organized as follows: 
• After the introduction, the second section introduces the issues related to neglected 
and emerging infectious diseases. We will specifically focus on malaria and on the 
influenza A virus subtype H5N1. 
• The third section highlights how Information Technologies could significantly 
improve the fight against these diseases. 
• The fourth section focuses on a specific piece of the puzzle, drug discovery and 
introduces the concept of in silico drug discovery to highlight its relevance for 
neglected and emerging infectious diseases. 
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• The last section describes how grids can greatly improve the in silico drug discovery 
process. 
1.2. Issues related to neglected diseases and emerging 
infectious diseases 
1.2.1.  Overview of neglected disease  
In order to fight neglected diseases, the issues surrounding them must first be understood. 
In the following section, there will therefore be an overview of the issues concerning 
neglected diseases and a focus on progress with malaria. 
Introduction 
Neglected diseases are here defined as: diseases without existing treatment; diseases with 
old, ineffective or difficult to administer treatment; or diseases with effective treatment but 
which is not locally available for the population. They are often referred to as tropical 
diseases, endemic diseases or orphan diseases [1,2,3]. 
They affect the poor population of developed and least developed countries. Infants and 
children are particularly concerned. They are one of the main mortality and morbidity causes 
in the world. For instance, HIV/AIDS, malaria and tuberculosis account for 5.6 million 
deaths; leishmaniasis is endemic in about one hundred countries; the clinical incidence 
number by year for the Chagas disease is 17 million [4].  
The economic impact of repeated episodes of illness and long-term disability is a major 
cause of underdevelopment in many countries today. The economic burden of malaria alone 
has cost Africa billions of dollars this decade. In addition to the cost of lost working days, the 
cost of treatment for repeated bouts of malaria can also be a huge burden for the poorest 
families [4,5].  
Solutions are needed to fight these diseases that deeply impact both the countries and 
their population. 
The search for vaccines and drugs 
It is estimated that only 10% of the world’s medical research is devoted to conditions that 
account for 90% of the global disease burden. There is thus an urgent need to develop better 
drugs and vaccines for diseases that are largely confined to least developed countries. 
 Today, no vaccines are available for malaria and AIDS and there are no prospects for 
vaccines becoming available soon. Drugs are the main support for disease control. But the 
vast majority of drugs available to date have at least one of the following drawbacks: 
insufficient efficacy or increasing loss of effectiveness, high level of toxicity, inaccessibility, 
and/or high costs [6]. Only 1% of the new drugs in the last century concern tropical diseases. 
This rate illustrates the lack of interest from pharmaceutical industries [7,8] and the lack of 
public-private partnership, with the exception of a few recent initiatives [9] presented in the 
paragraph below. Several factors depress the market for innovative new drugs for these 
diseases, including poor regulatory infrastructure in many countries, competing counterfeit 
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drugs [8,10,11] and the risk relating to intellectual property rights, innovation and access to 
essential medicines  [1,11,12]. 
New drugs are needed however for neglected diseases like malaria where parasites keep 
developing resistance to the existing drugs or sleeping sickness for which no new drug has 
been produced for years. New drugs against tuberculosis are also needed as the treatment now 
takes several months and is therefore hard to manage in least developed countries.  
Status 
A recent increase in funding opportunities through national governments and 
philanthropic institutions has allowed million dollar budget projects within the framework of 
public-private partnerships [13,14]. Medicines for Malaria Venture [15], Global Alliance for 
Tuberculosis Drug development, Drugs for Neglected Diseases Initiatives and Institute for 
One World Health regularly succeed in identifying drug candidates, called leads, followed by 
clinical development. Leading international pharmaceutical groups such as Pfizer, Sanofi-
Aventis and Novartis are involved in the activities of the United Nations and the WHO to 
combat the diseases of the poor. There are also important individual industry initiatives 
promoting Research and Development (R&D) for neglected diseases, such as a malaria 
initiative from Sanofi-Aventis, the Diseases of the Developing World Initiative from 
GlaxoSmithKline and the Novartis Institute for Tropical Diseases in Singapore by Novartis.  
Fighting neglected diseases means not only new drug or vaccine development but also 
providing help to medical infrastructures in least developed countries. Information, education 
and communication are the key fields to promote. For instance, the access to HIV/AIDS 
treatment has considerably improved in Sub-Saharan Africa: 10% of the people infected with 
HIV/AIDS are treated with antiretrovirals today [16]; but the treatments are complex and life-
long, and the drugs used for tri-therapy must be kept in a cool environment. Patient 
prevention activities and drug supply, storage and distribution infrastructures are being 
progressively deployed by national governments, international agencies or non-governmental 
organizations. 
1.2.2.  Focus on malaria 
After this brief introduction to neglected diseases, this section will focus on malaria to 
describe in more detail the different issues. 
Disease status  
The number of cases and deaths due to malaria is increasing in many parts of the world. 
There are about 300 to 500 million new infections, 1 to 3 million new deaths [17] and a 1 to 
4% loss of gross domestic product (at least 12 billion dollars) annually in Africa caused by 
malaria [18]. The main causes for the resurgence of malaria are the following: 
• the 2 most widely used drugs against malaria, chloroquine and sulphadoxine-
pyrimethamine, have been rendered useless by drug resistance in a large part of the 
world [19-21]; 
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• anopheles mosquitoes, the disease vector, have become resistant to some of the 
insecticides used to control the mosquito population. 
Figure 1 presents the world-wide distribution of malaria resistance [22,23].  
 
 
Figure 1: World-wide distribution of malaria resistance [22,23] 
 
Current efforts focus on chemoprophylaxis using artemisinin, an antiplasmodial molecule 
from Artemisia annua, which can be produced efficiently and cheaply. However the scientific 
community is worried about the massive use of artemisinin. Its efficiency might be ruined by 
the emergence of the parasitic resistance it could trigger [24,25]. 
Given the small number of available drugs and the resistance they induce, discovery of 
new targets, the molecules on which drugs usually act, and of new drugs remains a key 
priority.  
The search for vaccines and drugs 
Understanding the disease is essential in the drug and vaccine discovery process. Malaria 
is caused by a protozoan parasite, plasmodium. There are several species of plasmodium 
infecting cattle, birds and humans. Species infecting humans are Plasmodium falciparum, 
which causes the worst clinical condition, Plasmodium vivax, Plasmodium malariae and 
Plasmodium ovale. Malaria has a complex lifecycle, presented in figure 2, involving multiple 
stages in mosquitoes and humans [26]. 
• During a blood meal, a malaria-infected female anopheles mosquito inoculates 
sporozoites into the human host (1). 
• Sporozoites infect liver cells (2) and mature. 
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• Liver cells release merozoites (3). After this initial replication in the liver, the 
parasites undergo asexual multiplication in the blood.  
• Merozoites infect red blood cells (4) and mature. 
• Blood cells release merozoites (5). 
• Some parasites differentiate into gametocytes, the sexual stages (6). Blood stage 
parasites are responsible for the clinical manifestations of the disease. 
• The gametocytes, ingested by an anopheles mosquito during a blood meal (7), fuse to 
form zygotes, which give rise to sporozoites. 
• Sporozoites make their way to the mosquito’s salivary glands (8). 
• Inoculation of the sporozoites (1) into a new human host perpetuates the malaria life 
cycle.  
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Figure 2: Diagram of the life cycle of malaria [26] 
 
Several target proteins play a pivotal role in the life cycle of Plasmodium falciparum. 
These targets are well studied and have been validated for their significance for parasite 
survival as well as their “drugability” [26bis]. However, there is considerable concern in 
malaria so far as the available drugs focus on a limited number of biological targets. 
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Therefore, there is unanimity that substantial scientific effort should be devoted to the 
development of additional novel targets, in the hope that subsequently developed drugs would 
not demonstrate cross-resistance with presently known antimalarials. These potential 
antimalarial drug targets can be broadly classified into three categories, and each category has 
many individual targets. The three categories are i) targets involved in hemoglobin 
degradation (proteases like plasmepsins, falcipains), ii) targets involved in metabolism and iii) 
targets engaged in membrane transport and signaling [26ter].  
For instance, plasmepsin, the aspartic protease of Plasmodium, is responsible for the 
initial cleavage of human haemoglobin inside the food vacuole of the parasite inside the 
erythrocytes (see figure 2) [463]. The significance of plasmepsins in the Plasmodium life 
cycle and the presence of X-ray crystal structure data make plasmepsins ideal targets for anti-
malaria therapy and new approaches in rational drug design, respectively. But though several 
peptidic and non-peptidic inhibitors have been described as inhibitors for plasmepsins, none 
of them were effective in killing the parasite in cell culture. This is due to the fact that large 
size compounds cannot easily penetrate the food vacuole where hemoglobin degradation 
occurs. 
To increase the chances of developing new and better drugs and vaccines, it is very 
important to know the sequence of the genomes of the parasites that cause malaria. The 
knowledge of the gene and protein expression at different stages in the life cycle and under 
pressure from different drugs is also essential. The availability of genomic information for 
humans [27,28], Anopheles gambiae [29], the major vector in Africa, and Plasmodium 
falciparum parasite [30] now enables the development of new approaches to interfere with the 
mechanism of the development of infectious sporozoites in anopheles mosquitoes and to 
reduce contact between infectious mosquitoes and humans. All Plasmodium molecular data 
have been collected and organized in the PlasmoDB public database as early as sequencing 
outputs have been made available [31-34]. Much effort is also being devoted to biochemical 
and molecular studies of resistance mechanisms and to the mapping of resistance genes. For 
both vector control and chemotherapy, knowing the gene sequences of anopheles and 
plasmodium species should lead to the discovery of targets against which new insecticides or 
anti-malarial drugs can be produced [35]. 
At the same time, at least 35 malaria vaccine candidates have undergone phase 1 clinical 
trials in humans [36], and 13 have moved into more advanced clinical development. 
Preclinical development of more than a dozen other candidates is being supported [37]. 
Issues 
The drugs and vaccines under development are likely to be patented and only developed 
at prices unaffordable to governments or villagers in tropical countries. Genomics research is 
crucial to fight malaria, but this research must be strongly linked to ground studies in order to 
control the disease, especially in countries with annual health budgets of less than $10 per 
person [38]. 
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Evaluation of the impact of new drugs and new vaccines requires careful monitoring of 
clinical tests, especially in areas of high malaria transmission where it is important to 
distinguish recurrence of parasites, due to recrudescence of incompletely cured infections, 
from re-infection due to new mosquito bites. 
Disease Controllers are also faced with the necessity of monitoring goal-oriented field 
work on a long term basis. Monitoring tools to control malaria in plagued areas include 
reducing contacts between infected mosquitoes and humans by filling in breeding sites, 
larviciding, spraying houses with insecticides, insecticide-impregnated bed nets, and house 
screening. Effective application of these measures would lead to a reduction in malaria 
morbidity and mortality [22]. However, given the extremely high transmission rate of 
Plasmodium falciparum, especially where Anopheles gambiae mosquitoes predominate, the 
impact of these tools is limited by the capacity of mosquitoes to develop resistance and by the 
necessity to maintain the interventions for many years.  
1.2.3.  Overview of emerging infectious diseases 
In order to fight emerging infectious diseases, the issues surrounding them must first be 
understood. In the following section, there will thus be an overview of the issues concerning 
emerging infectious diseases and a focus on progress with influenza A virus subtype H5N1. 
Introduction 
Emerging infectious diseases are here defined as infections that have newly appeared in a 
population or have existed previously but are rapidly increasing in incidence or in 
geographical or human host range [39,40]. Diseases like HIV/AIDS, SARS, Nipah virus 
encephalitis and variant Creutzfeldt-Jakob are newly emerging diseases. Diseases like West 
Nile virus in the Western hemisphere and Dengue in South America are reemerging, or 
resurging, diseases. Agents of bioterror, like Anthrax, are deliberately emerging diseases. 
Figure 3 gives examples of emerging and reemerging infectious diseases throughout the world 
[39]. 
Several factors, which frequently differ for the different diseases, are involved in the 
emergence of infectious diseases such as: 
• economic development and land use, 
• human demographics and behavior, 
• international travel and commerce, 
• poverty and social inequality, 
• microbial adaptation and change,  
• or human susceptibility to infection. 
These factors ease disease dissemination, enhance infectivity and amplify pathogenicity 
[41]. About 75% of emerging pathogens are zoonotic [42], which means communicated by 
animals to humans. Avian influenza emergence is the result of interaction with animals. 
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Consequently there is a need for a global strategy against emerging infectious diseases 
that can affect many countries in the world in only a few months. The search for vaccines and 
drugs is difficult here, because it is a very long process. 
 
Newly emerging Deliberately emergingRe-emerging
 
Figure 3: Examples of emerging and reemerging infectious diseases throughout the world [39] 
 
The search for vaccines and drugs 
Although vaccination is the primary strategy for the prevention of infectious diseases, 
there are a number of likely scenarios for which vaccination is inadequate and effective drugs 
would be of the utmost importance. In the case of emerging infectious diseases, time is a 
critical factor in the sense that there is a risk of a world-wide pandemic. However, drugs take 
years of development and vaccines specific to newly arising strains require several months of 
preparation. 
Issues 
Several recent health events underscore the need for a public health system ready to 
address whatever disease problems which might arise. For example, the emergence of SARS 
in Asia in 2002, and the speed with which it was characterized and contained, underscores the 
importance of cooperation between researchers and public health officials [43]. In view of the 
pandemic threat, many strategies are studied and applied around the world: surveillance and 
disease control in animals, surveillance and disease control in humans, development of rapid 
diagnostic kits, drugs stockpiling [4], public relations and education, disaster management 
response, etc. Moreover, in the context of a pandemic, government and health care leaders 
need to be prepared to make difficult decisions based on ethical values [44]. 
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1.2.4.  Focus on influenza A virus subtype H5N1 
After this brief presentation of emerging infectious diseases, this section will focus on 
avian influenza to highlight the most relevant issues. 
Motivation 
Influenza A viruses have 16 H subtypes and 9 N subtypes. Only viruses of the H5 and H7 
subtypes are known to cause the highly pathogenic form of the disease. Influenza A virus 
subtype H5N1, also known as H5N1, is capable of causing illness in many animal species, 
including humans [45]. A bird-adapted strain of H5N1 is the causative agent of H119H 5N1 flu H, 
commonly known as avian influenza, and is H120Hendemic H in many bird populations. H5N1 flu 
killed tens of millions of birds and spurred the culling of hundreds of millions of other birds 
in an attempt to control its spread [46]. 
H5N1 causes severe disease in humans and poses an unprecedented pandemic threat [47]. 
Figure 4 presents the occurrence of influenza A viruses infecting humans from 1918 to 2005 
[40]. The length of the arrows indicates the duration of the virus presence. The influenza A 
virus transmission to humans has been observed since 1997, but there have been experiences 
of the subtype N1 at least since 1918, when it killed about 50 million people during the so-
called “Spanish flu” pandemic [48]. A risk exists for human-to-human transmission of the 
H5N1 virus [46,49]. Over the past few years, many more influenza strains have emerged with 
the capability of infecting humans. 
 
 
Figure 4: Influenza virus time line. Occurrence of influenza viruses infecting humans, from 
1918 to 2005 [40] 
 
There is a continuous research effort around the world to search for vaccines and drugs 
against all the known flu viruses. 
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The search for vaccines and drugs 
HA is the abbreviation for hemagglutinin, an antigenic glycoprotein found on the surface 
of the influenza viruses. It is responsible for binding the virus to the cell that is being infected. 
NA is the abbreviation for neuraminidase, an antigenic glycosylated enzyme found on the 
surface of the influenza viruses. It facilitates the release of viruses from infected cells [50]. 
The hemagglutinin (HA) and neuraminidase (NA) are most medically relevant as targets for 
antiviral drugs and antibodies. HA and NA are also used as the basis for the naming of the 
different subtypes of influenza A viruses. So H5N1 comes from the H and the N. 
No vaccine against the H5N1 influenza is yet available for humans or animals [51]. Even 
if a vaccine was available, vaccine supplies would be inadequate during a pandemic, 
particularly for the population of least developed countries [52,53]. For instance, the global 
demand for vaccines in the event of an H5N1 pandemic will be at least of 4 billion doses. But 
the vaccine production capacity of the world pharmaceutical companies would allow the 
production of no more than 100 million doses in 6 months. 
Figure 5 [54] presents the life cycle of the influenza virus: 
• First the individual virus enters the cell lining of the respiratory tract (1). 
• The cell is induced to take up the virus because hemagglutinin on the virus binds to 
the sialic acid (2 and 3). The main role of the M2 ion channel is to acidify the 
membrane-bound virus particle while it is contained within the acidic endosome [55]. 
• The virus then dispatches its genetic material (made up of RNA) and its internal 
proteins to the nucleus of the cell (4 and 5). 
• Messenger RNA is produced when some of the internal proteins duplicate the RNA 
(6). 
• This messenger RNA is used by the cell as a template for making viral proteins (7 and 
8) and genes which become new viral particles and leave the cell covered with sialic 
acid. This sialic acid needs to be removed so that the hemagglutinin molecules on one 
particle don't attach to the sialic acid on others, thus causing the new viruses to clump 
together and stick to the cell. 
• The sialic acid is removed from the surface of the new viral particle by neuraminidase 
(9) and the new viral particles are able to travel and invade other cells (10).  
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Figure 5: Schema of the life cycle of the influenza virus [54].   
 
Two classes of antiviral agents are used to treat influenza: the M2 ion channel inhibitors 
and the NA inhibitors. The M2 inhibitors amantadine and rimantadine inhibit influenza A 
viruses but drug-resistant mutants are largely present in treated patients [56,57]. The action of 
NA is essential for virus proliferation and infectivity; therefore, blocking its activity generates 
antivirus effects. Two of the present drugs, oseltamivir (Tamiflu®) and zanamivir (Relenza®) 
[58] were discovered through structure-based drug design targeting NA. 
Whereas zanamivir seems preferable in terms of development of resistance, the route of 
delivery could be problematic for some populations as it has to be administrated through oral 
inhalation instead of capsules like oseltamivir. Oseltamivir constitutes an important treatment 
option and stockpiling of this drug is part of pandemic-preparedness plans [59]. 
However, data on the development of drug resistance in human influenza A virus is 
scarce. Scientists showed that the N1 and N2 subtypes could evolve into variants under drug 
stress [60]. Furthermore, the report of development of drug resistance variants [61] is another 
potential concern. The adaptive mutation or re-assortment of the virulent avian influenza virus 
and the human influenza virus may lead to a more efficient form of transmission of the virus 
which could lead to human-to-human transmission and thus trigger an influenza pandemic. 
The full support of the international scientific community is urgently needed to 
understand better the spread and evolution of the virus, and the factors determining its 
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transmissibility and pathogenicity in humans [62]. This in turn demands that scientists with 
different fields of expertise have full access to comprehensive genetic-sequence, clinical and 
epidemiological data from both animal and human virus samples. Several countries and 
international agencies have recently taken steps to improve sharing of influenza data [63-66], 
following the initiative of leading veterinary virologists in the field of avian influenza.   
The search for vaccines and drugs is long and difficult so that other strategies need to be 
explored to avoid or prevent a pandemic. 
Issues 
Influenza experts and health officials throughout the world are extremely concerned 
about the global spread of avian H5N1 influenza and the possibility that it could lead to the 
next pandemic [46,67]. Initiatives have been started to establish national, regional [68] and 
world-wide collaborations. All countries worldwide should be able to prevent, detect early 
and control the virus quickly [69]. To minimize the threat from animal sources, governance, 
legislation, policies and resources try to be in compliance with the World Organisation for 
Animal Health (OIE) international standards. The veterinary services are a key actor in rapid 
disease control. 
1.3. Potential impact of Information Technologies 
In the previous section, we have described briefly the status of neglected and emerging 
infectious diseases in the world. Among the actions needed to better monitor and fight these 
diseases, many of them would benefit from a more systematic use of Information 
Technologies. In this section, we discuss how these technologies could have a significant 
impact on both neglected and emerging infectious diseases. 
1.3.1.  Information Technologies impacting neglected 
diseases 
Fighting neglected diseases suffers from a lack of means. Information Technologies 
opens new perspectives: 
• Genomics research opened new ways to find new drugs to cure malaria, vaccines to 
prevent malaria, insecticides to kill infectious mosquitoes and strategies to prevent 
development of infectious sporozoites in the mosquito [70]. Information Technologies 
impact these studies with tools to search and analyze huge amounts of data produced 
by genome sequencing. In silico biology supplies for instance the first steps of gene 
annotation via target identification or the modeling of pathways and the identification 
of proteins mediating the pathogenic potential of the parasite. 
• Information Technologies contribute to the development and deployment of new drugs 
and vaccines thanks to the collection of epidemiological data for research (modeling, 
molecular biology) and the monitoring of ground studies to control malaria and to 
control the clinical tests in plagued areas. Efficient in silico tools are required to 
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manage data in geographically distributed healthcare centers. These tools need to be 
adapted, according to local conditions such as existing infrastructure. 
• Information Technologies impact disease monitoring by the control of the policy 
impact and programs, but also thanks to monitoring and warning systems to detect and 
prevent abnormal disease evolution. Thus information from health centers, such as 
hospitals or dispensaries, could be collected and analyzed possibly in real time. 
Information about drug delivery and vector control could be monitored at the same 
time.   
• Helping the medical development of least developed countries involves improving the 
ability of southern countries to undertake health innovation. Information technologies 
strengthen the integration of their life science research laboratories in the world 
community by interconnecting southern and northern health centers. Sharing 
knowledge and expertise are possible with teleconsulting, telediagnosis, patient 
follow-up and e-learning, providing access to resources, including computing and 
storage resources [71]. High speed Internet network access in health care centers and 
laboratories is the first requirement to access international resources. 
Thus, Information technologies impact international collaborations through in silico 
support, data collection, monitoring system and resource sharing. This list of contributions 
addressing neglected diseases would greatly benefit from computing and data management in 
an adapted collaborative environment. 
1.3.2.  Information Technologies impacting emerging 
infectious diseases 
Time can be a critical factor in fighting emerging infectious diseases. Information 
Technologies can help with the following actions: 
• Early detection enables surveillance and disease control in domestic and wild animals, 
surveillance and disease control in humans, and rapid and transparent notification. 
Information Technologies contributes to these actions by data collection and data 
analysis tools used in a distributed model. Local, national and international chains of 
command involving health care centers need to be appropriate to identify and respond 
to infectious disease threats. Subjacent infrastructure and Information Technologies 
tools can support rapid information transfer in the different nodes. 
• After a possible urgent intervention, information technologies support expert and 
efficient collaboration in the world and computing resources required by trend 
analysis and prediction made by epidemiology. These studies impact on evaluation, 
capacity building and strengthening, and effective countermeasures. 
• Information Technologies impact anticipation and the preparation needed for essential 
medical supplies and equipment, and for pandemic response. Training and guidelines 
are required for health-care professionals and are easily available on web sites or by 
email. Information Technologies can contribute to the prevention by education 
required for people concerned by pandemic risk. 
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• Emerging infectious diseases have evolved into a crisis situation partly because of 
inadequate knowledge and understanding about the diseases. As soon as a new disease 
emerges, partnerships must be developed based on Information Technologies to 
conduct basic, applied and clinical research, to manufacture vaccines and drugs to 
prevent and treat disease, and to deliver these therapies to the patients who need them. 
In silico drug discovery with effective computing power contributes to speeding up the 
research, to fostering the necessary collaborations and to improving the quality of the 
output.  
In case of a pandemic risk, international collaboration among clinicians, researchers, 
government and industry is highly and quickly required for early detection, epidemiological 
watch, prevention, and a fast search for new drugs and vaccines. This list of contributions 
addressing emerging infectious diseases would greatly benefit from an efficient collaborative 
infrastructure accelerating actions and quickly discovering solutions. 
1.4. Developing in silico drug discovery  
In this section, we are going to focus on one of the most promising contributions of 
Information Technologies to drug development, namely in silico drug discovery.  
1.4.1.  Introduction to drug discovery 
Drug discovery is defined here as process by which drugs are discovered and/or designed. 
Drug candidates are inputs to the drug development process. Drug development manages 
preclinical safety studies and clinical phases, with clinical trials. Registration and delivery are 
the last steps of the full process. Drug discovery and development represent a complex multi-
phase (12-15 years) and multi million-dollar process (at least $800 million) [72-74].  
There are currently more than 200 major pharmaceutical companies. As in some other 
industries, economic pressures are forcing pharmaceutical companies toward greater 
efficiency [75]. Only 1 New Chemical Entity (drug candidate obtained by the drug discovery 
process) in 10,000 becomes a product [76] after preclinical evaluations and clinical trials. 
Biopharmaceutical properties such as oral bioavailability and formulation issues are 
responsible for about 39% of failures, whereas toxicity constitutes about 21%. These factors 
are as important as lack of efficacy, which is responsible for about 29% of failures [77-79]. 
Consequently biopharmaceutical properties and toxicity factors must be taken into account as 
soon as possible in the drug discovery process. 
Reducing the research timeline in the discovery stage and having enhanced information 
about the leads are key priorities for pharmaceutical companies worldwide. Collaborations 
with academic laboratories and small biotechnology or pharmaceutical companies are crucial, 
mainly in exploratory research, then in the chemistry stage and progressively less during the 
drug development phases [9].   
The diversity and complexity of the information required to arrive at well-founded 
decisions based on both scientific and business criteria is remarkable and well-recognized in 
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the industry. Thus the pharmaceutical R&D enterprise presents unique challenges for 
Information Technologists and Computer Scientists [80]. All aspects of managing, sharing 
and understanding this information by multidisciplinary project teams is critical to the R&D 
process and subject to substantial investment and exploration of new Information Technology 
approaches [81].  
This section will describe in silico drug discovery, or computer-aided drug discovery. We 
will particularly focus on two important steps of the process: protein structure prediction and 
virtual screening. 
1.4.2.  In silico drug discovery overview 
Motivation 
The drug discovery goal is to find new molecules that bind with specific macromolecules, 
known to play a key role in the disease evolution, in a manner that changes their function for 
the benefit of life.  
Recent progress in genomics, transcriptomics, proteomics, high throughput screening, 
combinatorial chemistry, molecular biology and pharmacogenomics has radically changed the 
traditional physiology-based approach to drug discovery where the organism is seen as a 
black box. The approach is now to understand how H121HdiseaseH and H122HinfectionH are controlled at the 
molecular and physiological level and to target specific entities based on this knowledge. 
In silico drug discovery is one of the most promising strategies to speed-up the drug 
discovery process. It is important to know and control the in silico process, that is described 
below. 
Process 
Figure 6 shows the different phases of a drug discovery process [82-86] with their 
approximate duration [87], their success rate [77-79] and the corresponding in silico 
contributions. 
  
Target
Identification and validation
- 2/5 years
- 30% success rate
Lead
identification
- 0.5 year
- 65% success rate
Lead
optimization
- 2/4 years
- 55% success rate
Target discovery Lead discovery
Gene expression analysis,
Target function prediction,
Target structure prediction
De novo design,
Virtual screening
Virtual screening,
QSAR
 
Figure 6: Representation of the different phases of the drug discovery process with their 
duration, their success rate and the corresponding in silico contributions. 
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A target is a cellular or genetic molecule which is believed to be associated with a desired 
change in the behavior of diseased cells and on which drugs usually act. The target 
identification and validation aims to isolate and select it. In silico drug discovery contributes 
to the target discovery by gene expression analysis, target function prediction and target three-
dimensional (3D) structure prediction for post-processing.  
To identify a lead compound, a substance affecting the target selected in a drug-like way, 
two different in silico pipelines can be used which speed up the process and reduce costs 
avoiding useless in vitro tests [88]: the de novo design and virtual screening. De novo design 
[89] builds iteratively a compound from the structure of a protein active site. Virtual 
screening selects in silico the best compound from a molecule database. 
Lead optimization addresses the development from the most promising lead compounds 
to a safe and effective drug. Instead of expensive and longer in vitro and in vivo tests, 
evaluation of the basic chemical properties can be achieved by virtual screening and 
Quantitative Structure Activity Relationship (QSAR). QSAR is a quantitative correlation 
process of chemical structure with well-defined methods, such as optimization for 
pharmaceutical properties (Absorption, Distribution, Metabolism, Excretion and Toxicity 
(ADMET)) or efficacy against the target organism [78,90].  
Status 
In silico drug discovery contributes to increasing biological system knowledge [91], to 
managing data in a collaboration space, to speeding up analysis and consequently increasing 
the low success rate of the traditional “wet” approach. The efficiency gains of such an 
integrated knowledge system could correspond to a saving of 35% costs, or about US$300 
million, and 15% time, or two years of development time per drug [92]. 
Nevertheless, in spite of increasing levels of investment in in silico techniques, there is a 
steady decline in the number of new molecules that enter clinical development and reach the 
market [93-95]. Many factors have changed over the past 10 years [96-99], particularly the 
domination of the target-based drug discovery paradigm [100-101], favoring screening and 
rational drug discovery programs. A new approach aims to integrate rational drug discovery 
with a strong physiology and disease focus [102]. 
Protein structure prediction and high throughput structure-based virtual screening are two 
important sets of methods for the in silico process. Improving the quality and the quantity of 
analyzed data during these steps will benefit the next steps in drug development. These 
methods are described below in order to understand their requirements. 
1.4.3.  Focus on the protein structure prediction 
The target in the drug discovery process is frequently a protein. Understanding the 
function and the physiological role of this target is fundamental for the discovery of novel 
drugs and protein-based products with medical, industrial or commodity applications [103]. 
Protein structure modeling is thus crucial for the next lead discovery step: virtual screening. 
Protein structure prediction is introduced below. 
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Motivation 
Time-consuming and relatively expensive X-ray crystallography and nuclear magnetic 
resonance (NMR) spectroscopy [104] determine experimentally physical molecular structure, 
but these methods are not widely applicable and sometimes inaccurate [105]. Only 1 in 20 
proteins form useful crystals for structure studies [106]. Furthermore, massive amounts of 
protein sequence data may be derived from large-scale DNA sequencing efforts such as the 
Human Genome Project [27,28]. Currently, the sequences of over a million proteins have 
been discovered using molecular biology, but only approximately 30,000 experimentally 
studied structures are known [107]. Protein structure prediction attempts to bridge this 
growing gap [108]. 
Protein structure prediction aims to determine the 3D structure of a protein from its 
amino acid sequence. In relation with experimentally determined structures [109,110], this 
complex process allows the identification of the structure-function relationships of protein 
families, the function of an individual protein, or provides disease target structures for drug 
design [111]. 
The pipeline is detailed in the next section. 
Process 
A wide range of approaches are routinely applied for such predictions: ab initio 
prediction, fold recognition, and homology modeling [112-115]. These methods are primarily 
based on sequence alignment and also possibly on secondary structure prediction methods. 
Ab initio [116], or de novo, protein modeling methods seek to build 3D protein models 
"from scratch", i.e. based entirely on physics and chemistry laws rather than on previously 
solved structures [117]. Solved structures are generally stored in the Protein Data Bank [118] 
(PDB). Local sequence, structural relationships and secondary structure prediction are 
incorporated into the prediction process [119]. 
Fold recognition [120], or protein threading, aims to find the best set of structures, or 
templates, in the PDB which are similar to a given target sequence. The most accurate models 
are obtained when a single template can be found in the PDB that has a high sequence 
similarity to the target protein. 
Homology or comparative modeling [112] refers to the process of building a model from 
one such unique template. Because a protein's fold is better conserved in the evolution than its 
amino acid sequence [121], a target sequence can be modeled with reasonable accuracy from 
a very distantly related template.  
Dynamic analyze of protein structure appears as a new computational method. It is 
increasingly common to model structure variation with time, otherwise known as 4D structure 
modeling. Structure-driven screenings have resulted in successful hit rates of about 10%, in 
stark contrast with hit rates of about 0.01% with conventional high throughput screening 
techniques [121]. 
Figure 7 [122] presents the modeling pipeline from a protein sequence to the 3D protein 
model (in yellow). Each stage (in pink) described above involves many different databases 
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(Uniprot, PDB, Prosite etc.) and tools (Blast, Clustalw, PHD, Modeler, Scope, Rosetta etc.). 
Bioinformatics techniques are used to analyze sequence, structure and physical-chemical 
studies of the conformational energies and dynamics of proteins [113,114]. The stage outputs, 
manually checked, determine the next steps (in green). 
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Figure 7: Protein structure prediction pipeline 
 
This pipeline shows the difficulties in obtaining a good protein structure prediction. A 
progress report about research difficulties and advances follows. 
Status 
Several factors make protein structure prediction a difficult task, including: 
• the protein size, 
• the large number of possible structures for one protein, 
• the multiple possible protein conformations depending on its environment, 
• the fact that the biologically active conformation may not be the most 
thermodynamically favorable. 
Generally low accuracy comparative models are based on less than 30% sequence 
identity [110,124,125]. Complex structures are difficult to obtain because of several technical 
problems that will probably take years to overcome [126]. But the great structural successes 
now almost invariably involve large macromolecular complexes [127-130]. The wealth of 
structural data from structure-genomics initiatives [131-134] gives greater applicability to 
homology modeling [135,136]. In some cases, structural bioinformatics using computational 
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technology in combination with experimental technologies allows the modeling of a protein’s 
structure and the production of drug targets in as little as 60 days [137].  
There is a wide range of applications for protein structure models for drug discovery 
[138]. Protein structure is used for target identification and selection, for the identification of 
hits by virtual screening, for the screening of fragments and for lead optimization [139]. 
Several examples are listed here: 
• Accuracy comparative models are frequently helpful in refining functional predictions 
that have been based on a sequence match alone because compound binding is more 
directly determined by the structure of the binding site than by its sequence. 
• The size of a compound may be predicted from the volume of the binding site cleft, 
and the location of a binding site for a charged compound can be predicted from a 
cluster of charged residues on the protein. Fortunately, errors in the functionally 
important regions in comparative models are often relatively small because functional 
regions such as active sites tend to be better conserved in the evolution than the rest of 
the fold. 
• Accuracy comparative models may be useful for assigning the fold of a protein. Fold 
assignment can be very helpful in drug discovery, because it can cut short the search 
for leads by pointing to compounds that have been previously developed for other 
members of the same family [140,141]. 
Many tools are commercialized or available online [142]. Automation makes comparative 
modeling accessible to both experts and non-specialists alike, but technical aspects, such as 
the delay in waiting for the server response limits the number of components that can be 
included and increases the number of software developed in-house [113]. Many of the servers 
are tested at the bi-annual CAFASP meetings and continually by the LiveBench and EVA 
[143-147] web servers for assessment of automated structure prediction methods. However, in 
spite of automation, manual intervention is generally still needed to maximize the accuracy of 
the models. The modeling methods tend to require vast computational resources, and thus 
have only been carried out for tiny proteins. There are distributed computing projects that 
attempt to solve the protein prediction problems [148-150].  
1.4.4.  Focus on high throughput structure-based virtual 
screening 
Once a molecular target has been identified, high throughput screening can be applied to 
experimentally identify interesting compounds, called ligands. A complementary method is to 
apply ligand-based or structure-based virtual screening to screen in silico a database of 
molecules. The next section will focus on the high throughput virtual structure-based 
screening that is an important step in the discovery of leads for drug development. 
Motivation 
In the first step of high throughput screening, several bioassays are set up and several 
hundreds to thousands of compounds are tested. Then the active compounds are identified and 
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their potency is estimated. In the final step their chemical structure and mechanism of actions 
are determined. Screening has become a highly sophisticated, automated modern technique 
[151-153] that screens hundreds to thousands of compounds against a target in a few weeks 
and subsequently analyzes the data to identify novel leads. Active compounds are 
characterized by ICB50 B values lower than 10 μM [139] where IC50 is the in vitro concentration 
of an inhibitor that is required for 50% inhibition of a target. Lead optimization is needed to 
lower this value below 10 nM. 
There are now millions of chemicals that can be synthesized. But it is very expensive to 
screen such a high number of compounds in the experimental laboratories using high 
throughput screening techniques. Besides the heavy costs and the in vitro limitations (for 
instance, the low solubility of certain molecules), the hit rate in high throughput screening is 
quite low, in the range of 1 per 100,000 compounds when screening is done with targets such 
as enzymes [154,155]. In addition, screening does not tell why and how the detected hits act 
upon the target [156]. Rather than performing a large, costly, high throughput screen, a more 
focused screening campaign is often more appropriate for the most tractable targets for which 
there is information about compounds and protein structure [139]. Compounds for such a 
campaign can be processed through a virtual screening pipeline. 
Virtual screening is about selecting and ranking in silico the best candidate drugs, i.e. the 
molecules which could impact the target biochemical activity. It is used for instance as a filter 
for removing the toxic compounds which are likely to fail in the final stages of the drug 
discovery process. High throughput virtual screening tests large chemicals libraries for their 
ability to interact with the target. Millions of chemical compounds available in the 
laboratories or companies are also recorded in 2D or 3D electronic databases. If high 
throughput screening was carried out in silico in a reliable way, one could reduce the number 
of molecules requiring in vitro and then in vivo testing from a few million to a few hundred.  
The tools available for performing the computational analyses can be categorized as 
ligand-based or structure-based. The ligand-based, or similarity-based, strategy is to use 
information provided by a molecule or a set of molecules that are known to bind to the 
desired target and to use this to identify other compounds in a database with similar properties 
[157-161]. When the target structure is known, structure-based, or receptor-based, methods 
are preferred [162,163]. This second method is detailed below. 
Process 
Once a target structure is available, the identification of chemical starting points for lead 
optimization can be achieved through virtual docking, [164-168]. These approaches require a 
detailed scoring of the interactions [169] between the target and the ligands. Then the use of 
molecular dynamics and molecular mechanics computations improves the quality of in silico 
scoring [170]. All these methods are explained below. 
Figure 8 describes a typical workflow of a structure-based virtual screening run against a 
specific target and a compound database (in yellow) [171,172]. It consists of many steps (in 
pink), possibly in repeated automated cycles, or with visual check points (in green). 
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The first step consists in filtering and preparing a compound database for the docking 
step. Libraries of compound 3D structures are made openly available by academic 
laboratories or by chemistry companies which can produce them. In the random approach 
[173], compounds for docking are selected from a compound database with a large variety 
and according to their drug likeness [77,174] or pharmacokinetic properties [175,176]. In the 
focused, or directed, approach, the selection of compounds is made using a set of criteria, e.g. 
by pharmacophore or docking models [165,166,177-179]. 
At the same time as the first step, the active site of the protein needs also to be prepared 
for the docking tool (adding charges, hydrogens, water molecules…) [171]. All available 
target structures can be used to generate only one composite structure, or the screening 
process can be conducted on each individual structure requiring more computing time. 
The next step is molecular docking. Protein-ligand docking is about computing the 
binding energy of a protein target to a library of potential drugs using a scoring algorithm. 
The target is typically a protein which plays a pivotal role in a pathological process, e.g. the 
biological cycles of a given pathogen (parasite, virus, bacteria…). The goal is to identify 
which molecules could dock on the protein active sites in order to inhibit its action and 
therefore interfere with the molecular processes. Many docking software codes [180-187] are 
available under a variety of licensing policies. They differ in the sampling algorithms used, 
the handling of compound and protein flexibility (Many docking algorithms make the 
simplifying, but potentially quite inaccurate, assumption that the protein receptor is a rigid 
object and attempt to dock the ligand to it), the scoring functions they employ, and the CPU 
time required to dock a molecule against a given target [171]. Performance of the docking 
code depends on its speed and its ability to accurately predict the binding mode, i.e. the 
orientation and conformation of the compound inside the active site. 
The different available docking tools use different scoring methods [188]. Scoring is the 
prediction of binding affinity, which is used in ranking the solutions. There is a wide choice 
of scoring functions available [189], and they can be categorized as being physical-based 
(force-field), empirical or knowledge-based. Even if some progress has recently been made 
[190], further analyses are required to refine the docking score, to estimate the participation of 
water molecules, to minimize the number of false negative or positive hits or to propagate the 
true hits to the top of the list [172,191,192].  
Post-analysis, the last step, is then required before final visual inspection. Consensus 
scoring [193-195], incorporation of solvation energies, better description of electrostatic 
interactions [196-197] and geometrical analysis of the compound-protein surface area can be 
used. Molecular dynamics [163,198,199] enables a flexible treatment of the target-ligand 
complexes at room temperature for a given simulation time and therefore is able to refine 
ligand orientations by finding more stable complexes. Molecular dynamics partially solves 
potential deficiencies in conformation and orientation search which might arise from docking. 
It also allows the re-ranking of molecules based on more accurate scoring functions [200]. 
This post-analysis method is time and memory-demanding but more accurate than docking 
methods. 
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Figure 8: Structure-based virtual screening workflow 
 
As explained before, the virtual screening pipeline requires significant computing 
resources. As a consequence, a progressive integration of the computational methods in 
traditional drug discovery is being observed.    
Status 
Current efforts within the pharmaceutical industry are directed at reducing the time and 
costs for drug development. High throughput virtual screening seems to be a well accepted, 
rapid, efficient and cost effective technology used by several pharmaceutical companies and 
academic institutes for screening chemical compounds in the drug discovery process 
[174,201]. But within many groups, virtual screening remains marginal [202]. The reason for 
this is that they have invested in facilities for high throughput screening. Sophisticated 
logistics and dedicated manpower allow 1 million compounds to be screened in less than two 
months. Consequently, the use of in silico screening to reduce the number of compounds 
docked in vitro is still limited [203]. The limited adoption of virtual screening comes also 
from the wrong structures of some protein models, the inaccuracy of scoring functions, the 
lack of flexibility of the target protein in docking methods [92,139,167], the lack of an 
Chapter 1. In silico drug discovery against neglected and emerging infectious diseases 
 
 
  37 
automated virtual screening pipeline and the high computation time required to screen 
millions of compounds [161,171,204]. 
Despite these difficulties, applying in silico techniques before, after and in parallel with 
high throughput screening improves the overall process quality in terms of information 
content and success rate [203]. Successful examples of novel hits identification and 
significant enrichment have been described in the literature [205-215]. For instance, Doman 
[205] compared the traditional and virtual screening performances for the protein tyrosin 
phosphatase 1B. The virtual screening hit rate reached 34.8% while the hit rate of high 
throughput screening was only 0.021%. Selected molecules had better ICB50 B and drug-like 
quality. 
 Virtual screening can definitively improve the quality of the drug discovery output 
[Davies] as it is much more a technique to reduce costs induced by experimental screening. 
Current drug discovery is driven by data [216]. Successful lead discovery needs high quality 
target and compound data [72]. These data need to be reusable, shareable, suitable and finally 
used to generate reliable predictions [217]. Data integration in the in silico but also traditional 
drug discovery process is thus a challenge [218].  
1.4.5.  Challenges in the development of in silico drug 
discovery 
The previous sections explained that reducing the research time and cost in the discovery 
stage and enhancing information about the leads are key priorities for pharmaceutical 
companies worldwide. To achieve this goal, in silico drug discovery must be able to square up 
to the challenges described below: 
• The in silico drug discovery process includes the management of a large variety and 
quantity of scientific data. For example: images, sequences, models, databases. Data 
integration is thus a challenge to increase knowledge discovery but also to ease the 
complex workflow. This implies data format standardization, dataflow definition in a 
distributed system, infrastructure and software providers for data storage, services for 
data and meta-data registration, data manipulation and database updates.  
• The in silico drug discovery process also includes the management of a large variety 
and quantity of software. Software integration is another challenge to build efficient 
and complex workflows and to ease data management and data mining. Software can 
be provided in a distributed environment such as a web server on the Internet. 
Different experts are absolutely necessary to maintain and update software and 
workflows to propose new methods or pipelines, to use remote services, exploit 
outputs, and finally to propose compounds for assay. A software workflow will assist 
the scientist and the decision-maker in organizing their work in a flexible manner, and 
in delivering the information and knowledge to the organization. 
• Deploying intensive computing is a challenge for in silico drug discovery. For 
instance, computing 1 million docking probabilities or modeling 1,000 compounds on 
one target protein requires in the order of a few TFlops during one day. Very large 
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computing resources are also needed to describe accurately protein structure models 
by computational methods based on all-atom physics-based force fields including 
implicit solvation. Computing power is also required for bioinformatics resource 
centers where server access is saturated by the large number of short tasks requested 
by users. 
• Joining the new Information Technologies with life science to enable in silico drug 
discovery requires strong remote collaboration between different public and private 
experts when addressing neglected and emerging infectious diseases. It also involves 
strong sharing of resources: data and knowledge, software and workflow, and 
infrastructures such as computing, storage and networks. The collaboration space 
needs experts to maintain the resources. Having tools and data accessible to everyone 
in collaboration requires intuitive interfaces that need to be maintained. These 
interfaces reduce the development time of new methods. They also help the 
integration of data and software from in silico drug discovery but also from 
experimental processes.  
• Security is a key challenge for pharmaceutical industries but also for academic 
institutes in most cases. Effective protection of intellectual properties and sensitive 
information requires, for instance, authentication of users from different institutions, 
mechanisms for management of user accounts and privileges and support for resource 
owners to implement and enforce access control policies. 
Challenges to develop in silico drug discovery are data and software integration, intensive 
computing deployment, remote collaboration and resources sharing, and of course security. 
Thus, there is a need for a powerful and secured environment sharing and integrating remote 
resources such as tools, data, computing and storage. 
1.5. Grid added value for in silico drug discovery 
Developing in silico drug discovery for neglected and emerging infectious diseases 
requires a robust infrastructure and relevant services to support distributed resource sharing. 
Resources are here defined as: computing, storage and network; as well as data, knowledge, 
software and workflow; but also instruments and sensors; and finally people and organization.  
The grid is a new Information Technology that can provide these resources. A grid is the 
combination of networked resources and the corresponding management software, which 
provides services for the user. Grid technology provides the collaborative Information 
Technology environment to enable the combination between life science research, field work, 
health systems, pharmaceutical industries and infrastructure. It proposes a new paradigm for 
the collection and analysis of distributed information where data are no longer centralized in 
one single repository. On a grid, data can be stored anywhere and still be transparently 
accessed by any authorized user. The computing resources of a grid are also shared and can be 
mobilized on demand. The grid will be further defined in chapter 2. 
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The grid added value in the development of in silico drug discovery for neglected and 
emerging infectious diseases has multiple dimensions: 
• grids offer unprecedented opportunities for resource sharing and collaboration; 
• grids open exciting perspectives for handling information flows; 
• grids provide the resources to speed up the execution of time-consuming software. 
Grids offer unprecedented opportunities for resource sharing and collaboration. 
Grid allows 
• the sharing of resources in a cross-organizational collaboration space between the 
pharmaceutical industry and academic research institutions, and between developed 
and least developed countries, 
• the creation of as a virtual laboratory for the different actors, increasing cooperation 
and communication between partners,  
• the mobilizing of resources routinely or in an emergency, 
• the sharing of diverse, complex, large and distributed information for collaborative 
exploration and mutual benefit, 
• the use of new Information Technology such as large databases or time-consuming 
software, 
• the optimal exploitation of resources by taking advantage of spare computing cycles or 
by maximizing the use of high performance computing platforms usage, 
• the reduction of hardware costs. 
Grids open exciting perspectives for handling information flows. 
Grid allows 
• the deployment of services for healthcare and research centers in endemic regions, 
• the deployment of infrastructures to collect data and improve disease surveillance and 
monitoring, 
• the building of knowledge space with genomics and medical information 
(epidemiology, status of clinical tests, drug resistances, etc.), 
• access to relevant data, periodically updated data bases and publications, 
• the federation of regional or international databases for disease study and monitoring 
of vector control, clinical trials and drug delivery, 
• the provision of transparent and secure access to storage and the archiving of large 
amounts of data in an automated and self-organized fashion, 
• connection, analysis and structuring of data and information in a transparent mode 
according to pre-defined rules (science or business process based). 
Grids provide the resources to speed up the execution of time-consuming software. 
Grid allows 
• access to large computing resources for in silico drug discovery, data analysis and 
mathematical modeling,  
• the application of high performance computing to new areas, 
• the production of additional or more accurate analyses, 
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• the facilitation of the exchange of tools and workflows between scientists, 
• the performance of computing intense tasks in a transparent way by means of an 
automated job submission and distribution facility, 
• access to services and resources 24 hours a day, 
• the running of the same job on many platforms across different sites, 
• access to computing resources by a single efficient path. 
Grids are unique tools for collecting and sharing information, networking experts, 
mobilizing resources routinely or in an emergency. Grid is thus an appropriate environment to 
develop in silico drug discovery for neglected and emerging infectious diseases. 
1.6. Conclusion 
In this first chapter, the challenges raised by neglected and emerging infectious diseases 
have been described. We have demonstrated how Information Technologies can contribute to 
address some of these challenges in the fight against neglected diseases by offering support to 
in silico pipelines, data collection, monitoring systems and international resource sharing. 
Fighting emerging infectious diseases requires also early detection, epidemiological watch, 
prevention, fast search for new drugs and vaccines thanks to international collaborations. We 
have also described in this chapter the interest of in silico drug discovery in reducing costs 
and time to market of new drugs. Developing in silico drug discovery requires data 
integration, software integration, computing resources, remote collaboration and resource 
sharing, with strong security constraints.  
Grids are unique tools for collecting and sharing information, networking experts, 
mobilizing resources routinely or in an emergency. Grid is a support to share resources and 
collaboration, to handle information flows, and to provide the resources to speed up the 
execution of time-consuming software. Consequently grid technology can contribute to 
lowering the barrier between the pharmaceutical industry and academic research institutions, 
and between developed and least developed countries. The philosophy of sharing resources in 
projects through the grid opens exciting perspectives for such topics as neglected and 
emerging infectious diseases as it fosters international collaboration. 
In the next chapter we are going to enter into the details of what a grid is and more 
precisely what are the best grid environments to be used to develop in silico drug discovery.  
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Chapter 2. Computing grids 
2.1. Introduction 
In the first chapter, challenges to fight neglected and emerging infectious diseases and to 
develop in silico drug discovery were presented. Grid technology is a solution to collect and 
share information, network experts, mobilize resources routinely or in an emergency. 
Computing grids are still a relatively new notion even if the distributed computing 
concept is older. The first aim was the desire to share computing resources. But today many 
complex services have been conceived to build a full user-oriented environment. There are 
many grids but a common requirement is the need to have efficient resource management 
through a multi-layer set of software, called middleware.   
There are two main grid hardware types. The desktop grid (inspired from peer-to-peer) 
concentrates on sharing systems such as desktop PCs connected to the Internet. The cluster 
grid aggregates distributed machines such as clusters. Desktop PCs networks can amass 
computing power, as does the SETI@home project. As well as computing resources, 
computing grids deploy advanced services like data management. The two technologies are 
complementary, but a cluster grid seems better suited to perennially sustain infrastructure. 
There are also different cluster grid infrastructures and technologies in the world. There 
are many criteria to choose the best one for a given objective. For instance, the European 
project EGEE is the largest production cluster grid in the world and is adapted for computing 
power and data intensive applications. The French national grid RUGBI, based on existing 
grid technologies, provides a more flexible and secure environment for companies and 
academic institutions in life sciences. 
The aim of this chapter is to define what a grid is and more precisely what are the best 
grid environments to be used to develop in silico drug discovery services against neglected 
and emerging infectious diseases.  
The chapter is introduced as follows: 
• After the introduction, the second section introduces some definitions. 
• The third section will focus on the most widespread grids, the desktop and cluster 
grids in order to compare them. 
• Then the infrastructures and the technologies of the grids used will be justified and 
described in the fourth and fifth sections. 
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2.2. Defining the grid 
This first section gives several ideas to help better understand what a grid is. Following 
the exploration of several different proposals for a definition, there will be a grid taxonomy, 
and then an explanation of the general architecture of a grid. 
2.2.1.  Some definitions 
Research in a grid environment and research about grid technology has greatly increased 
in the last 10 years [219]. One common reason is explained by Moore’s law, illustrated by 
figure 9 [220]. The rapidly decreasing cost of broadband networks allows data, applications 
and hardware access from everywhere. Workflows can now be built with remote resources. At 
the same time, the large deployment of computing resources on the Internet and the World 
Wide Web has stimulated resource mutualization. 
 
 
Figure 9: Moore’s law vs. storage improvements vs. optical improvements [220] 
 
Ian Foster and Carl Kesselman, pioneers of the grid, proposed a definition in 1998: “A 
computational grid is a hardware and software infrastructure that provides dependable, 
consistent, pervasive, and inexpensive access to high-end computational capabilities” [221]. 
In 2000, with Steve Tuecke, they added to the original statement: grid computing is concerned 
“with coordinated resource sharing and problem solving in dynamic, multi-institutional 
virtual organizations” [222]. Then in 2002, Ian Foster modified again his definition arguing: 
the grid is “a system that coordinates resources that are not subject to centralized control, 
uses standard, open, general purpose protocols and interfaces, delivers non-trivial qualities 
of service” [223]. 
But several scientists differ [224,225] or propose other definitions [226-234]. For 
instance, a general definition is given by Andrew Grimshaw: “A grid is all about gathering 
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together resources and making them accessible to users and applications”. He proposes also a 
more detailed definition: “A grid enables users to collaborate securely by sharing processing, 
applications, work flows and processes, and data across heterogeneous systems and 
administrative domains for collaboration, faster application execution, and easier access to 
data” [235]. 
The grid promises to share resources for scientific collaborations on an unprecedented 
scale [222,236]. The computing grid name comes from the well-known analogy with an 
electrical power grid [237]. The computing power would be delivered just like electricity 
from an outlet, without knowing where the power came from or its complexity and reliability. 
An obvious similarity between computational and electrical grids is that both aggregate 
heterogeneous power sources (thermal, hydro or nuclear power and workstations, clusters or 
supercomputers). But the comparison is limited in many areas probably because the grid field 
is much younger than the electrical power grid. For instance, a computing grid still needs an 
operational model, coordinated systems operation to ensure network stability, and ease of use 
[238].  
Today the grid concept can be applied in all public or private sectors: science, business, 
engineering, medicine, culture etc. [236,237,239]. For instance, a scientific collaboration can 
pool computers and storage across participating institutions to obtain instantaneous access to 
more resources than available locally [235]. The resources may be administered by different 
organizations, distributed and heterogeneous. Gathering together resources (e.g. computing 
power, data, applications…) and making them accessible in a secure manner to users and 
organizations involves dealing with the physical characteristics of the Grid. This differs from 
the Internet where the user has to choose to which machine he wants to connect and which 
information he wants to retrieve out of the tremendous amount of data available [240]. The 
end-user does not need to know where the resource is physically located, the type of machine 
it is on, that it may have failed and recovered, etc. It requires virtualization of the shared 
resources and high-level interfaces [241]. Of course, grid computing power is no substitute for 
developing intelligent software: the grid is a tool to enhance research and collaboration. 
2.2.2.  A grid taxonomy 
Instead of concluding on a universal definition of the grid, this section presents briefly 3 
different grid architectures to reach the end-user goal. Most grids fall into one or several of 
these categories: computational-oriented grid, data-oriented grid and knowledge-oriented grid 
[237]. 
Computational grid 
A computational grid is defined here as an environment providing access to a network of 
distributed processors. Processors are located in workstations (e.g. Seti@home [242]), 
clusters (e.g. EGEE [243] or OSG [244]) or/and supercomputers (e.g. DEISA [245] or 
TeraGrid [246]) [247,248] across multiple organizations. Computational grids can support 
distributed and parallel computing [221,249], high throughput computing [221] or on-demand 
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computing [250,251]. Different services are available to submit jobs, monitor them and 
collect the results. Moreover, due to the processor heterogeneity (speed, architecture, software 
platform, memory, storage, connectivity etc.), information management is needed to select the 
best node for such applications and to use it efficiently. Furthermore, it requires basic data 
management like data transfer. 
This approach is adapted to application, which can be easily divided into jobs that are 
solved independently. Such a task is called an embarrassingly parallel job. Many existing 
resource-intensive applications are using grids for computing in science, engineering and 
commerce. These include Monte Carlo simulations and parameter sweep applications, such as 
ionization chamber calibration [252] or drug design [253]. The advantages are numerous: 
allowing on-demand aggregation of resources at multiple sites, processing data applications, 
reducing execution time, providing access to remote databases and software, taking advantage 
of time zone and random diversity (in peak hours, users can access resources in off-peak 
zones), providing the flexibility to meet unforeseen emergency demands by renting external 
resources for a required period [238]. 
Data grid 
A data grid [254-256], or information grid, is defined here as an environment providing 
access to distributed data [257]. Another definition is an environment that provides a dynamic 
logical name space for coordinated sharing of heterogeneous distributed storage resources 
based on local and global policies across administrative domains. Data are public or private 
databases (e.g. BIRN [258]), files (e.g. Gnutella [259]) or metadata. The metadata represents 
information about the data itself (files instance, origin, relationships between data…). 
Different services are available to collect, query, move, replicate, integrate and analyze the 
distributed data [260]. Moreover, computational power is required at least to organize the 
data. 
This approach is adapted to data access and sharing application such as medical data 
sharing. Few applications are using grids only for data management [254,261]. Data grids 
need to support the access to a large amount of data [262] in dedicated data storage devices or 
flowing from scientific instruments and sensors [263]. Secure remote access to databases can 
enable cross-correlations among databases maintained by different groups or within a single 
company. Because of the cheaper cost of disk space, memory space and computing cycles in 
comparison with bandwidth, it is better to avoid moving data in large quantities [250]. This 
implies computing close to the data.  
Knowledge grid 
A knowledge grid [264-266] is defined here as an environment providing access to 
distributed knowledge understanding and manipulation. Knowledge can be defined as the sum 
of all types of data and information within the scope of interest and is composed of relevant 
databases, information sources, document/knowledge bases, metadata and a knowledge map 
[267]. Knowledge needs a semantic ontology [268,269]. Ontologies are a formal way of 
representing knowledge in which concepts are described by their meaning and their 
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relationship to each other [270]. Different services are needed like the distributed mining and 
extraction of knowledge from data repositories available on the GRID. 
This approach is adapted to respond to high-level questions and finds the appropriate 
processes to deliver answers in the required form. Today, there is no knowledge grid 
operational on grid infrastructure, even if several initiatives exist [271,264]. It requires 
computational power and data management to manipulate concepts, to automate the process 
of knowledge discovery and to run complex in silico experiments [272,273]. Knowledge grid 
should support virtual laboratories (e.g. myGrid [274], Virtual lab [275]) and is particularly 
important for pharmaceutical research [276].   
2.2.3.  Grid architecture 
From this taxonomy, it can be concluded that the complexity of the underlying hardware 
resources needs to be managed and hidden by a software layer providing services for users 
[235].  
Thus, figure 10 presents a common grid architecture schema [233,235,277,278].  
 
Networked Resources across Organizations
Computers, clusters, networks, storage systems, scientific instruments…
GRID FABRIC
Local Resource Managers
Operating syst., queuing syst., lib. & app. kernels, Internet protocols…
Distributed Resources Coupling Services
Security, information services, data access, process, quality of Service…
CORE MIDDLEWARE
Development Environment and Tools
Languages/libraries, monitors, resource brokers, app. services, web tools…
USER-LEVEL MIDDLEWARE
Applications and portals
Science, engineering, web-enabled app., prob. solving env., collaboration…
APPLICATION
 
Figure 10: Example of common grid architecture 
 
The grid fabric layer consists of distributed and various resources across organizations 
controlled by local resource managers. The core middleware layer offers services to abstract 
the complexity and the heterogeneity of the fabric level. The user-level middleware layer 
provides higher level abstractions and services thanks to the core middleware interfaces. The 
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applications and portals are developed using grid-enabled programming environment and 
interfaces and the services provided by the user-level middleware.   
This architecture is a model, but there are multiple types of grids, according to their 
goals, their technologies, their ownership or their hardware for instance.  
2.3. Desktop and cluster grid computing 
Hardware resource is another way to classify grids. Those resources may include 
supercomputers, clusters, instruments such as telescopes and microscopes, computer-
controlled factory floor tools, servers, desktop machines, laptops, PDAs etc. [235]. This 
section presents and compares the 2 most common grids: the desktop grids and the cluster 
grids. They are specially adapted for CPU (Central Processing Unit) intensive and 
embarrassingly parallel applications, which are involved in the in silico drug discovery 
process. 
2.3.1.  Desktop grid overview 
Motivation 
In the last decade, observers have reported low CPU usage in desktop PCs around the 
world [279-282]. Many of these cheap PCs are connected to the Internet. At the same time, 
the demand for CPU power, in science for instance, has exploded [283]. Consequently, 
several initiatives were proposed to take advantage of this available computing power. For 
instance, Seti@home initiative [242] sustained a processing rate of about 60 Teraflops for 
several years [284]. 
A desktop, or scavenging, grid [285] is defined here as the sharing of idle desktop 
workstations, or PCs, cycles to solve scientific problems. This computing is also called global 
or internet computing [286]. The computing resources can be available internally to an 
organization like a company. When the computing resources are freely available from the 
public through the Internet, the desktop grid is called a volunteer grid [287,288]. This 
definition requires voluntary participation as opposed to parasitic computing that can force 
computers on the Internet to produce results [289]. 
A desktop grid needs to be potentially deployed on millions of machines. The next 
paragraph presents an example of deployment. 
Deployment 
Desktop grids were inspired from peer-to-peer computing [290,291]. In true peer-to-peer 
computing, there is no central authority; thus each node not only works, but also can schedule 
new tasks. But for a desktop grid, one or several central authorities control computation of the 
work units, automatically upload input and collect outputs through the Internet, check output 
integrity and facilitate analysis. The computing task is sent to the client by the server upon 
client request [283].  
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Figure 11 presents an example of a project deployed on a desktop grid using the BOINC 
framework. BOINC (Berkeley Open Infrastructure for Network Computing) is one of the 
main software platforms for public-resource computing that provides built-in support for 
distributed computing on heterogeneous PCs connected to the Internet or to Intranet networks 
[284,292]. 
The initial step is the project preparation: the framework is installed on different project 
servers (pink components) and the project-specific components are developed and integrated 
into the framework (green components). Then, the desktop computers of participants are 
registered in the BOINC database thanks to the web server (1). The client software is then 
automatically installed on them. The BOINC database contains information about project 
applications, participants, work and results (2). First, the client computer connects to the 
server and asks for work (3) (this is called pull-mode). Then the scheduling server downloads 
the instructions, the applications and input files for the core client (4). Once the computation 
is done, the results are uploaded onto the scheduling server and the output files are stored 
thanks to the data servers (4). Validation and post-processing are then executed (5). 
 
Client API
Application client
Web server
BOINC 
database
BOINC server
Client computers
Scheduling server Data servers
Project back-end
-Retry generation
-Result validation
-Garbage collection
Project-specific 
back-end
- Work generation
- Result processing
1
3
5
4
2
Core client
 
Figure 11: Example of a project deployed on a desktop grid using the BOINC framework 
 
There are many criteria required for the deployment of an application on a desktop grid 
[283,293-296]: 
• The application must be divisible into independent work units of an appropriate size. 
Depending on the network, the amount of data transferred should be small and rare. 
• The software must run on multiple operating systems. Download must be fast and not 
require a lot of disk space. The process to download and install the software must be 
executed automatically. The code upgrade must be automated. 
• The process to submit jobs and to retrieve the output must be executed automatically. 
The software has the lowest work priority on the PC. The work is only carried out 
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when the screen-saver is active for less interference. Virtual memory should not be 
used to avoid blocking the rest of the system. The intermediate results may be saved to 
minimize losses in case of system crash. 
• It should be noted that network bandwidth and Moore’s law impose lower and upper 
computing time limits for tasks that are worth distributing [297]. The resulting range 
from seconds to months is reflected in current global computing projects, with several 
hours as a typical value. 
• The process must meet the security standards. The execution environment protects the 
participant’s PC from potentially malicious code from a computing application. 
Different methods are used to control the output integrity against hardware 
malfunctions, incorrect software modifications, or malicious attacks. Encryption and 
user keys can also be used. 
Furthermore, several features are required for an application in a volunteer grid :  
• The application must be readily available. 
• The output must not be lost if the participant wishes to stop his participation or stop 
the automated online connections. 
• The application and the application web site must have good graphical user interface 
and great content about the project to attract and keep participants. Progress and 
statistics should be displayed. 
Thus only certain types of applications are useful for a desktop grid. But there are many 
initiatives to build frameworks with different technologies and to use them in applicative 
projects.  
Initiatives 
Many projects have used or are using BOINC, including Climateprediction.net [298], 
LHC@home [299] or Einstein@Home [300]. Other projects develop their own software 
framework, like Condor [301], XtremWeb [302] or Folding@home [150,303]. United 
Devices [304], Entropia [305] and Platform Computing [306] are the main commercial 
providers of distributed computing platforms. They have the same server functions as BOINC 
and use relational databases to store task participant data [307]. 
The best known initiative is SETI@home [279,308], for which the framework is BOINC. 
Millions of participants processed a database of large pulsar signals in a search for 
extraterrestrial intelligence. Radio data signals are distributed through the internet by a central 
server to PCs, where they are analyzed by a screensaver program to assess the presence of a 
non-random signal that runs while the computer would otherwise be idle. The notion of 
virtual organizations [222,309] and virtual enterprises [310] emerged from this success. The 
understanding that 10,000 desktop PCs with an average performance of 500 megaFLOPS and 
appropriate software are equivalent to a 5 teraFLOPS supercomputer developed a 
computational economy for sharing and aggregating resources to solve problems [283,311]. 
As a consequence, there are many different desktop grid initiatives in life science [283]. 
Predictor@home [149] is using the BOINC framework to accommodate both protein structure 
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conformational sampling and protein refinement. World community grid [312] is using 
United Devices and BOINC platforms to support the Help Defeat Cancer project, 
fightAIDS@home and the Human Proteome Folding project. This last project is being carried 
out in collaboration with grid.org [313]. Grid.org is using United Devices platform to support 
the Smallpox Research project, the Anthrax Research project and the Cancer Research 
project. French Decrypthon [314], is using the United Devices platform to accelerate the 
proteomic and genomic research in human diseases. D2OL [315] is using its own platform to 
screen large compound databases against targets of different diseases such as malaria and 
avian influenza. Many pharmaceutical companies, such as Bristol-Myers Squibb and 
Novartis, are using idle time of thousands of desktop computers. They acquire teraflops of 
cheap computing power for their drug discovery research. 
Desktop grids are highly used by different projects, but they are mainly only for 
computational projects. A cluster grid offers a larger variety of services. 
2.3.2.  Cluster grid Overview 
Motivation 
A cluster is a set of computing units physically gathered in the same place and 
coordinated to improve computer capacity and storage. They are used in many different areas 
such as science organizations and companies. Clusters can have different sizes and can be 
composed of heterogeneous PCs. The basic required services are load balancing and back-up 
mechanisms. Two of the advantages of this approach are the scalability and the cost: a cluster 
can grow simply by adding new cheap PCs to it. But this growth will be limited by the need to 
communicate between computers. An answer to the increasing requirements in computing and 
storage is the building of cluster grids inside or between organizations [221]. For instance, the 
need to manage the future huge data production from the Large Hadron Collider of CERN in 
2007 [316] has motivated the high energy physics community to interconnect all clusters of 
their European computing centers and research laboratories with large bandwidth network 
connections.  
A cluster grid [317] is defined here as the sharing of geographically distributed clusters to 
solve problems. They allow selection and aggregation of distributed resources, such as 
instruments across multiple organizations.  This enables exploration of large problems with 
huge data sets, but also small but daily needs. High-level services for complex applications 
can also be built on cluster grid [276]. They can be the infrastructure for data and knowledge 
grids, supporting collaborations and expertise.  
A cluster grid may interconnect hundreds of clusters supporting each day thousands of 
jobs. An example of deployment is presented below. 
Deployment 
A cluster grid is the combination of networked resources operated by common or 
interoperable middleware(s), which provides services for communities structured usually in 
virtual organizations [243]. The middleware is a set of software components that sits between 
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the user application and the underlying resources. It provides services to access and to use 
resources. A virtual organization is a grid-wide identification and authorization unit 
representing a community of users sharing some grid resources. Inside this virtual 
organization, there is some degree of trust, accountability, and opportunities for sanctions in 
response to inappropriate behavior [278]. 
Figure 12 presents an example of project deployment on a cluster grid [233] using the 
Globus Toolkit. The Globus Project is developing open-source and standard-based 
technologies to build computational grids. It is one of the main world-wide middleware for 
cluster grids [318]. 
 
Grid client
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Figure 12: Example of project deployment in a cluster grid 
 
The initial step is the project preparation. The management services and the user 
interface, which is the grid entry point for the user, are installed on workstations (in pink).  
Only three services are figured here, but there are many other possible services in a 
middleware, such as security, user management, accounting, etc. The computing element is 
the service representing the computing resources which here is a cluster. The storage element 
is the service representing the storage resources which here is a disk. The project-specific tool 
on the user interface is developed to interface the applications with the grid tools to access the 
grid (in green). Then, available elements in the grid nodes are published in the information 
system (1). The next possible step is the upload of the data on the storage elements and their 
registration thanks to the data manager (2).  After that the application tasks are submitted by 
the user from the user interface on the task manager with the application software and 
optionally other data (3) (this is called push-mode because the client submits work). The task 
manager asks the information system and possibly the data manager to select the most 
adequate resources according to the task description. Next, the tasks and their data are 
submitted to the computing elements to be executed possibly with copied data from the 
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storage elements (4). At the end of the task, the output can be stored on a storage element and 
registered in the data manager. The task report and the data outputs are transferred on the user 
interface through the task manager, to be checked and processed by the project-specific tool.  
Many different applications and uses are possible on a cluster grid notably thanks to the 
infrastructure flexibility, its permanent availability and the services developed in the different 
projects [319]. 
• The application might be divided into independent work units of an appropriate size. 
Parallel jobs are also appropriate when using only one cluster. Depending on the 
network, small or large data can be manipulated easily.  
• The software may be installed on one or multiple operating systems, depending on the 
cluster grid middleware. The installation process is more or less easy depending on the 
proposed services. 
• The applications are managed by the task manager and are executed on resources. 
Resource specifications of the cluster work units are registered in the information 
system and exposed to the task manager. 
• The process has security features thanks to the services and the existing trust between 
the different partners in the virtual organization. Several tools are available such as 
certificates, public key infrastructure for authentication and integrity, encryption, 
usage/access policies, etc. The control of the job output is under the responsibility of 
the application specific tool. 
Many different applications can be deployed on a cluster grid. The number of cluster grid 
projects and technologies has vastly increased in the last decade. A few of them are described 
in the next paragraph. 
Initiatives 
There are an increasing number of applications that employ cluster grid technologies 
[320-327]. Some of them integrate sensor networks with grid computing to enable real-time 
modeling and data collection [328]. The Grid is laying the foundation of e-Science, a new 
way to carry out research through distributed global collaborations enabled by the Internet 
[283]. E-science can be defined as digitally enhanced, or electronic, science in global 
collaboration. Many large collaborative e-science projects worldwide are now applying these 
technologies in different disciplines [329-333]. Promising grid-enabled virtual laboratories are 
in progress [276]. In the long term, the grid is going to impact the organization, the resource 
management, the network, the security and the administration of the community concerned.  
Several grid projects orientated towards the life sciences are underway, such as the North 
Carolina BioGrid [334], the Canadian BioGrid [335], the EUROGRID project [336], the 
cancer biomedical informatics Grid [337-339], the Simdat project [340] and the Biomedical 
Informatics Research Network [258]. All these projects involve the sharing of computational 
resources and the large-scale movement of data. One example is OpenMolGrid [341], an 
extensible, grid-enabled environment using UNICORE for the molecular science and 
engineering system that is effectively used in molecular design [342,343]. Other projects 
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focus on grid-enabled frameworks for developers or users, like P-grade [344] which provides 
a visual environment for application development, Triana [345] for workflow formulation, 
GridSphere [346] for creating web portal environments or Genius [347] for job submission 
and data access. 
There are high-quality grid middleware such as Globus, Nordugrid ARC [348], LCG-2 
(LHC computing Grid release 2) [349] and gLite [350], Legion [351], Gridbus [352], 
UNICORE [353], e-Toile [354] or Grid’5000 [355]. These software act as middleware 
interlinking resources of multiple computers within or between institutions using open and 
general purpose protocols for secure high performance distributed computing [356]. For 
instance, UNICORE is an open-source grid middleware, which offers a fully integrated 
solution consisting of a powerful and easy-to-use Java-based graphical user interface and 
server side components. Several chemistry- and biochemistry-related applications have 
already been successfully integrated [357-359].  
In addition, several commercial organizations, such as IBM, Sun, HP, Oracle and Nice 
are actively involved in the development of enterprise and global utility grid technologies 
[239]. Some companies host their own private cluster grids, although deployment is still 
complex [360]. Sun recently proposed Internet-based access to a utility computing resource at 
the affordable price of $1 for 1 hour of computing. Many economic models are studied 
[361,362]. 
A need has emerged for communities to have standards and a standards-based 
architecture that would facilitate better interoperability among various grid middleware 
systems and Grid-enabled applications [338,363]. The Open Grid Services Architecture 
(OGSA) [364,365] based on web Services Resource Framework [366] aims at unifying web 
and grid service frameworks. A web service is a software system designed to allow inter-
computer interaction over a network. Web services allow grid developers to take advantage of 
standard message formats and communications mechanisms for communicating between 
heterogeneous components and architectures. OGSA standards integrate Globus Toolkit 
technologies with web services mechanisms [367]. To facilitate standardization of fast-
evolving Grid technologies, the Global Grid Forum [368] was founded. The OGSA-DAI 
[369,370] is an implementation of the OGSA Data Access and Integration Standards 
developed within the Global Grid Forum. It provides tools and runtime support for 
development and deployment of data services in the grid. 
2.3.3.  Comparing desktop and cluster grids 
Desktop and cluster grids are the main widespread grids. It is legitimate to compare them 
in order to choose the best infrastructure to deploy in silico drug discovery for neglected and 
emerging infectious diseases. Table 1 compares desktop and cluster grids [257,283,371,372]. 
The main added values of desktop grids are their deployment simplicity, their 
infrastructure and deployment costs and the computing power gain. This computing power 
gain is potentially huge for volunteer grids. Moreover, desktop grid technology has proved its 
maturity, even if the platforms are still under development: they can generate production 
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discontinuities on the grid management server because of software update or hardware 
failures [149]. 
 
Features Desktop grid Cluster grid 
Deployment simplicity Yes No 
Infrastructure and deployment costs Cheap Expensive 
Computing power gain Variable, potentially huge Variable 
   
Applications scope Limited Extended 
Data management Very limited yes 
Network bandwidth Expensive, scarce Abundant 
Availability and reproducibility Variable Yes 
Additional services No Yes 
Resources management No Yes 
Secured resources No Yes 
Standards No In progress 
Enabling collaboration Very limited Yes 
   
Code stability Good Many updates 
Fault tolerance Limited Limited 
Security Limited Limited 
Table 1: Comparison of desktop and cluster grid features 
 
The main disadvantages of desktop grids are the limitations on applications deployment: 
only embarrassingly parallel applications with limited data management requiring low 
network bandwidth can be deployed. Another limitation is the intermittent participation time 
of the participating PCs: the average connection time of the PC can be only 28% [373]. 
Global security management is a critical challenge and still an issue for the user who provides 
data and application, but also for the participant that installs the software at home 
[149,283,374]. Fault tolerance is a major criterion to deploy a production grid [330,375]. 
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Computational errors management is difficult for a desktop grid [149,259], even if methods 
like computing replication contribute to solve this problem [295]. 
An important added value of cluster grids is that they accept a larger number of 
applications from all areas thanks to high network bandwidth, large data management and 
better availability of resources. Furthermore, beyond the 24 hours a day availability of 
resources, the cluster infrastructure guarantees a stable environment for the scientist for 
storing results and rerunning experiments. Many complex services can be implemented, such 
as data replication, metadata management, workflow management or service discovery [319]. 
Standard development for infrastructure and service interoperability is in progress [278]. 
Moreover, cluster grid resources are powerful, reliable, flexible and secure. Many security 
features exist in a cluster grid: authentication [221], authorization [376,377], data encryption 
etc. There is trust between users of a community (a virtual organization) and the resources 
administrators in the project. For instance, it is hard to become an authorized user. But the 
process is not yet fully secure, particularly in the area of data management (data safety, 
legacy…). For all these reasons, a cluster grid environment enables international collaboration 
and expertise sharing.    
But cluster grids are still complex to deploy (technically, but also organizationally 
between partners), clusters are more expensive to maintain, and their potential computing 
power is lower than a world-wide volunteer grid. Moreover, even if computational grids can 
now produce research results, the code stability of a cluster grid is not yet reached. Another 
limitation is the fault tolerance. Resubmission systems exist in a cluster grid, but the success 
rate is still low.  
Thus desktop and cluster grids seem complementary and could be used simultaneously in 
a project or in an organization. However, the advantages of cluster grids are more important 
for a large number of applications and users. This environment is starting to give a stable 
environment for building complex experiments and knowledge spaces although there remain a 
few challenges [257]. Poor reliability is not acceptable for a production environment, and 
particularly for users who pay to access the grid. The security aspect is vital for the 
involvement of companies or sensitive public research (nuclear power stations, drug 
discovery…). The grid needs to be hidden to the user. Easy-to-program interfaces are 
necessary for application developers. 
To conclude this comparison, a cluster grid seems more relevant to develop an in silico 
drug discovery process to fight neglected and emerging infectious diseases. Thus, the 
applications developed during this thesis were deployed on cluster grid environments. These 
grid infrastructures and technologies are now described. 
2.4. Some cluster grid infrastructures: EGEE, AuverGrid, 
TWGrid and RUGBI 
In the previous sections, the advantages of cluster grids were established. The drug 
discovery process is typically composed of a set of CPU consuming applications with large 
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data sets to analyze. Beyond the computational aspects, cluster grids open perspectives for 
building a collaboration space enabling the discovery of drugs against neglected and emerging 
infectious diseases.  
The performance of a cluster grid infrastructure depends on many criteria [92]: maturity 
(robust, powerful), value (impact on cost, time and success probability), competitive 
advantage (sustainable), organization (drive change), deployment (ease of use, ease of 
configuration, non-intrusiveness at participating sites), success (new users, results). Today no 
grid projects meet all these quality requirements. 
The European EGEE grid infrastructure is one of the most advanced production grids, 
satisfying several of these criteria. The French regional AuverGrid and the national Taiwan 
TWGrid are 2 daughter infrastructures of EGEE. The RUGBI infrastructure was built 
specifically for life science industrials and academic institutions to meet some specific 
requirements. Thus these 4 infrastructures, on which bioinformatics services were deployed, 
are now briefly described. 
2.4.1.  The EGEE infrastructure 
The EGEE (Enabling Grid for E-sciencE) [243] project brings together experts from over 
27 countries with the common aim of building on recent advances in Grid technology and 
developing a production Grid infrastructure which is available to scientists 24 hours-a-day. 
The project aims to provide researchers in academia and industry with access to major 
computing resources, independent of their geographic location. The project was built on the 
successes of the European DataGrid Project [378]. The EGEE project is at this moment in its 
second phase (EGEE-II).  
The EGEE infrastructure is now the largest production scientific grid in the world with a 
large number of applications installed and used on the available resources [379]. Expanding 
from originally two scientific fields, high energy physics and life science, EGEE now 
integrates applications from many other scientific fields, ranging from geology to 
computational chemistry. The infrastructure, whose map is presented in figure 13, involves 
more than 200 sites spread across Europe, America and Asia, 20,000 CPUs, 10 petabytes of 
disk space, 10,000 concurrent jobs and 60 Virtual Organizations. The production service is 
based today on the mixed LCG-2/gLite services. The grid is organized hierarchically, with 
resource centers that are under the responsibility of Regional Operation Centers (one per 
federation) which themselves are coordinated by the Operations Management Center (OMC). 
The goal of this hierarchy is to offer an efficient, responsive and scalable grid service to the 
users. 
Applications are deployed within the framework of a Virtual Organization. A Virtual 
Organization is a grid-wide identification and authorization unit representing a community of 
users sharing some grid resources. For instance, the biomedical Virtual Organization scaled 
up to about 3,000 CPUs and 21 TB disk space in the summer of 2005. 
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Figure 13: Map of the world-wide infrastructure EGEE with Operating Centers 
 
EGEE is connected with several infrastructure projects, like NAREGI [380] in Japan and 
OSG [243] in the USA. It supports other infrastructure projects like SEEGRID [381] in 
South-Eastern Europe and EELA [382] in South America. Other related projects address 
specific high-level services such as DILIGENT (digital library) [383] or specific application 
areas such as BIOINFOGRID (bioinformatics) [384]. Furthermore, the EGEE project wants to 
support and promote the development of an African Grid infrastructure to benefit the 
continent and help reduce the digital divide. To achieve this, it promotes the extension of 
recent connections to the European Grid infrastructure, and the leveraging of this 
infrastructure for the development of a sister network in Africa [385]. 
The EGEE infrastructure demonstrates its success by the number of active applications 
and the new projects that want to collaborate with it. Among the infrastructures based on the 
same technology as EGEE, we are going to describe the AuverGrid and the TWGrid 
infrastructures. 
2.4.2.  The AuverGrid infrastructure 
AuverGrid [386] is the first French regional grid, deployed in the Auvergne region. Its 
goal is to explore how a grid can provide the resources needed for public and private research 
at a regional level. AuverGrid aims to share technological expertise and to transfer grid 
competences from European projects to public and private regional actors.  With more than 
800 CPUs available at 12 sites, AuverGrid hosts a variety of scientific applications from 
particle physics to life science, environment and chemistry. The infrastructure enables 
pluridisciplinary collaboration between institutes and industries. The production service is 
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based on LCG-2 services. Some application services created in the RUGBI project are used 
now in AuverGrid. Figure 14 illustrates the transfer of expertise from the EGEE and RUGBI 
networks to the AuverGrid project [387]. CC-IN2P3, LPC and the Biopôle of Clermont-
Limagne are stations of three lines, the EGEE, RUGBI and AuverGrid infrastructures. They 
allow the transfer of expertise from Europe and France to many institutes of the French region 
Auvergne. 
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Figure 14: Map of the infrastructure AuverGrid [387] 
 
AuverGrid is a successful example of an infrastructure integrating new institutes and new 
applications. The deployment of the thesis applications proved its reliability. 
2.4.3.  The TWGrid infrastructure 
The Taiwan Grid, TWGrid [388], is responsible for operating a Grid Operation Center in 
the Asia-Pacific region. Apart from supporting a world-wide Grid collaboration in high-
energy physics, TWGrid is also in charge of federating and coordinating regional Grid 
resources to promote the Grid technology to e-Science activities (e.g. life science, 
atmospheric science, digital archive, etc.) in Asia. The production service is based on the 
mixed LCG-2/gLite services. 
TWGrid aims first to support the high energy physics community. But it has also 
integrated new applications, like life science. Their central role in the Asia-Pacific region 
proves the reliability of their infrastructure. 
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2.4.4.  The RUGBI infrastructure 
The goal of the RUGBI project [389] is to design and deploy on the basis of free 
technologies and existing infrastructures a computing grid offering a set of services to analyze 
proteins. These services aim to support academic biologists and small and medium life 
science enterprises. They were identified through an analysis of the needs of three French 
biotech companies located at Biopôle Clermont-Limagne. Today the RUGBI grid offers 
direct, secure and high-performance access to different software and databases, listed in table 
2. The RUGBI grid is able to be enriched easily by new free or commercial tools thanks to the 
deployment service described in chapter 3. 
 
Category Resources 
Alignment tools Blast (MPI), Clustal, Fasta 
Tools for protein secondary structure prediction  Gor, Simpa, Predator, Sopm, Dsc, Phd 
Metabolic pathways identification tool in network DDTool 
Virtual screening tool Autodock 
Genomics and proteomics database EMBL, UniProtKB 
Metabolic pathways database KEGG 
Structural database PDB, NCI Diversity set 
Table 2: Tools and databases available on the RUGBI grid. 
 
There are two portals to access the RUGBI grid. SecProt [390] gives an anonymous but 
limited access to protein secondary structure prediction methods. The general RUGBI portal 
[391] provides all available services but requires personal registration to control the access to 
logical and physical resources. It is hosted on several servers to avoid saturation by a unique 
entry point. The user can manage his applications, his data and his task flows; he can also 
manage his profile, rights and even his group (like a company or a team).  
Figure 15 presents the RUGBI architecture. The RUGBI grid currently has 5 sites in 
Clermont-Ferrand, Lyon and Grenoble interconnected by a high speed network. They can 
have different components, such as a web portal to access the grid, a Controller server to 
manage the grid, an exploitation server for grid administration, a computing cluster and a 
storage bay. Users from academic institutions and Biopôle Clermont-Limagne access the grid 
with a client and a certificate. 
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Figure 15: RUGBI architecture with the node composition 
 
The RUGBI infrastructure is young, but it is based on web services technology. This 
project was chosen to explore the creation of new bioinformatics services during this thesis, 
because it offers a Service Oriented Architecture. 
2.5. Some cluster grid technologies: EGEE and RUGBI 
An infrastructure is based on the middleware, which is the software layer which 
interconnects resources and services. During the thesis, the middleware of the EGEE, 
AuverGrid and TWGrid infrastructures was LCG-2. The middleware of the RUGBI project 
was built on web services. This section gives the main concepts of the grid technologies used 
in EGEE and RUGBI.  
2.5.1.  The EGEE grid technology 
The grid relies on advanced software, called middleware, which interfaces resources and 
applications. The LCG-2 middleware deployed on the EGEE infrastructure provides many 
components: a User Interface, a Computing Element, a Storage Element, a Workload 
Management System relying on resource broker machines, a Data Management System, an 
Information System, an Authorization and Authentication System, an Accounting System, and 
several monitoring and installation services. All the grid activities and resource sharing within 
EGEE are operated and coordinated within the scope of Virtual Organizations, the virtual 
communities across laboratories and institutes around the world. Middleware services find 
convenient places for the application to be run, optimize use of resources, organize efficient 
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access to data, deal with authentication to the different sites that are used, run the job and 
monitor progress, recover from problems and transfer the result back to the user. 
The main contributors to the LCG middleware are the Virtual Data Toolkit [392], the 
European DataGrid Project [378], the DataTAG Project [393] and the LHC Computing Grid 
[349]. The middleware LCG is based upon the Globus toolkit release 2. The main middleware 
components are briefly described [394] below. See [395] for a complete and detailed 
overview. 
The User Interface 
The User Interface is the gateway to the EGEE grid components. This machine hosts the 
personal user accounts and user’s certificates. From the User Interface, a user can be 
authenticated and authorized to use the EGEE grid resources. It provides the command line 
interface and APIs to perform the grid operations. 
The Computing Element 
A Computing Element is built usually on a homogeneous cluster of computing nodes 
called Worker Nodes and a node acting as a grid gate or front-end to the rest of the grid. The 
Computing Element is responsible for accepting jobs and dispatching them for execution to 
the Worker Nodes through batch schedulers. On the Worker Nodes, all commands and 
Application Programming Interfaces for performing actions on the grid resources and grid 
data are available. Each EGEE site runs at least one Computing Element. 
The Storage Element 
A Storage Element provides uniform access to large storage space. The Storage Element 
may control large disk arrays or mass storage systems. Almost all EGEE sites provide one or 
more Storage Elements. The main file access protocol is GSIFTP, which is used for the file 
transfer. The GSIFTP protocol offers the functionality of FTP enhanced with the Grid 
Security Infrastructure security based on a X509 certificate (public/private key) infrastructure. 
The Workload Management System 
The Workload Management System is responsible for the management and monitoring of 
jobs submitted from a User Interface. The Job Description Language [396] is used for 
describing computation tasks. It specifies executable files, data dependencies and specific 
application requirements. 
An example of Job Description Language for a basic “echo” job is presented in figure 16. 
The concatenated attributes “executable” and “arguments” give the full command line: 
“/bin/echo Hello reader!”. The unix standard and error outputs are redirected automatically to 
the files stdout.log and stderr.log. The files will be downloaded on the User Interface at the 
end of the job thanks to the OutputSandbox attribute. 
 
Chapter 2. Computing grids 
 
 
69 
Executable = “/bin/echo”;
Arguments = “Hello reader!”;
StdError = “stderr.log”;
StdOutput = “stdout.log”;
OutputSandbox = {“stderr.log”, “stdout.log”};  
Figure 16: Basic job attributes of a Job Description Language file 
 
A set of services running on the Resource Broker machine helps to match job 
requirements in the Job Description Language file to the available resources (as gathered from 
the Information System), schedules the job for execution to an appropriate Computing 
Element, tracks the job status, and allows users to retrieve their job output. Figure 12 from the 
section 2.3.2 summarizes the process. 
A sandbox is a service to pack and unpack a collection of files and to transfer it. The 
Input Sandbox service uploads the files from the User Interface to the Computing Element via 
the Resource Broker. The Output Sandbox service downloads the files from the Computing 
Element to the User Interface via the Resource Broker. The Logging and Bookkeeping service 
keeps information on a job status and allows the user to query its status. A status corresponds 
to a step in the job submission process. Current statuses are: 
• “Submitted” corresponds to jobs submitted by the user through the User Interface and 
not yet handled by the Resource Broker. It corresponds also to jobs failed and 
automatically resubmitted by the Resource Broker. 
• “Waiting” corresponds to jobs accepted by the Resource Broker but which are not yet 
allocated to a Computing Element. 
• “Ready” corresponds to jobs for which the matching resources are found and which 
are submitted to a Computing Element. 
• “Scheduled” corresponds to jobs accepted by a Computing Element and which are 
queuing for execution. 
• “Running” corresponds to jobs executed on a Worker Node. 
• “Done” corresponds to jobs for which the execution is finished. 
User credentials for a limited lifetime (Proxies) can be automatically renewed through a 
Proxy Service. A proxy service offers a computer network service to allow clients to make 
indirect network connections to other network services. 
The Data Management System 
The Data Management System allows users to move files in and out of the grid, to 
replicate them among different Storage Elements, and to locate them. A number of available 
and supported protocols are employed for data transfer. Globus GridFTP protocol [397] is the 
most commonly used. GridFTP is a ftp protocol implementing secured and reliable 
multichanneled transfers, optimized for high bandwidths over wide-area networks using the 
Globus Security Infrastructure as security layer. A central file catalogue, the Replica Location 
Service, keeps information about file location and about some file metadata. A Logical File 
Name, given by the user, is associated to a file and its replica. It can be used to designate data 
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to be registered and retrieved independently of their physical storage location. The LCG File 
Catalogue replaced the Replica Location Service of the EGEE biomedical Virtual 
Organization during the spring of 2006. The LCG File Catalogue has the same functionalities 
as the Replica Location Service.  
The Information System 
The Information System provides information about the grid resources and their status. 
The information is published by the Grid Resource Information Service running on each 
individual resource (Computing Element and Storage Element). Then the information is 
propagated into a hierarchical database structure: firstly in the Grid Information Index 
Services at every site and then in the Berkeley Database Information Index as a central 
collector. The Grid Resource Information Service is based on the Globus Monitoring and 
Directory Service. Information is published following a specific schema that goes under the 
name of Glue [398]. 
Limitations of the EGEE technology 
The EGEE project builds an efficient production middleware and infrastructure to 
provide scientists with large computing and storage needs. It is for instance appropriate for 
high throughput structure-based virtual screening, which requires huge computing power to 
analyze large databases. But there are some limitations for other applications such as protein 
structure prediction, which requires many different short tasks using frequently updated 
databases. This complex resource management increases the grid overhead time. The data and 
meta-data management is limited to some basic functions (transfer, registration, replication). 
Moreover, EGEE middleware is still complex to use and hardly accessible to users without 
skills in computer science. There is a need to build high-level services adapted to the specific 
needs of bioinformatics and offering a user-friendly and secure environment. 
The RUGBI grid technology was built to meet these requirements. 
2.5.2.  The RUGBI grid technology 
The RUGBI grid technology is based on web services. The first part of this section gives 
some definitions about the web services used by the RUGBI grid. Then the components of the 
architecture are presented. 
Focus on Web services technology 
This section is mainly based on [399]. The World Wide Web Consortium ( TW3CT) [400] 
develops interoperable technologies (specifications, guidelines, software, and tools) to lead 
the Web to its full potential. The initial idea behind web services [401] was to enable the 
World Wide Web to become the support for real applications and to be a means of 
communication between them. 
The web services specifications, recommended by the W3C, propose a set of standards 
and protocols allowing interaction between distant machines over a network. These 
interactions are made possible through the use of standardized interfaces which describe 
basically what are the available operations in a service, which messages are exchanged 
Chapter 2. Computing grids 
 
 
71 
(requests and responses), and where the service is physically located on the network and 
through which support. This interface, which is just a conceptual representation of an 
application written in a given programming language, is written in WSDL (Web Service 
Description Language) [402]. The typical file extension is “.wsdl”. 
The WSDL describes the structure of the data sent to and received from the service, the 
different operations supported on the service, how to communicate with the service, and 
finally where the service is located. 
The glue between the services, or between a server hosting a web service and a client 
(any piece of software that will communicate with the web services), which enable them to 
communicate are these request and response messages. They can be described in a 
standardized way on the network and be exchanged with a standard protocol over basic http or 
SMTP or any common Internet protocol. All the messages and description languages are 
based on XML (Extensible Markup Language). 
The XML is a way of describing data. An XML file can contain the data too, as in a 
database. Its primary purpose is to facilitate the sharing of data across different systems, 
particularly systems connected via the Internet. The advantages of the XML format are: the 
XML document transfer through the network is simple; the XML is understood by the 
Relational Data Base Management Systems or XML native Data Base Management Systems; 
the XML file is flat; the XML is extensible. 
The XML native Data Base Management Systems is a database designed from the ground 
up to store XML data, like Apache Xindice. A known query language is XPath. The DTD 
(Document Type Definition) is a XML schema language used to describe the structure 
constraints of a XML document. It is like a grammar, defined by the XML user, allowing the 
checking of XML document validity. 
The main language used to make web services communicate with each other is SOAP 
(Simple Object Application Protocol). SOAP is a protocol for exchanging XML messages 
over a network. It defines a certain structure for the XML messages (the SOAP envelope), and 
a framework that defines how these messages should be processed by the software. SOAP has 
the advantage of being implemented in several languages and toolkits. 
Web services provide a convenient service oriented framework and this architecture is 
well suited for distributed system integration. They offer great interoperability (mainly 
because of standardized specifications). They enable the communication of processes and 
transfer of data independently of the programming language of the underlying applications. 
Therefore, by extension, virtually almost any piece of software can be exposed as a web 
service. They can be considered as firewall-friendly, because they are based on standard 
Internet protocols. 
But web services are semantically poor. They are not adapted for transferring huge 
quantities of data. The performance can be worsened due to the overhead of sending XML 
messages. 
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Thus, to build an infrastructure, it is necessary to implement grid components, such as 
grid wide security standards, resource scheduling and other components. The RUGBI grid 
technology combines the web and the grid components. 
Architecture 
Figure 17 presents the different layers of the grid. The different components of the 
RUGBI grid are: 
• The Computing Elements and the Storage Elements, composed of the operating 
systems, the batch manager, the grid components of Globus and the grid components 
developed by the RUGBI project associated to the web services interfacing to the 
Controller. 
• The Controllers hosting the grid components and the web services, and associated to 
the database servers supporting the Information System. 
• The grid portals interfacing to the Controllers. 
• The exploitation server for logging, bookkeeping and grid administration. 
All the elements, except the exploitation server, are distributed on the different nodes of 
the grid.  
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Figure 17: Multi-layer architecture of the RUGBI grid 
 
The grid components provide the tools for the job submission (job submission, node 
selection), the tools for the job execution (logging, database management…), and the common 
tools to all components (Virtual Organization management on the nodes, user session 
management, cluster management…). For instance, the WorkflowEngine module [403] 
manages the different subtasks for an execution (job, data transfer, grid component 
invocation, fault-tolerance…). Most bioinformatics jobs require only a few minutes of CPU; 
contrary to other grid middlewares adapted to long tasks, grid components allow an efficient 
submission of short tasks. Another example is the DatabaseFinder module used mainly to find 
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the best location of a given database on the grid for a given user. This module ensures also 
that a database used by a job will not be modified or deleted during the job execution. This 
module is used by the database update service explained in chapter 3. The grid components 
are based on the Globus Toolkit (2 and 4). GridFTP is used for grid data transfer. This choice 
was based on the fact that GridFTP is quite standard, and used in several grid middlewares. 
The Controller, thanks to web services, manages grid users and groups, manages grid 
components and logical resources (applications and databases), defines the rights to the 
resources, defines resource configuration, locates the resources (storage spaces and logical 
resources), executes the job work flows, allocates the jobs to the best sites, updates and 
synchronizes the Information Systems, manages data, exploits the grid information to produce 
the work and connexion history and manages user and group subscription. Each service is 
described by a WSDL file and each method is described by its name, its arguments, its results 
and its description. The storage format is XML, with a DTD for each resource type, a 
Relational Data Base Management System or a XML native Data Base Management System.  
The communication protocol between the portals and the Controller server is based on 
SOAP for its flexibility and its exchange security.  
Combining grid components and web services eases the creation of efficient user 
services.  
2.6. Conclusion 
In this second chapter, grid technologies were defined and described in order to address 
the requirements of the in silico drug discovery process against neglected and emerging 
infectious diseases. Many grid definitions exist, and there are many ways to classify them, 
depending on their goals, their technologies, their ownership or their hardware for instance. 
The complexity of the underlying hardware resources needs to be managed and hidden by 
software layers providing services for users.  
The middleware, or grid operating system, differs for the desktop and cluster grids. They 
are the most widespread grids, and their objectives are different. A desktop grid provides a 
powerful and easy to deploy computing power environment whereas a cluster grid is service-
oriented and provides a durable environment with various resources. The best type of grid to 
address the requirements of in silico drug discovery against neglected and emerging infectious 
diseases is the cluster grid. 
There are different cluster grid infrastructures and technologies in the world. The choice 
of a grid infrastructure depends on many criteria. The European grid EGEE, the French 
regional grid AuverGrid and the Taiwan national grid TWGrid are large production 
infrastructures, based on the EGEE technologies, providing a powerful environment for 
computing and data intensive applications. The French national grid for bioinformatics 
RUGBI is an infrastructure, based on web services, providing a useful environment for 
industrials and academic institutions in life sciences. The work described in this document 
was deployed on these different infrastructures. 
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The aim of the next chapter is to propose services for grid-enabled protein structure 
prediction on the RUGBI grid. We are going to describe a software and database deployment 
service and a database update service.  
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Chapter 3. Services for protein structure 
prediction in a grid environment 
3.1. Introduction 
In chapter 1, we introduced the concept of in silico drug discovery. One step of the 
process is protein structure prediction, which aims to determine the 3D structure of a protein 
from its amino acid sequence. Understanding the function and the physiological role of a 
protein target is fundamental for the discovery of new drugs. This complex process 
contributes for instance to the identification of the function of an individual protein or the 
provision of target structures for drug design. 
Scientists need access to many public or private software and databases to analyze 
sequences and structures as well as physical and chemical properties. But technical aspects, 
such as the delays in waiting for the server response due to multiple accesses, limit the use of 
the protein structure prediction servers. Chapter 2 explained that a cluster grid can address 
these requirements by providing a secure environment to share resources (software, database, 
computing power, storage…). 
The RUGBI grid was developed to offer a direct, secure and high performance access to 
different software and databases to analyze proteins. The services which are going to be 
described in this chapter were developed to enable protein analysis in a grid environment. 
They are not specific to protein structure prediction. Grid-enabled protein analysis requires a 
deployment service to allow registration, modification and consultation of bioinformatics 
software and databases. Once registered, the software or the database is automatically 
installed on determined grid nodes in grid private space and is ready to use thanks to 
automatically generated interfaces. 
But scientists have to be able to access easily the last update of the databases in order to 
apply the software. The frequent and regular update of the databases is a recurrent issue for all 
host or mirror centers. A service to update and distribute biological databases makes available 
the last version of a flat file database on the grid for the jobs launched by a RUGBI user. It 
must be noted that, in the context of bioinformatics, the term database refers to a large set of 
catalogued sequences (for instance: protein sequences), and does not include standard data 
management systems [404]. 
The aim of this chapter is to present two grid-enabled services to deploy and update 
protein structure prediction software and databases. Services were developed for a broad 
range of bioinformatics applications but are particularly relevant for protein structure 
prediction in the perspective of in silico drug discovery. 
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The chapter is introduced as follows: 
• After the introduction, the second section gives a brief summary of related works on 
this topic. 
• The third section is about the service used to deploy software and databases in the 
RUGBI framework. 
• The fourth section concerns the database update and distribution service in the RUGBI 
grid. The objectives, architecture, results, limitations and perspectives are presented in 
the third and fourth sections. 
3.2. Related works 
The grid-enabled bioinformatics services of the RUGBI grid aim to offer a personalized 
and secured working environment on grid. The software and database deployment service, 
based on web services, helps the user to install and use their own software and databases in a 
computing grid environment. The database update and distribution service downloads and 
spreads automatically and periodically the database on determined grid nodes. Some projects 
propose bioinformatics services in a grid environment to ease the use of distributed and 
shared resources between many actors. 
The word resource is used for logical resources (data, software, licenses) and physical 
resources (Computing and Storage Elements). 
Grid-enabled software and database deployment 
Several projects like North Carolina BioGrid [334], EuroGrid BioGrid [405], Asia Pacific 
BioGrid [406] and GénoGrid [407], share computing and storage resources for a community 
with the aim of deploying data analysis tools. Dedicated web interfaces give access to public 
databases which are integrated in the environment. But there is no common bioinformatics 
service to register and install a new software or database. 
A Problem Solving Environment is an integrated computing environment for composing, 
compiling, and running applications in a specific area [408]. Projects like MyGrid [274], 
Proteus [409] and ProGenGrid [410] develop Problem Solving Environments [411] 
bioinformatics grids. 
MyGrid is a project dedicated to the integration of distributed data, workflow 
management and environment personalization. The knowledge, the services and the 
bioinformatics resources are categorized with ontologies. An ontology defines the terms used 
to describe and represent an area of knowledge. Taverna [412], a component of this user 
toolkit, is a powerful tool to realize in silico experiments. But MyGrid does not provide 
computing or storage resources. A scientist can register his software (their service) or his 
database, but they are installed on his own computing or storage resource. Issues about access 
saturation or execution delay due to computing limitation for instance are not resolved. 
Proteus and ProGenGrid build service oriented architecture to gather tools and databases, 
encapsulated in web services and to execute them transparently on grid using ontologies and 
Chapter 3. Services for protein structure prediction in a grid environment 
 
 
  83 
workflows. This model aims to bridge the gap between Information Technology and the life 
sciences using both web and grid components. They are between the two previous project 
types, using ontologies, workflows, grid execution and result presentation. However, Proteus 
is proteomics-oriented only. Furthermore, the user in both projects cannot install and use their 
own software and databases.  
In comparison with these related works, the services we developed allow an identified 
user to deploy any public software and database in their private storage space. If the user has 
the corresponding license, a commercial tool can also be deployed with the help of node 
administrators if necessary. The services described here provide software components to ease 
biologists’ activities with metadata, ensure the interface with the exploitation service of the 
grid infrastructure, guarantee interoperability between databases and software and manage 
program execution and public or private data manipulation. All services are integrated in a 
secure and robust environment. 
Database update and distribution in a grid environment 
The biological database providers [413,414] make them publicly available in ftp servers. 
Each bioinformatics center or laboratory [415] needs to download the updated database to 
give access to its users. There are update services, but they can be integrated in a specific 
commercial tool, such as the SRS-Prisma module of SRS [416], a web-based retrieval system 
for biological data. There is an update server development [327] but the aim of this package is 
to download the update of several public databases in an unique local database, instead of 
distributing the database on many nodes. Scientists working on a grid infrastructure such as 
EGEE need to have the ability to deploy the database they are interested in on the grid nodes 
they select. 
A large number of research papers and development projects focused on file replication. 
But there is not much literature about database update services in a grid environment. A 
review is carried out in [417]. 
In this paper, the authors proposed a Replica Consistency Service conceived for data 
grids, allowing asynchronously replica updates in a single-master scenario. This method is 
close to the method described in this document, but their service is designed for relational 
databases whereas the RUGBI service is flat file-oriented. 
xNDT redistributes databases from the Swedish EMBnet node to a number of national 
EMBnet subnodes [418]. It is being adapted for a grid environment but it is limited for the 
moment to MySQL relational database and is still in development. 
The service proposed here is based on the same process as [417], but it is specialized for 
flat files.  
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3.3. Service for the deployment of software and 
databases 
3.3.1.  Service objective 
The software and database deployment service allows registration, modification and 
consultation of bioinformatics software and databases. Once registered, the software or the 
database is installed on determined grid nodes and ready to use thanks to automatically 
generated interfaces. Each registered RUGBI user is authorized to deploy software or 
databases on a private grid space. The user is considered as the administrator of the resource. 
He also decides the access rights associated to the resource (public, group, individual). The 
deployment process can be achieved through three steps presented in figure 18: Resource 
information registration, Resource download and resource installation using the Information 
System. 
 
Resource information
Registration
Download
Resource
Install
Information System
 
Figure 18: Resource deployment process 
 
After this first service description, the next section presents the service components. 
3.3.2.  Service components 
Some of the components needed for the service were detailed in chapter 2: the Storage 
Element where the resource is stored, the Computing Element where the software is installed 
and the Controller managing the Information System and the deployment service. They will 
not be described again here. 
The next paragraph defines bioinformatics software and databases to understand how to 
deploy them on the grid. Then the Information System is presented. The last paragraphs 
describe briefly the database update service and the execution service: service functionalities 
are used by the deployment service. The database update service will be detailed in chapter 
3.4. 
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Software and databases to be deployed 
A bioinformatics software command line requires basically the pathways of input file(s), 
parameter file(s), database file(s) and/or output file(s). The execution modes of bioinformatics 
software are various and difficult to model. For instance, one of these command line 
components can be a repository instead of being the name of the file. A component can also 
be implicit without appearing in the command line (see Blast execution mode [419]). The 
installation process can also be varied. One example of this diversity is the download 
localization (ftp, sftp, http, shttp...) of the software. Finally, some complementary information 
is available like software publication and licensing.  
A biological database records data generally split into textual entries composed of a 
datum with associated metadata. In a protein sequence database, like Swissprot [420], the 
datum is the sequence and metadata are items such as the identifier of the protein or the 
bibliographic references. For the RUGBI project, only the sequence flat files will be used by 
the software, and thus installed on the grid. But the process is the same for a full database. 
These worldwide databases are available on the Internet through for example HTTP or FTP 
transfers for a desktop or site usage. Their structure is varied (multiple files and repositories). 
Complementary information is available like database publication and licensing. 
The Information System 
The Information System manages the users, the computing and storage resources, the 
software, the databases, etc. There are four types of information by resource: the 
administration information for the installation, the configuration and the deployment; the 
information used by the portals to define the user interface; the configuration and localization 
information, for the allocation and localization services; and the execution information for the 
execution services. The Information System is hosted by the Controller. Each Controller has 
an updated Information System.  
The Database Update Service 
The Database Update Service can be used by the deployment service to download a 
resource from an external location on a Storage Element and to distribute it on other 
determined grid sites. The Database Update Service is hosted on a Storage Element. It uses 
the resource information from the Information System. 
The Execution Service 
The Execution Service can be used by the deployment service to install a resource on a 
working repository of a Storage Element or a Computing Element. Its main role is to manage 
the job execution on a node, including for instance data or software transfers from the 
working repository to the temporary repository of a Worker Node.  
The next section presents the Deployment Service architecture. 
3.3.3.  Service architecture 
Protocols were designed to help administrators to deploy resources. Protocols describe 
the different steps required to install the resources and ensure the communication between the 
Chapter 3. Services for protein structure prediction in a grid environment 
 
 
  86 
actors of these protocols thanks to the Information System. This section provides the Unified 
Modelling Language (UML) class diagram of the Deployment Service, the DTD model of 
software and database resources rendered as a graph diagram and the UML sequence diagram 
for a resource deployment. 
The UML class diagram of the Deployment Service 
Figure 19 is a UML class diagram for the Deployment service. The service is a part of a 
global Resource Service. Software and database resources and deployment methods are 
developed.  
 
 
Figure 19: UML class diagram of the Deployment service 
 
A resource can be physical (a grid site) or logical. Logical resources are software, 
database or data (the data resource is used by the Data Manager of the RUGBI project). 
Software and database attributes are for instance their name, their description, their version, 
their XML file URL and their administrator mail. Software and databases are described in the 
next section. 
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The resource class is used by several services. Here are shown the ExecutionService for 
the job execution and the ConfigurationLocationService to configure and locate a physical 
resource. 
The ResourceServices methods allow the resource deployment through the portal. The 
createResource method defines a resource (its parameters, its install mode…) thanks to the 
resource DTD model (described below) and transfers the resource from an external location to 
a dedicated repository in an internal Storage Element. The deployResource method transfers a 
resource from the dedicated repository to a working repository and installs it (compilation, 
parameters…). The replicateResource method replicates the resource on different grid nodes. 
Other methods, such as editResource, deleteResource, etc., allow resource manipulation. 
Methods of the ResourceRequest table allow a search of resources by type, and the 
addition, deletion or updating of a resource (from version n to version n+1). 
The DTD models of the resources 
Information about software and databases is dynamic and textual. It is easily described in 
XML files. These files have their own DTD for each resource type. The DTDs of the software 
and database XML files are rendered as graph diagrams in figures 20 and 21. 
The DTD graph diagrams are composed of: 
• The mandatory element Software or Database which contains unique attributes like 
Identifying and resource Name. 
• The mandatory element Characteristics contains the common information about the 
resource (attributes Version, Date, Confidentiality…). It is subdivided into a 
mandatory element Copyright (attributes commercial or free Category, Weburl…) and 
other informative elements (Author, Bibliography…). 
• The element Deployment manages the install on a grid site and the composition of the 
resource. For the database resource, this element possesses a few attributes such as 
deployment Type or Number of Files.  
o The mandatory element Install possesses several attributes for the resource 
install such as Required Space or Path; Install and Uninstall Scripts or 
Required Architecture are specific to the software resource. The Download 
element is necessary with attributes like Protocole or Url.  
o The element Structure describes the structure of the set of Files (attributes 
Name, Size, Format, mandatory…) and Directories (attribute Path) of the 
resource.  
o The element Environment for the software resource is still not used. 
• For the database resource, the element Use indicates software authorized to use the 
database. 
• For the software resource, the element Execution describes all software parameters 
necessary for the execution and for the saving of the generated output. The element 
Execution contains for instance the attributes Input Usage and Output Usage which 
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explain how the input or the output is recognized by the software (file, command line 
parameter, location, location of implicit input or output…). 
o The elements Processparamfile and Globalpreexe specify if there is a pre-
process on the parameter file or globally before the execution (like a format 
conversion). 
o The element Processresultfile and Globalpostexe specify if there is a post-
process on the result file or globally after the execution (like a format 
conversion).  
o The element Parameter is used for the command line creation (attributes Type 
of the argument like file or value; argument Rank in the command line; 
Optional or mandatory in the command line, simple or advanced Category for 
the submission interface of the software…). Examples of the subdivided 
elements from the element Parameter are the element Storagepath, which 
indicates where an output is stored or should be stored, or the element Ihm, 
used to generate the submission interface of the software and composed of a 
description and a type (list, file, text, value…).  
o Finally the elements Inputstructure and Outputstructure describe the structure 
of the input or output environment. 
 
characteristics : mandatory
deployment : optional
 
Figure 20: DTD model rendered as a graph diagram of the database resource.  
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characteristics : mandatory
deployment : optional
 
Figure 21: DTD model rendered as a graph diagram of the software resource. 
 
Information about software and databases is used for: 
• The resource deployment and localization by the end-users and the site administrators 
• The resource information description for the end-users 
• The resource choice by the end-users 
• The software interface generation by the portals 
• The software execution (task flow creation: generation of the command line, transfer 
of the resource on the execution site, output storage) 
• The update service 
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Each resource file can be easily managed by its administrator with the methods described 
in the UML class diagram. 
The UML sequence diagram for resource deployment. 
Figure 22 presents the UML sequence diagram for software deployment. The 
ResourceService manages the deployment. The UpdateService and the ExecutionService 
execute the resource transfer and install. 
 
: User : Portal : UpdateService : ExecutionService: ResourceService
selectResoureService
createResource( )
deployResource( )
downloadResource( )
installResource( )
replicateResource( )
distributeResource( )
saveXML( )
saveXML( )
saveXML( )
 
Figure 22: UML sequence diagram for resource deployment 
 
Service implementation 
The Resource Service and the Information System are hosted on the Controller server.  
The server is in Java for its portability, as well as for its integration with other technologies 
(All the Globus Toolkit APIs are available in Java). The storage format for information is 
XML, with a DTD for each resource type, a Relational Data Base Management System or a 
XML native Data Base Management System. Queries between the Resource Service and the 
Information System are carried out thanks to XPath with the Java API Jaxen [421]. 
Communications are made with SOAP (for instance communications between the portal and 
the Controller). Technologies used for data transfer are reported in the database update 
service. 
The next section describes a case study of a software deployment. 
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3.3.4.  Result: Case study of a software deployment 
Using the deployment service, diverse databases and software were integrated (see table 2 
in chapter 2.4.4). A case study for demonstration is the deployment of Gor [422], a tool for 
protein secondary structure prediction. 
Protein secondary structure consists of local inter-residue interactions mediated by 
hydrogen bonds. The most common secondary structures are alpha helices and beta sheets. 
The random coil indicates an absence of regular secondary structure. The GOR method 
predicts protein secondary structures of an amino-acids sequence using all possible pair 
frequencies within a window of 17 amino acid residues. After cross-validation on a data base 
of 267 proteins, the version IV of GOR has a mean accuracy of 64.4% for a three state 
prediction (Q3: percentage of residues predicted correctly as helix, strand, coil or for all three 
conformational states). The program gives two outputs, one eye-friendly giving the sequence 
and the predicted secondary structure in rows. The second gives the probability values for 
each secondary structure at each amino acid position. The predicted secondary structure is the 
one of highest probability compatible with a predicted helix segment of at least four residues 
and a predicted extended segment of at least two residues. Gor is simple open-source 
command line software. It has few parameters, calls only two small databases and produces 
two small outputs. In this case study, the aim is to predict secondary structures of the aspartic 
hemoglobinase II, or Plasmepsin 2, of Plasmodium falciparum (Primary accession number of 
Swissprot: P46925) thanks to Gor IV.  
Once connected to the RUGBI portal with its personal certificate, the scientist accesses a 
view of his environment. He can see for instance the list of software he is authorized to use. 
Figure 23 shows the Administration interface for software management. 
 
 
Figure 23: Software administration interface 
 
The first stage of the deployment of Gor on the grid is the choice of the grid site where 
the software will be deployed. Once selected, the registration interface appears to describe the 
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software. Figure 24 presents the registration interface with the attribute Characteristics to fill 
in, conceived from the DTD model of the resource, and the XML file generated automatically 
after validation. 
  
 
Figure 24: Registration interface of the Gor software generated by a DTD model and XML 
file generated after registration. 
 
The user must fill in the fields with the resource information. After validation, the 
software administrator can see this new resource in the list of his available resources 
(Software utilization interface). The user will then deploy the software on his private space 
(see figure 23) thanks to the information from the elements Deployment, Install and 
Download of the software resource (see figure 21). A task flow is generated to download the 
resource from its external storage source or from the user local machine, to transfer the 
resource in the storage space, to install it (if compilation is required, only the site 
administrator is authorized to install it), then to update the site’s configuration. The XML file 
is registered in the Information System of the Controller and replicated on the other 
Controllers of the grid. The software will be accessible through a portal only for users 
authorized by the software administrator (Group menu). Different versions of the same 
software can be installed. At the end of this protocol, the resource is ready to be used on all 
portals. The deployment is completed. 
An example of use of the XML file is the Gor submission with the amino-acids sequence 
Plasmepsin 2 by a classical submission interface. Figure 25 presents the XML file of the Gor 
software and the automatically generated access interface. The simple mode requires only the 
amino-acids sequence in fasta format. The registration format is thus a file (the text which can 
be written in the access interface, such as in figure 25, is automatically converted into a file). 
The corresponding Parameter attributes are Category, with the value “simple”, and Type, with 
the value “file”. The Object attribute is Format with the value “fasta”. The expert, but 
optional, mode is partially visible in the figure. Default values are registered in the XML file. 
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For instance, the Parameter attribute value of the Ihm attribute “Description Number of 
sequence” is 267. 
 
 
Figure 25: XML file of the Gor software and the access interface automatically generated. 
 
Once the interface has been filled and validated, the task execution and the job 
monitoring are processed independently. The full command line is recomposed from the XML 
file and the user information. The interoperability between software and databases is checked 
thanks to the attributes on format, directory and use restriction. An email is automatically sent 
to the user once the process is finished. Figure 26 presents on the left the execution report of 
the task run on CSSI-Grenoble-Cluster-4.0 node. On the right is presented the predicted state 
for each amino-acid of the Plasmepin 2 sequence. The H is a helix, the E is an extended or 
beta strand and the C is a coil. 
The user can register the result on their local disk or on the grid in order to save it and 
eventually use it again with other software. The installed software can also be used again with 
other data. The environment is thus personalized and saved for a specific user in the RUGBI 
environment. This deployment service is paramount to make grid use transparent for the 
scientist. 
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Figure 26: Prediction visualization in text format of Plasmepsin 2 with Gor IV 
 
3.3.5.  Service limitations and perspectives 
However, the service has some limitations. 
Limitations 
As this service aims to integrate a large number of software and databases, the resource 
data models presented in figure 24 and 25 are complex. The user that wants to register their 
resource needs to know it very well. One example is the number of elements and attributes to 
describe the software command line. The registration step can be long, even if many elements 
are optional. The user administrator can decide to register only the software simple mode 
without advanced options for instance.  
A second limitation is the management of licenses. Registering and using in-house 
private software is easy and secure in the RUGBI grid. But there are license modes that 
cannot be automatically managed with the registration interface. 
A third limitation is the risk of accumulating many different versions of the same 
software confusing the view for the end-users of a group. This problem can appear if the 
group is large or badly managed. The problem will not appear for the installation of software 
or databases in public space because this installation needs be validated by the RUGBI grid 
administrators. 
Perspectives 
Despite these limitations, the deployment service is a key for the future of the RUGBI 
grid. New software and databases are regularly emerging. Thanks to the grid flexibility and 
automation, a scientist can build his personalized environment with his favorite resource. 
Solving the limitation issues presented above could increase the number of users.  
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The registered information on resources is useful for all other RUGBI services. It could 
also be used by a workflow manager, a project manager or an annotation manager. The 
RUGBI grid can be easily extended with these new services thanks to web services. A 
bioinformatics experiment manager is under preparation by a RUGBI partner. Moreover, the 
Embrace network of excellence will promote the web services, and in the future, services 
developed in the Embrace framework could be integrated in the RUGBI framework. 
The database deployment service would be extremely limited without a database update 
and distribution service. This is the topic of the next section. 
3.4. Database update service 
3.4.1.  Service objective 
The RUGBI grid aims to offer its services to a community of scientists, for instance in 
protein structure prediction. Some of the applications call third party databases. As the main 
criterion of the grid is sharing out, there will be several spaces storing the databases for the 
jobs, from which they will directly pick up the information. Most of the required databases are 
stored and updated on ftp repositories. For instance, the Swissprot database is updated 
biweekly as a new complete database file including all the new entries added since the last 
release. It is a goal in itself to give the users the most up to date version of each database for 
their jobs to run on. It must be noted that only the last version of the database will be available 
on the RUGBI grid. Previous versions of the database (n-1, n-2 etc.) will not be kept for 
storage space reasons: for instance, it takes only 6 versions of the EMBL [423] sequence 
database to reach one terabyte of data. 
Hence a service that will update each database site through the grid according to the last 
modification on their repository is needed. The system must be light and transparent enough 
to not disrupt job execution and to automate the procedure thus requiring a minimum of 
human intervention. At the end the service should be a black box delivering up to date 
databases on the grid that should prevent users from wondering which is the version deployed.  
The update process can be achieved through the three steps presented in figure 27. First, 
given that all necessary information on the databases deployed and their respective repository 
locations are available, the comparison step informs the system if an update is needed. It is 
quite obvious no process is going to be started if the databases on the grid are already up to 
date, it would just consume unnecessary computing power and network resources. The 
comparison process indicates which parts of the database have been subject to modification 
and updates the grid database information. Those parts will be downloaded during the second 
step from the repositories. In the worst case, the entire database will be downloaded. The third 
step updates all the databases distributed on the grid thanks to the grid Information System. 
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Figure 27: Database update process 
 
After defining the components and the architecture of the service, we will describe its 
deployment on the RUGBI grid. 
3.4.2.  Service components 
The service was developed in the framework of the RUGBI project. Several components 
needed for the service were detailed in chapter 2 and previously in this chapter: the Storage 
Element where the database is stored, the grid components for the storage process, the 
Controller managing the Information System and the DTD model of a database resource. 
They will not be described again here. 
The next paragraph defines databases to understand how to update and distribute them on 
the grid. Then the concept of Storage Element of Reference is explained. Finally the 
DatabaseFinder service is described. 
Databases to be updated and distributed 
The databases required in the RUGBI project for in silico drug discovery are 
UniProtKB/Swissprot [420], UniProtKB/TrEMBL [420], EMBL [423], PDB [118], KEGG 
[424] and NCI [425]. The genomics and proteomics sequence databases EMBL and 
UniProtKB are used in the sequence alignment step of the protein structure prediction 
pipeline. The protein structure database PDB is used in the homology modeling step. The 
metabolic pathways database KEGG is used to identify molecular networks. The compound 
structure database NCI is used in the virtual screening pipeline. 
They are constituted of several flat files, organized in directories. They are just handled 
as file systems: files can be added, removed or modified and are available directly on ftp 
servers anonymously. 
The Information System of the RUGBI grid is based on XML description files of each 
element of the grid. There is an XML file for each database to specify for example its URL on 
the ftp server, the update frequency, etc. 
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The external database repository described in this chapter is an ftp server but the database 
update service will be able to download information from other servers, like http. 
The Storage Element of Reference 
There are several Storage Elements of Reference, one per database, which are 
repositories of the databases on the grid. A repository space is a persistent space used to store 
information (jobs cannot use this space). These grid repositories should be synchronized with 
the ftp servers. 
Per Storage Element of Reference, there are several Storage Elements where the working 
repositories for the jobs can be found. A working repository is a space used to store 
information currently used by running jobs (as jobs are using these spaces, they are protected 
as critical sections). 
 The DatabaseFinder service 
The RUGBI architecture also includes a service called the DatabaseFinder, used mainly 
to find the best location of a given database on the grid for a given user. Furthermore, the 
service manages locks put on the databases by the running jobs to prevent their modification 
while the job is being executed. Moreover it can forbid a job to use a database in a given 
location, hence allowing the update service to perform its operations without disrupting job 
execution. Locks are needed to ensure the safety of jobs and the integrity of the replication of 
the databases. For security issues, locks are automatically removed after a given period of 
time and jobs must renew their locks to protect the critical sections on which they run. If a job 
is stopped during its execution or if there is a failure preventing it from removing its lock, the 
lock will be limited in time. 
3.4.3.  Service architecture 
The service is intended to be a direct interface between the database ftp servers and the 
Storage Elements of the grid. Our main developments will focus on the RUGBI grid 
infrastructure but the whole service is designed to work as a standalone tool that we can adapt 
easily to any middleware architecture and with any database. 
The database update service as a client/server application 
The update service as a client/server application is conceived in two parts communicating 
with each other. Figure 28 presents the update service architecture. 
Firstly, the server, or master service, deployed on the Storage Element of Reference 
regularly checks external sites, typically ftp servers, for updates. It performs a comparison of 
the version available on the ftp with the one deployed on the grid using the XML description 
file of the databases given by the Information System. 
If there is a difference, based on the date or a new file or repository, the update service 
replaces or rebuilds the databases by downloading the necessary files or directory on to 
repository spaces on the Storage Element of Reference. Other optional processes like format 
change or index computation are possible and can be described in the install attribute of the 
file. 
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After that first step, the master service queries the Information System to know the 
Storage Elements that host the database and notifies the clients deployed on them to update 
the database. The Configuration and Location service is used here. When an update 
notification is received by a client, it extracts the data from the Storage Element of Reference. 
To do that, it simply downloads the differences on the repository of the Storage Element of 
Reference in a new local working space, closed for jobs, using the specified transfer protocol. 
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Figure 28: Architecture of the update service 
 
As soon as the number of Storage Elements (clients) that have successfully deployed the 
update reaches a given threshold, the DatabaseFinder service is notified to register the new 
database. This implies that the working space will open and accept new jobs. If a database 
version is already on the Storage Element (in a working space), the same service is notified to 
unregister the old version. New jobs will not be allowed to run on the old version, since it is 
unregistered, but will use the new registered version. Running jobs, still submitted with the 
old version, are not stopped. 
When the grid has registered the new deployed database, the XML description file of the 
database is updated on the Information System and the old one deleted. 
As soon as no more jobs are using the old version, the server is notified by the Database 
Finder Service and it deletes the old version. That notification is propagated through the grid 
so that any Storage Element hosting this version will delete it. The whole process can be 
repeated through time to keep the databases updated. 
For each database with a running update service, there is a database administrator. This 
administrator is responsible for changing the database file if the external database model 
changes. He can also launch himself an update when he thinks it is necessary. This transparent 
Chapter 3. Services for protein structure prediction in a grid environment 
 
 
  99 
service frees the user and the database administrator of technical constraints. They can 
concentrate on understanding and exploiting the data themselves. 
Service implementation 
For its integration the service must borrow some mechanisms from RUGBI and Globus 
Toolkit. The GridFTP protocol is used for grid data transfer. The external data transfers are 
done through basic ftp when the external site hosting the database is an ftp server. Signed 
proxy and X509 certificates are used for authentication and interoperability with several grid 
components. In order to allow further deployment of the service or interfacing with other grid 
infrastructures a basic core version was developed and the specific developments inherent to 
the integration with specific grid components were built on this core. Developments were 
made in Java for portability and modularity.  
As the RUGBI grid was based first on Globus Toolkit version 3, and later on Globus 
Toolkit version 4, the sub services were also implemented as web services, messaging with 
SOAP protocol, in order to achieve better connectivity with the other services, and to avoid 
the handling by grid sites of exotic firewall configurations: they should just allow inbound 
and outbound connectivity for web services (8080 for Apache tomcat) and gridftp (2811 most 
of the time). The developments were done in an Apache Axis environment. 
3.4.4.  Result: periodical database updates and distribution 
on the RUGBI sites 
The RUGBI grid has currently five sites in Clermont-Ferrand, Lyon and Grenoble. The 
client Update Service is deployed on each Storage Element of the grid (in each of these sites). 
The Clermont-Ferrand site hosts the Storage Element of Reference of the grid. Thus, the 
master service was deployed there.  
The following bases are deployed and updated periodically from their repositories in 
Clermont-Ferrand and Grenoble: UniProtKB/SWISSPROT (700 MB), UniProtKB/TREMBL 
(2.4 GB), EMBL (release without annotations: 180 GB), KEGG (13 GB), PDB (2.9 GB), NCI 
(900 MB), representing a total of 200 GB. All database files in correct format and yet indexed 
are directly downloaded from the external reference sites. 
These databases have an update cycle of 15 days on the grid. Once the update of a 
database is initiated from the portal by the database administrator, its reference site runs the 
update process each 15 days. The volume of the transfers required by each update varies from 
several kilobytes to several gigabytes depending on the databases and their activity. 
Performance of the complete update process depends on the network bandwidth. 
3.4.5.  Service limitations and perspectives 
The service presents several limitations. 
Limitations 
A biological database records data as textual entries composed of a datum to which are 
associated metadata. In a protein sequence database the datum is the sequence and metadata 
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are items such as the identifier of the protein or the bibliographic references. The Database 
Update Service allows to only update the sequence flat files which will be used by software. 
The process is the same for a full database and could be implemented, but it requires indexing 
which is CPU intensive. The Database Update Service should be interconnected with indexing 
applications parallelized on the grid. 
Only one Storage Element of Reference can host the service for a dedicated database. 
This is a single point of failure because the service must be permanent and can not be stopped. 
Other Storage Elements of Reference could be configured to host the service for the database, 
but it requires synchronization. 
Relational databases are also used in life science, but the service is limited for updates of 
flat files. The CONStanza system [417] is designed for relational databases. The development 
of a new system merging functionalities from both services is being considered. 
Perspectives 
The service, packaged as a middleware component, is installed and deployed on the 
RUGBI grid by the site administrators as a grid plug-in. Its deployment on the French 
regional grid AuverGrid, which uses the EGEE middleware LCG-2, requires some interfacing 
with the job submission system to allow jobs to put locks on site databases to secure updates. 
Instead of being installed on a Storage Element, the service could be deployed on a User 
Interface with a specific service certificate registered in the biomedical Virtual Organization. 
Used in conjunction with a database declaration server, the update service could be easily 
added to the DIET middleware [426], which follows the gridRPC API defined within the 
Global Grid Forum [427] and presents a hierarchical architecture where agents manage 
scheduling and some persistence mechanisms. 
The new gLITE middleware [350] should be theoretically quite similar to RUGBI with its 
web service-friendly architecture providing APIs for new service integration. The update 
service could therefore be easily interfaced to gLITE. 
Another perspective is to offer this service as a software application instead of a service. 
It could become a part of a grid workflow, and called only when a database update is 
necessary. 
There are also future plans to optimize the deployment of databases: for example, being 
able to split databases and lock only parts of them. The service will mature through its 
deployments on grid middlewares in production environments. 
3.5. Conclusion 
In this third chapter, two grid-enabled services to deploy and update protein structure 
prediction software and database were deployed on the RUGBI grid. 
The deployment service aims to ease the use of software and databases for non-grid 
expert users on a grid environment. It allows registration, download and installation thanks to 
interfaces generated by the Information System describing software and databases. The 
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environment is personalized for each user in the RUGBI environment. This deployment 
service is paramount to make grid use transparent for the scientist. Developments are still 
needed to improve interfaces and enrich functionalities. 
The aim of the Database Update Service is to provide the grid users with the most up to 
date version of any biological flat file database, to do it transparently and without disturbing 
any running jobs. The frequent and regular update of the databases is a recurrent issue for 
scientists and all host or mirror bioinformatics centers. This service ensures that the user’s 
analysis on grid will be carried out with the last available version of the database. It is 
installed for a precise database by its administrator but runs autonomously and periodically 
for small updates and for large new versions. Developments are still needed to interconnect 
the service with an execution service to parallelize recurrent time-consuming tasks such as 
indexing. There is a plan to migrate the service onto other grid environments like EGEE.  
Deployment and update services for protein structure prediction software and databases 
contribute to personalizing the working environment for biologists and life science industrials. 
The developments were carried out so that they would be easily modifiable and 
interoperable with new services. In the future, it will be possible to add an in silico 
experiment manager, with administration aspects, deployment of workflow, and project 
qualification, to valorize experimental results. This service will define and manage 
experiments with traceability, constituting a virtual laboratory. 
Permanent bioinformatics services must be conceived for daily in silico drug discovery, 
but large scale grids allow large scale challenges in life science that could never be carried out 
before. The aim of the next chapters is to present the deployment of high throughput virtual 
screening by virtual docking against neglected and emerging infectious diseases and to report 
issues related to the deployment and the monitoring of the in silico docking experiment as 
well as experience with grid operations and services. 
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Chapter 4. HGrid-enabled high throughput 
structure-based virtual screening by docking 
4.1. Introduction 
Structure-based virtual screening is one of the first steps of the drug discovery process 
once a molecular target has been identified. It is about selecting the compounds, i.e. the 
molecules, which could impact the target biochemical activity. High throughput structure-
based virtual screening by molecular docking is a technique which can screen millions of 
compounds rapidly, reliably and cost effectively. It is particularly useful in the discovery of 
drugs against neglected and emerging infectious diseases where reducing the duration and the 
cost of the process is essential.   
WISDOM is an international initiative to enable a virtual screening pipeline on a grid 
infrastructure against neglected and emerging infectious diseases. Its first venture was to 
deploy large scale in silico docking on a public cluster grid infrastructure. Given the very 
large amount of data involved in the computation, such a large scale deployment is a stressful 
experiment for the grid infrastructure, which is called a data challenge. Several applications 
were already deployed at a large scale on cluster or desktop grid infrastructures. For instance, 
the particle physics experiments on the Large Hadron Collider currently being built at CERN 
are the first applications having set up such data challenges on a public cluster grid. 
The preparation of the deployment included the development of an environment for job 
submission and output data collection. This environment had to be able to handle the 
submission of about 70,000 15-hour long jobs and the collection of an equivalent number of 
output data. One major issue was the handling of job resubmissions whenever a job failed for 
any reason. 
The aim of this chapter is to describe the WISDOM production environment designed for 
a large scale deployment on the public cluster grid infrastructure EGEE.  
The chapter is introduced as follows: 
• After the introduction, the second section introduces the requirements for such a 
deployment. Then different grid-enabled initiatives to deploy large scale virtual 
screening or particle physics experiments are reported. 
• The third section describes the bioinformatics components of a docking experiment. 
These first three sections are important in order to understand how to build an efficient 
WISDOM production system. 
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• Finally, the last section presents the design of the WISDOM production system: 
specific issues, preparatory steps on the AuverGrid infrastructure, production system 
design, license management and accounting data management are detailed.  
4.2. Requirements 
Advances in combinatorial chemistry have paved the way for synthesizing millions of 
different chemical compounds. Thus there are millions of chemical compounds available in 
the laboratories and recorded in 2D or 3D electronic databases. But screening millions of 
chemical compounds in silico is a complex process. Depending on each compound’s 
structural capacity, screening requires from minutes to hours of computation time on a 
standard PC and produces several megabytes of data. Consequently, screening all the 
compounds in a single database would require years and hundreds of megabytes to terabytes. 
However, the problem is embarrassingly parallel and the computation time can be reduced 
very significantly by distributing data to process over a grid gathering thousands of 
computers. For instance, reducing the virtual screening time from 100 years on a basic PC to 
only 1 month requires more than 1250 dedicated processors.  
Such deployment on a large scale requires:  
• Multidisciplinary collaboration providing the application package adapted to the grid. 
The application package is composed of data and software. Bioinformatics 
applications are not designed for grid computing. Their code can not be modified for 
several reasons, such as application copyright or application invalidity in case of 
modifications. A common strategy is to split the application into shorter tasks, or jobs, 
in order to distribute them in parallel on the different Worker Nodes of a grid. The 
splitting factor is often dependant on the number of smaller subsets that can be 
produced by splitting the database.  
• Robust, stable and large infrastructure access providing maintained computing and 
storage resources. Reliable resource estimation is required before the deployment. The 
application package needs to be installed on at least one resource to be available. 
• System providing automated and fault-tolerant job submission, job monitoring and 
output retrieval. The number of jobs for a large scale deployment is very high (tens of 
thousands to millions). Preparation, fast submission and efficient monitoring on a 
distributed and heterogeneous environment such as a grid are a manually labor-
intensive task. This tool must be able to manage large data or large numbers of small 
data. This tool must provide monitoring data for the process control by the user. Fault-
tolerance involves identification, failure resolution and job resubmission process. Thus 
this production system is at the interface with the grid middleware managing 
resources. 
• User interface for deployment management. Today, large scale deployment is still a 
task for a grid expert. Consequently, the deployment system does not require an end-
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user-friendly interface. But it requires at least simple command lines management and 
an expert monitoring view.  
• License management for commercial software. There are several types of licenses. For 
instance, the license price can depend of the number of processors used. Such a system 
is not viable in a grid infrastructure gathering thousands of processors. Editors have 
not yet adapted their license system to the grid.  
• Efficient and responsive user support of the infrastructure. A failure in a large scale 
deployment can impact a large number of jobs. The deployment can be stopped to 
solve the problem. Thus fast feedback and quality of service are important. 
• Tools providing global statistic data and figures about the large scale deployment. A 
large scale deployment involves many actors, such as a site administrator, an 
organization leader or a funding provider. The deployment must be assessed to prove 
its performance and to identify new issues. 
Thus large scale deployment of computing and data intensive tasks requires a large 
infrastructure interfacing to a system providing many efficient services. Beyond these 
requirements, in the context of the fight against neglected diseases, the required tools and 
infrastructures should be freely available for the application. Additionally, in the context of 
the EGEE project, the deployment tools interfaced with the EGEE infrastructure should use 
the EGEE middleware components for preference. 
The next section presents several projects and applications aiming to deploy virtual 
screening on grid, but also large scale application from other scientific fields. 
4.3. Related works 
Recently, high throughput virtual screening projects on grids have emerged with the 
perspective to reduce costs and time. Below are reported the main advanced projects on 
desktop and cluster grids. Then several deployment tools of large scale experiments on cluster 
grid are presented. 
Several criteria, when they are available in publications or technical reports, are used to 
describe the grid performance of the deployment tools. 
• The total CPU time corresponds to the cumulated amount of CPU used for a given 
application. 
• The duration represents the total elapsed time between the submission of the first job 
and the end of the last job. 
• The crunching factor represents the gain of time obtained thanks to the grid 
deployment. It is simply obtained by dividing the total CPU time by the execution 
duration. 
• The approximated distribution efficiency is defined as the ratio between the crunching 
factor and the maximum number of jobs running in parallel on the grid. This 
parameter is based on the approximation that the maximum number of jobs running in 
parallel on the grid corresponds to the number of available processors during the 
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overall period of the deployment, and the crunching factor is the constant number of 
running jobs. 
4.3.1.  High Throughput Virtual screening on a cluster grid 
The Virtual Laboratory project [253] was the pioneer in enabling molecular modeling for 
drug design on geographically distributed resources. It optimizes for time or cost the use of 
grid resource. The Nimrod-G [252,428] resource broker, based on Globus, is used for 
scheduling and on-demand processing of docking jobs on the World-Wide Grid resources. 
The Virtual Laboratory is used by the Australian BioGrid Portal to easily submit docking jobs 
[429]. The test case reported in [429] was deployed on 7 nodes with about 450 CPUs in only 
few hours.  
The purpose of the Drug Discovery Grid [430] is to set up a desktop and cluster grid 
environment with aggregated computing and data resources to provide drug virtual screening 
services and pharmaceutical chemistry information services. BOINC is the desktop grid 
middleware and Nimrod-G is the cluster grid middleware. The Drug Discovery Grid 
composed of 5 sites with 336 CPUs was used to screen 120,000 compounds against an 
interesting target for the treatment of hyperlipidemia, cholelithiasis and cholestasis.  
GROCK [431] is a portal that facilitates mass screening of potential molecular 
interactions in the Life Sciences. It aims to facilitate for users the performance of huge 
amounts of computational tasks using EGEE. They use LCG-submitter, a tool developed by 
the Experiment Integration and Support team as an interface with the EGEE middleware for 
job submission and monitoring. The GROCK portal is not yet available and no deployment 
has been reported.  
The Grid-based Virtual Screening of Dengue Virus Target Proteins project, supported on 
the national Swiss grid SwissBioGrid, aims to find new compounds against Dengue [432]. 
The first massive deployment was made on 4 heterogeneous nodes (desktops and clusters) 
with 360 CPUs using the in-house middleware ProtoGrid. They docked 500,000 compounds 
and consumed about 4 CPU years. First results are promising but the technology choice for 
the middleware on SwissBioGrid is not yet confirmed.  
These four initiatives aim to provide full virtual screening environments on large grids. 
But there are no reports of virtual screening deployment on thousands of processors for many 
weeks such as is required for high throughput virtual screening. Access to the grid 
infrastructures used by these applications (except Grock) is not possible for external 
initiatives such as WISDOM. 
4.3.2.  Large scale deployment on a desktop grid 
There are a few efforts that use desktop grids for processing docking jobs in parallel 
against a specific target. One effort is the FightAIDS@Home project [433], which is based on 
the World Community Grid [312] and Autodock [434] docking application. World 
Community Grid sets 400,000 CPU units for three different projects. The Cancer Screensaver 
Project [296] has used 447,000 CPU years since 2001. Over 3.4 million computers have 
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joined the initiative. D2OL [315] is using its own platform to screen a large compound 
database against targets of different diseases such as malaria and avian influenza. 
Novartis is a successful example of the deployment of an internal desktop grid. Their 
vision is to manage the knowledge and the informatics of virtual screening in their tightly 
protected grid environment [267]. They deployed the first automated modeling and docking 
pipeline on grid using the commercial United Devices platform. From 400,000 compounds, 
they selected a few promising molecules against the protein kinase CK2 with 1200 computers 
in 6 days instead of 6.4 years [435]. The crunching factor is about 387, thus the approximated 
distribution efficiency is only 32%.  
A protein structure prediction application experience, Predictor@home, was recently 
reported in [149] which will aim to deploy the BOINC framework with 6786 desktop PCs for 
3 months consuming 380 CPU years. Use of the BOINC framework requires specific 
application developments. Even if the deployment succeeds, there are still technological 
challenges such as server limitation and service stops due to maintenance.   
These initiatives group together many computing resources, but they are based on 
desktop grid technologies. There are no detailed experience reports about data challenge 
deployment (except Predictor@home). 
4.3.3.  Job submission systems for large scale applications 
on the cluster grid EGEE 
Many different applications were deployed on the large scale EGEE infrastructure. The 
particle physics experiments are the first applications to have taken benefit from the 
infrastructure. Their experience for large scale deployment is thus presented below. 
The four particle physics experiments on the Large Hadron Collider 
Four particle physics experiments associated with the Large Hadron Collider (LHC) are 
currently being built at CERN: Alice [436], ATLAS [437], CMS [438] and LHCb [439]. The 
volume of data generated by these experiments is expected to be in petabytes which need to 
be distributed to physicists around the world for analysis. Even though the detector will not 
take data until 2007, there is a large-scale data simulation and analysis effort underway for 
each experiment. Each experiment developed one or several analysis job submission systems 
and tested them at a real large scale on one or several grids (tens of sites, hundreds of CPU 
years, terabytes of managed data). Below are presented the job submission systems of each 
experiment used on the EGEE infrastructure. 
Alien, the job submission system of the Alice experiment 
Alien [440] was developed for the Alice experiment. It offers a single interface for 
ALICE users. It is a pull model service: a server holds a master task queue of jobs and uses 
the Resource Broker to submit many job agents. Once running on a Worker Node of a 
Computer Element, an agent calls a large job set, which is waiting in the task queue. Thus the 
job set is executing on all free Worker Nodes of the cluster bypassing the Resource Broker. 
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No Information System is included in Alien. The monitoring system of the Alice experiment 
uses MonaLisa [441].  
This system is clearly powerful for the Alien user. But it is concurrent to the EGEE 
Workload Management System, composed of Resource Brokers, used by other grid users. 
Moreover information extracted from Resource Brokers for the global accounting of the 
EGEE project is consequently incomplete [442].  
The ATLAS production system, the job submission system of the ATLAS experiment 
The ATLAS production system [443] uses middleware components as much as possible. 
A job supervisor submits, monitors and resubmits if necessary the jobs to an executor. In a 
first time, the executor was in-house job submitter using the Resource Brokers. Then, Lexor-
G [444], using the Condor-G service [445], was integrated to avoid the Resource Brokers, 
increase the job submission rate to the grid and make better use of the CPU resource. The data 
management is based on the EGEE Data Management System. A relational database manages 
the job information. Ganga [446,447] is used for the User Interface. The monitoring system of 
the ATLAS experiment uses GridICE [448]. A few services are dedicated (like Resource 
Brokers) to the experiment providing better stability and management. 
Several of the problems encountered during the ATLAS experiment deployments were 
very similar to the problems met during the WISDOM deployment (Data Management, site 
instability…). But they were not reported before the WISDOM production system 
development. Moreover, the deployment experience can not be fully validated in an open grid 
environment as long as the ATLAS experiment is using dedicated services. 
BOSS and CRAB, the job submission system of the CMS experiment 
The CMS experiment used CRAB [449] as a User Interface and BOSS [450] as a 
monitoring system. CRAB is a command line environment interfaced with BOSS allowing 
the job preparation, submission, follow-up and output retrieval using the EGEE grid 
technologies. BOSS (Batch Object Submission System) has been developed to provide real-
time monitoring and bookkeeping of jobs submitted to a compute farm system. It parses the 
log files of the jobs (i.e. the standard output and standard error of the job executable). It needs 
to be installed on each Worker Node. The last deployment of the CMS experiment [451], 
involving 15,000 jobs, was done with 2 dedicated Resource Brokers during two weeks with a 
success rate of 90%. 
CRAB is not a full automated environment because the user needs to manage a set of jobs 
by command line. Moreover, BOSS retrieves information only from Worker Nodes, not from 
Resource Brokers. The grid overhead time is thus not reported. CRAB was not validated by 
such a large scale experiment when the first WISDOM deployment was developed.  
DIRAC, the job submission system of the LHCb experiment 
The DIRAC [452,453] Workload Management System is made up of central services and 
distributed agents. With the same approach as Alien, agents submitted to EGEE or DIRAC 
sites are requesting jobs whenever the corresponding resource is available. The execution 
environment is checked before jobs are delivered to the Worker Nodes. Pilot agents go 
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through the Resource Brokers as normal jobs. The monitoring data are stored in a relational 
database. The Data Management System is the same than as the EGEE grid. Ganga is used for 
the User Interface. During a LHCb experiment deployment [454], DIRAC managed up to 
5,000 simultaneous jobs. There are gains in efficiency when the number of users is reduced. 
Again, the DIRAC system is well adapted for LHCb experiment users, but does not profit 
other grid communities. 
JAM, the job submission system for an application to find functional analogous gene 
products 
Job Application Monitoring (JAM) is the grid framework used to find functional 
analogous gene products [455]. It was first used by the CMS experiment. JAM manages large 
job submissions and monitoring thanks to the EGEE components and a relational database in 
the same model as the BOSS system. The output retrieval is done by scripts bypassing the 
Resource Brokers. The application was recently deployed on the INFN and EGEE 
infrastructures using 3 Resource Brokers. 2,400 CPUs were used by 95,000 jobs and 60 CPU 
years were consumed in 1 month on 64 Computing Elements. The crunching factor is thus 
730. The success rate is 45%. 
This job submission system is close to the WISDOM system, except in the use of a 
relational database. The low success rate is corrected by the resubmission process. The 
application was deployed after the first WISDOM deployment. Such a deployment also 
confirms issues revealed by the WISDOM experience. 
GridICE and Monalisa, two monitoring services for users 
To manage a large scale production, a grid monitoring and accounting tool is very helpful 
for tracing the progress as well as the failures of the jobs. GridICE [448] and MonaLisa [441] 
services collect information from agents deployed on the grid nodes and from the Information 
System. Such information is stored in a database which enables, via a web interface, to 
retrieve the real time status and historical events about jobs and services. Views focus on 
different aspects of job and resources monitoring. 
These two distinct and user-friendly services are limited to the scope of a Virtual 
Organization. They are thus not adapted for an individual application inside a Virtual 
Organization such as the WISDOM application deployed in the biomedical Virtual 
Organization. Moreover, there are nodes or Resource Brokers where the GridICE and 
MonaLisa agents are not installed. Furthermore, the grid resources can be incorrectly 
configured. The partial information is thus difficult to interpret for an end-user.  
4.3.4.  Comparison with the WISDOM production system 
Compared to these initiatives, WISDOM is the first attempt to deploy large scale in silico 
docking on a public grid infrastructure. As highlighted above, previous virtual screening 
deployments were either limited to grids of few clusters or to desktop grids. The job 
submission system (Alien, BOSS, DIRAC, the ATLAS production system, JAM) and 
monitoring system (GridICE, MonaLisa) review lead the WISDOM initiative to develop its 
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own production system. Compared to Alien and DIRAC system, the WISDOM production 
system aims to be developed on EGEE middleware components, without dedicated services. 
The BOSS system bypasses the monitoring information from the Resource Brokers. The 
ATLAS production system and the JAM system were not fully validated when the WISDOM 
production system was developed. The two studied monitoring systems GridICE and 
MonaLisa are not adapted for a single application in a Virtual Organization. 
Before detailing the WISDOM production system, the next section describes the 
bioinformatics components to be deployed. 
4.4. The bioinformatics components 
Virtual screening deployment by docking required selection and preparation of docking 
software, biological targets and a library of virtual or effective compounds to test. 
4.4.1.  The target 
The target is typically a protein which plays a pivotal role in a pathological process, e.g. 
the biological cycles of a given pathogen (parasite, virus, bacteria…). The goal is to identify 
which molecules could dock on the protein active sites in order to inhibit its action and 
therefore interfere with the molecular processes.  
For each target to be docked, 3D structures are required. The 3D coordinates of the 
structures are routinely obtained from the Protein Data Bank (PDB) [118]. The active site of 
the protein needs also to be prepared according to the docking tool (adding charges, 
hydrogens, water molecules…). All available target structures can be used to generate only 
one composite structure, or the screening process can be conducted on each individual 
structure requiring more computing time. The structure should have a resolution of less than 2 
Angstrom. Finally, if needed, the target structure files are converted into a format ready for 
use by the docking software. The size of a target structure is in the order of hundreds of 
kilobytes to megabytes.  
Figure 29 presents a step in target preparation. 5 target structures selected from PDB are 
superimposed with their compounds. The different protein structures used as templates share 
high sequence similarity. Variations exist in the loop regions and are indicated in yellow. The 
co-crystallized compounds are represented as balls and sticks in red.  
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Figure 29: Five target structures with their co-crystallized compounds are superimposed. This 
picture is generated by using Rasmol software. 
 
4.4.2.  The chemolibrary 
Chemolibraries are libraries of compound 2D or 3D structures. They are made openly 
available by academic laboratories or by chemistry companies which can produce them. They 
are updated monthly like supplier catalogs. Compounds for docking are selected before 
docking according to different criteria (diversity, drug likeness…) and the target 
(hydrophobic, docking models…). 3D structure of 2D compounds can be predicted. 
Each compound database requires storage space in the order of tens of megabytes to 
terabytes. Information about the compound to be docked must be extracted from the database. 
If needed, the compound structure files are converted into a format ready for use by the 
docking software. Docking scores of compounds are computed after carefully adjusting the 
parameters of the docking software. 
Figure 30 presents the two-dimensional (2D) schema of WISDOM-490500, a compound 
docked during the first WISDOM deployment. 
 
 
Figure 30: 2D schema of the compound WISDOM-490500 
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4.4.3.  The software 
Many docking software are available either open-source or licensed. They differ in the 
sampling algorithms used, the handling of compound and protein flexibility, the scoring 
functions they employ, and the CPU time required to dock a molecule to a given target. The 
docking applications share the same processing model master/worker. The tasks are 
independent and the data can be easily splitted. Only a small proportion of the execution time 
is spent on data communication. 
The docking tools used in the first WISDOM initiative are FlexX [180], a commercial 
software made graciously available by BioSolveIT [456] for a limited time, and Autodock 
[434], a software which is open-source for academic laboratories and which uses a different 
docking method. Before a docking experiment, different parameter sets are generated 
according to the software and the target. The size of a software is in the order of megabytes. 
The output of a docking-based screen is a set of 3D models of the predicted binding mode 
of each compound against the target structure, together with a ranking that is a measure of the 
quality of fit. The size of the output is different for each docking software. It is in the order of 
kilobytes for each single computation. The output size of a large scale deployment is in the 
order of hundreds of megabytes to terabytes. 
Bioinformatics components need to be installed or sent on the grid. The next section 
focuses on the WISDOM production environment in charge of running the docking 
application. 
4.5. The WISDOM docking production environment on 
EGEE 
The grid is often perceived in life science as a tool for time-consuming applications, but 
no life science application had been deployed at a large scale on a cluster grid infrastructure 
before WISDOM. Preparation of the deployment included the development of an environment 
for job submission and output data collection. This environment had to be able to handle the 
submission of about 70,000 15-hour long jobs and the collection of the output data. 
A major issue was to handle job resubmission whenever a job failed for any reason, as the 
grid success rate was typically of the order of 80% [457]. Large scale tests were made on the 
French regional grid AuverGrid to validate the environment and to identify potential issues 
and bottlenecks. Other issues were raised by the data challenge, like the usage of licensed 
software on the grid or the need for a high throughput job submission scheme. 
In this section, specific issues related to WISDOM deployment are introduced. Then, the 
results and lessons learned from the large scale tests deployed on the French regional grid 
AuverGrid are presented. Finally, the WISDOM production environment which was designed 
to achieve production of a large amount of data in a limited time with a minimal human cost 
using EGEE middleware services is detailed.  
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4.5.1.  Specific issues relating to WISDOM deployment 
A docking job requires an input file (the target), a database of independent molecules (a 
compound file), a set of parameters provided in a file or by command line and a docking 
software. A number of issues need to be addressed to achieve significant acceleration from the 
grid deployment. Previous experience with LCG middleware indicated potential bottlenecks: 
• Grid performances are impacted by the amount of data moved around at job 
submission. As a consequence, the files providing the 3D structure of targets and 
compounds should preferably be stored on grid Storage Elements in preparation for 
the data challenge.  
• The rate at which jobs are submitted to the grid resource brokers must be carefully 
monitored in order to avoid their overload. The job submission scheme must take into 
account this present limitation of the EGEE brokering system. 
• The grid submission process introduces significant delays for instance at the level of 
resource brokering. The jobs submitted to the grid computing nodes must be 
sufficiently long in order to reduce the impact of this middleware overhead. 
• Use of licensed software requires designing a strategy to distribute licenses on the 
grid. 
The WISDOM production system was designed to address the issues listed above. It had 
also to automatically recover from errors to avoid extremely tedious manual intervention. 
Indeed, the job success rate has kept increasing on the EGEE infrastructure since April 2004 
but the achieved efficiency of the order of 80% required handling about 20% of failed jobs. 
In the next sections, preparation of the large scale deployment is described as well as the 
production environment which was developed to maximize job throughput on the grid after 
analyzing the tests on the AuverGrid regional grid. The strategy adopted for the deployment 
of licensed software is also discussed.  
4.5.2.  WISDOM preparation 
The preparation took place in several steps. 
In order to limit the amount of data transferred at job submission, docking software were 
stored on each Computing Element. The files providing the structures of the target and the 
compounds were stored on the Storage Elements. The number of compounds docked per job 
was estimated so that the job duration was approximately 15 hours. FlexX being much faster 
than Autodock, different compound files were used as input to the 2 docking software. As a 
result, about 600 MB of data were stored on each grid Storage Element of the biomedical 
Virtual Organization. 
To achieve this preparation step, two packages were developed. They are responsible for 
installing the application components on the resources and for testing these components, 
together with the resources and grid services. Indeed, a stress usage of the grid in a limited 
time requires resources to be available immediately and reliably. This requires checking the 
status of the biomedical Virtual Organization services and of each of the grid node 
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committing resources to the Virtual Organization. A very important inefficiency factor comes 
from sites which are wrongly configured and where jobs systematically fail.  
Before WISDOM was launched at its full scale on the EGEE infrastructure in the summer 
of 2005, deployment went through a ramping process in order to study the performances of 
the production system and to identify potential bottlenecks. During Christmas break in 
December 2004, up to 150,000 compounds were docked on the AuverGrid infrastructure, a 
regional grid which brings together the main laboratories of the Auvergne region using EGEE 
middleware to share technologies, skills and resources. Several instances of variable size were 
submitted. Table 3 presents some of the parameters which were monitored for 2 of the 
instances submitted, one of 50 jobs (2,000 dockings) and one of 500 jobs (100,000 dockings): 
• The total CPU time corresponds to the cumulated amount of CPU used for a given 
instance. 
• The duration represents the total elapsed time between the submission of the first job 
and the end of the last job. 
• The crunching factor represents the gain of time obtained thanks to the grid 
deployment. It is simply obtained by dividing the total CPU time by the execution 
duration. 
• The grid performance is a measurement of the grid efficiency. It takes into account 
grid inefficiencies due to job submission failure, aborted jobs, and loss of resources 
due to competing jobs by other users, etc. It is computed by analyzing all error 
messages from the grid Information System and job log file. For instance, the second 
test case was launched in a period with an important number of competing jobs, which 
explains the relatively low grid performance. 
• The CPU time for 1 job indicates the average computing time for each job on one of 
the grid PCs. 
• The grid overhead time for 1 job indicates the extra time due to the deployment on the 
grid. It includes all the extra delays coming from the different grid components 
(scheduling, queuing...). 
• The data transfer time corresponds to the time needed to transfer the input data to the 
working nodes at job submission time. 
We can conclude from table 3 that the submission of longer jobs was definitely more 
efficient as it reduced the relative grid overhead. Delays due to data transfer were found to be 
negligible, but this was expected as the different sites used for this test on AuverGrid benefit 
from high bandwidth network connections.  
During these tests it was also noticed that upgrading grid nodes to new versions of 
middleware was often generating instability and loss of efficiency. The necessity to adapt our 
deployment process to the grid limitations was understood, for instance the limited number of 
files on each Storage Element or Worker Node or the fact that each Resource Broker uses a 
different Berkeley Database Information Index for listing available resources. Due to the low 
Berkeley Database Information Index update frequency in a large scale system, a resource can 
still be registered in the Information System even if it is in fact out of the grid. 
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Metrics 2000 docking in 50 jobs 100,000 docking in 500 jobs 
Total CPU time 2.5 days 188 days (6.3 months) 
Duration 2.5 hours 40 hours 
Crunching factor 24  113  
Grid performance 50% 30% 
CPU time for 1 job 1.2 hours 9 hours 
Grid overhead time for 1 job 7.2 minutes 30 minutes 
Data transfer time for 1 job < 1 minute 2,5 minutes 
Table 3: Relevant parameters of 2 test cases deployed on the AuverGrid infrastructure during 
WISDOM preparation. 
 
4.5.3.  WISDOM execution 
Based on the experience acquired during the testing phase on AuverGrid, the WISDOM 
production system, presented in figure 31, was developed in Perl, except for the multithreaded 
job submission tool which was developed in Java. The entry point is a simple command line 
tool. Its users during the data challenge were members of the Biomedical Task Force which 
gathers a team of engineers with recognized expertise in application development and 
deployment. 
This software environment was developed to allow the submission and monitoring of job 
sets which were called instances. The different jobs of a given instance have the same target 
input and docking software. They only differ in the molecules of the compound library which 
are docked. Tasks needed to submit an instance were automatically executed by the 
WISDOM execution system. The user, authenticated by a proxy certificate, had to start his or 
her instance execution following a precise submission schedule to avoid too much 
concurrency between the computation participants leading to a grid overload. Once the 
computation has started, the WISDOM environment takes care of monitoring jobs and 
registering results. The user only has to check regularly if the process is running correctly, up 
to the end of all the jobs belonging to the instance. The overall process progression could be 
monitored through an output file for follow-up messages and an error file in case of problems.  
For each instance, a configuration file contained the instance information (software, 
target, database, parameter settings) and the grid parameters (number of jobs for the instance, 
Resource Brokers, Computing Elements, Storage Elements). A shell script and a Job 
Description Language file were created for each job and used by the submission tool. 
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Figure 31: Design of the WISDOM production system. 
 
On the Worker Node, after the environment was configured, the shell script downloaded 
the database file from a Storage Element chosen by the Information System using the LCG 
API. Then binaries were called with the target and parameter settings transferred with the job. 
The compressed result was stored on a Storage Element and registered in the grid file 
catalogue. A backup copy was also generated on another Storage Element. For the sake of 
simplification, the most relevant metadata relative to the output (software, parameter settings, 
compounds database, etc.) were stored in the name of the output itself. Output, errors and 
accounting messages were transferred on the User Interface. 
A multithreaded job submission was developed specifically for a bulk and efficient 
submission on the Resource Brokers to address the limitation of LCG API which submits jobs 
one by one on one Resource Broker (with a minimal latency time of 7 seconds). The aim of 
the tool was to reduce the time needed for sequential submission of the jobs on Resource 
Brokers by parallelizing job submission on several Resource Brokers. 
Once the jobs were submitted, the supervisor needed a real-time overview of the 
production. For a large number of jobs, the WISDOM environment includes an automatic 
monitoring tool which was developed to check the status of the jobs with the bulk monitoring 
LCG API and to prompt a reaction if needed.   
Discovering and fixing failures was crucial for the process, and for the evaluation of grid 
performances. For each job that failed, the system was able to track the fault in the Workload 
Management System status message or in the job output content. After any corrective 
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operation, like deletion of a faulty Computing Element in the attributes of the Job Description 
Language file, the job was resubmitted. Preventive actions were also taken during the process. 
Then GridFTP was used to transfer data on the grid automatically from the Worker Node 
when the LCG Data Management Service failed. The output files were also carefully stored 
on several Storage Elements for security reasons. 
4.5.4.  License management 
During the data challenge, commercial docking software (FlexX) with floating licenses 
was used on the EGEE infrastructure. 3000 floating licenses were made available by 
BioSolveIT for 3 weeks to be distributed on the grid.  
Each job using FlexX software contacted the Flexlm server at the beginning of the job 
and asked for a license, namely an ASCII file with specific keys generated for this server. 
Then the job was able to run without connection to the license server. Accessing floating 
licenses on the grid behind firewalls required known IP and the opening of two specific ports 
for institutes hosting Worker Nodes. During the first three weeks of the data challenge, FlexX 
licenses were available through the license server. Afterwards, the Autodock phase started in 
August for about 2.5 weeks.  
4.5.5.  Collection and presentation of accounting data 
Accounting data are required to evaluate the performance of the grid and to quantify the 
large-scale deployment on the grid. It is also a means to find missing docked compounds in 
the output file: after the data challenge, a control was done to find out if the missing 
compounds were due to a grid failure or to the docking process. 
At the end of the instance execution, Logging and Bookkeeping services of each 
Resource Broker are used for bookkeeping with LCG APIs. Data are transferred on a remote 
machine from the User Interface to be stored in a relational database. A web site provides 
access to the database to dynamically build different statistics and histograms. 
4.6. Conclusion 
In this fourth chapter, a grid-enabled high throughput structure-based virtual screening by 
docking application was defined. 
A large scale deployment of computing and data intensive tasks, called a data challenge, 
requires a large infrastructure interfacing to a job submission system providing many efficient 
services. In the context of the fight against neglected diseases, the required tools and 
infrastructures should be freely available for the application. Additionally, in the context of 
the EGEE project, the tools interfaced with the EGEE infrastructure to deploy the application 
should use the EGEE middleware components for preference.   
Many initiatives aim to provide a full virtual screening environment on large grids. But 
there are no reports of virtual screening deployment on thousands of processors for several 
weeks such as is required for high throughput virtual screening. Other initiatives are based on 
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desktop grid technologies, but this system is limited for a full virtual screening deployment. 
The particle physics experiments, associated with the Large Hadron Collider currently being 
built at CERN, are the first applications having deployed such a data challenge. But their job 
submission systems bypass the EGEE middleware components, use dedicated services or 
were not validated at the time of the WISDOM development.  
WISDOM is the first attempt to deploy large scale in silico docking on a public grid 
infrastructure. A docking application is composed of target structures, a compound database 
and software associated with parameter settings. Such an application can be deployed on the 
EGEE grid thanks to the WISDOM production system. Experience acquired during the testing 
phase on AuverGrid infrastructure brings to light some issues, such as grid nodes instability or 
low update frequency of the Information System. The WISDOM production system is 
designed to achieve production of a large amount of data in a limited time with a minimal 
human cost using EGEE middleware services. It is able to interact with a license server. 
Accounting data are collected.  
The aim of the next chapter is to present the first achieved deployment of the WISDOM 
production system against malaria. Issues related to the deployment and the monitoring of the 
in silico docking experiment as well as experience with grid operation and services will be 
reported. 
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Chapter 5. First large scale deployment against 
malaria 
5.1. Introduction 
The first large scale deployment within the framework of WISDOM (World-wide In 
Silico Docking On Malaria) is motivated by three goals: 
• The grid goal is the deployment of a CPU consuming application generating large data 
flows to test the grid operation and services. Given the very large amount of data 
involved in the computation, such a large scale deployment is a stressing experiment 
for the grid infrastructure called a data challenge. 
• The bioinformatics goal is the computation of a large scale virtual docking 
experiment, involving millions of compounds. 
• The biological goal is to propose new inhibitors for a family of proteins produced by 
Plasmodium falciparum.  
The first large scale docking experiment ran on the EGEE grid production service from 
11 July 2005 to 19 August 2005 against targets relevant to research on malaria and saw over 
41 million compounds docked for the equivalent of 80 years of CPU time. Up to 1,700 
computers were simultaneously used in 15 countries around the world. Resources were made 
freely available from computing centers and laboratories of institutions in the framework of 
the EGEE project. 
The WISDOM production system described in the previous chapter was used to achieve 
this production of a large amount of data in a limited time with a minimal human cost using 
EGEE middleware services. The aim of this chapter is to report issues related to the 
deployment and the monitoring of the in silico docking experiment as well as experience with 
grid operation and services. Docking experiment preparation and output analysis were leaded 
by Faunhofer Institute SCAI. 
The chapter content is as follows: 
• After the introduction, the second section presents in detail the three objectives of the 
data challenge. 
• Then an analysis of the large scale deployment is proposed, followed by a description 
of achievements in terms of scale. 
• Perspectives about the biological results from the deployment, the grid-enabled virtual 
screening against malaria and a new data challenge against neglected diseases will be 
presented in the last section. 
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5.2. Objectives 
5.2.1.  Grid objective 
As discussed in the previous chapter, a large number of applications are already running 
on grid infrastructures. Even if many have passed the proof of concept level [475], only a few 
are ready for large-scale production with experimental data. Large Hadron Collider 
experiments at CERN, like the ATLAS collaboration [394], have been the first to test a large 
data production system on grid infrastructures [458]. In a similar way, WISDOM aimed at 
deploying a scalable, CPU consuming application generating large data flows to test the grid 
infrastructure, operation and services in very stressing conditions. 
Docking is, along with BLAST [459] homology searches and some folding algorithms, 
one of the most prominent applications that has successfully been demonstrated on grid 
testbeds [460]. It is typically an embarrassingly parallel application, with repetitive and 
independent calculations. Large resources are needed in order to test a family of targets, a 
significant amount of possible drug candidates and different virtual screening tools with 
different parameter and scoring settings. This is both a computational and data challenge 
problem to distribute millions of docking comparisons with millions of small compound files. 
Moreover, docking is the only application for distributed computing that has prompted 
the uptake of grid technology in the pharmaceutical industry [435]. The WISDOM scientific 
results are also a means of making a demonstration of the EGEE grid computing 
infrastructure for the end users community, of illustrating the usefulness of a scientifically 
targeted Virtual Organization, and of fostering an uptake of grid technologies in this scientific 
area. 
5.2.2.  Bioinformatics objective 
The bioinformatics objective is to deploy high throughput virtual screening by docking 
on a public cluster grid. Docking is a first step for in silico virtual screening. Basically, 
protein-compound docking is about computing the binding energy of a protein target to a 
library of potential drugs using a scoring algorithm. The goal is to identify which molecules 
could dock on the protein active sites in order to inhibit its action and therefore interfere with 
the molecular processes essential for the pathogen. Libraries of compound 3D structures are 
made openly available by chemistry companies which can produce them.  
Many docking software are available either open-source or licensed. The docking tools 
used in this project are FlexX [180], a commercial software made graciously available by 
BioSolveIT [456] for a limited time, and Autodock [434], a software which is open-source for 
academic laboratories and which uses a different docking method. 
FlexX predicts the geometry of the protein-ligand complex using an incremental 
construction algorithm and estimates the binding affinity in less than 15 seconds. It offers a 
fast method for docking conformationally flexible ligands, full specification of the active site, 
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including oxidation states, metals ions, and side chain protonation states, and automatic ligand 
positioning. 
Autodock carries out quick conformation search of small compounds in the binding sites, 
fast calculation of binding energies of possible binding poses, prompt selection for the 
probable binding modes, and precise ranking and filtering for good binders. 
Altogether 4 different parameter variations, or assay conditions, were generated for 
FlexX (location of water molecules, overlap volume) and 2 for Autodock (2 genetic 
algorithms). 
Chemical compounds were obtained in sybyl mol2 format from the ZINC database [461]. 
ZINC is a free database of commercially-available compounds for virtual screening. It 
contains over 4.6 million compounds. They are filtered with the Lipinski drug like rules and 
prepared in ready-to-dock and 3D formats. Docking scores of compounds taken from a subset 
of the ZINC database, the ChemBridge [462] database (~500,000 compounds) were computed 
on the above scenarios using FlexX and Autodock. Another drug like subset (~500,000 
compounds) of ZINC database was docked on the above scenarios using only FlexX because 
the computing resources made available to the data challenge were not sufficient to do it also 
with Autodock. The ChemBridge database molecules were converted from mol2 format to 
pdbq format in preparation of the Autodock run. 
5.2.3.  Biological objective 
As discussed in chapter 1, malaria is a dreadful disease affecting 300 million people and 
killing 1.5 million people every year [17]. Malaria is caused by a protozoan parasite, 
plasmodium. There are several antimalarial drugs presently available. But the constant 
emergence of resistance and the costs of the present drugs are worsening the disease condition 
[17]; therefore it is important to keep exploring new strategies to fight malaria. The one 
investigated within WISDOM aims at the haemoglobin metabolism, which is one of the key 
metabolic processes for the survival of the parasite. 
There are several proteases involved in human haemoglobin degradation inside the food 
vacuole of the parasite inside the erythrocytes (see figure 2). Plasmepsin, the aspartic protease 
of Plasmodium, is responsible for the initial cleavage of human haemoglobin and is later 
followed by other proteases [463], as showed in figure 32 [464]. 
There are ten different plasmepsins coded by ten different genes in Plasmodium 
falciparum (Plm I, II, IV, V, VI, VII, VIII, IX, X and HAP) [465]. High levels of sequence 
homology are observed between different plasmepsins (65-70%). Simultaneously they share 
only 35% sequence homology with their nearest human aspartic protease, Cathepsin D4 
[466]. This and the presence of accurate X crystallographic data make plasmepsin an ideal 
target for rational drug design against malaria. 
Though several peptidic and non-peptidic inhibitors have been described as inhibitors for 
plasmepsins, none of them were effective in killing the parasite in cell culture. This is due to 
the fact that large size compounds cannot easily penetrate the food vacuole where hemoglobin 
degradation occurs. 
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Figure 32: The hemoglobin degradation inside the food vacuole during the erythrocytic phase 
of the life cycle. 
 
The 3D coordinates of three plasmepsin II structures (1lee, 1lf2, 1lf3) and one plasmepsin 
IV structure (1ls5) were obtained from the PDB. The protein targets are prepared in a format 
ready to use for Autodock (pdbqs) and FlexX (mol2). 8 target scenarios for FlexX and 10 
target scenarios for Autodock were prepared based on the inclusion of different water 
molecules in the proteins during the docking process. Table 4 summarizes the experimental 
setup for the WISDOM deployment.  
 
Parameter Value for FlexX assay Value for Autodock assay 
Number of structures 8 10 
Number of assay conditions 4 2 
Number of docked compounds 999,810 499,918 
Table 4: Experimental setup for the WISDOM data challenge 
 
5.3. The first WISDOM deployment 
The deployment took place in July and August 2005. During this period, 10 users 
launched jobs from 5 User Interfaces, monitored the process with the help of the WISDOM 
environment and interacted with the user support of the EGEE project and the nodes 
administrators. 72,751 jobs were launched for a total of 80 CPU years, producing 1 TB of data 
(500 GB, doubled for the back-up). Figure 33 gives an overview of the 15 countries with 58 
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grid sites available for the first WISDOM deployment in the biomedical Virtual Organization, 
which scaled up to about 3,000 CPUs and 21 TB disk space in the summer of 2005. 
 
10UK1Poland1Germany
1Taiwan2Netherlands9France
7Spain15Italy1Cyprus
2Russia1Israel1Croatia
1Romania3Greece3Bulgaria
sitescountrysitescountrysitescountry
 
Figure 33: Countries with grid sites contributing to the first WISDOM deployment during the 
summer 2005 
 
In the next section, the deployment is further documented. Firstly, achievements in terms 
of scale are described, and then the grid performances measured during the deployment are 
discussed. Finally, the performances of the different grid services are also discussed.  
5.3.1.  Achieved deployment for the first data challenge 
For the sake of simplicity, the WISDOM deployment has been split into 6 phases:  
• Phase n°1 corresponds to the high throughput submission of FlexX jobs against the 
ChemBridge database of compounds. Many problems due to the grid (sites, Resource 
Broker…) and to the WISDOM production system (load balancing, process 
management…) were discovered during this early period. 
• Phase n°2 corresponds to the resubmission of failed jobs after phase 1  
• Phase n°3 corresponds to a second high throughput submission of FlexX jobs with the 
second drug like compound base. This phase ended on August the 1st, when the 
number of available FlexX licenses was reduced to 100.  
• Phase n°4 corresponds to the resubmission of failed jobs after phase 3 
• Phase n°5 corresponds to a first high throughput submission of Autodock jobs with the 
ChemBridge database of compounds 
• Phase n°6 corresponds to the resubmission of failed jobs after phase 5.  
Figure 34 shows the number of docked compounds over time during the months of July 
and August 2005. Figure 35 shows the number of running and waiting jobs vs. time. Figure 
36 shows the amount of transferred output vs. time. 
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Figure 34: Number of docked compounds vs time. 
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Figure 35: Number of running and waiting jobs vs. time. 
 
Chapter 5. First large scale deployment against malaria 
 
 
127 
 
1 2
3
4
5
6
 
Figure 36: Amount of transferred output vs. time. 
 
The different phases show very different patterns: 
• Phases 2, 4 and 6 are resubmission phases where the number of jobs submitted and the 
amount of data produced are significantly lower than in the high throughput docking 
phases 1, 3 and 5 
• Phase 1 corresponds to a ramp-up phase where many bugs were identified and dealt 
with 
• Data output as well as docking throughput were highest in phase 3 of production with 
FlexX. Indeed, Autodock software is about 3 times slower than FlexX software. 
The shift between the curves of waiting and running time on figure 35 illustrates the 
latency introduced by the grid. This latency is further documented in the “grid node 
performances” section but it is worth noticing already that such latency, of the order of a few 
hours, is acceptable only if the submitted jobs are themselves hour-long jobs.  
In what follows, the phases 1 to 4 will also be called the FlexX phase while the last 2 
phases will also be called the Autodock phase.  
Table 5 presents several parameters relevant in evaluating WISDOM deployment scale 
for the Autodock and FlexX phases. The following points are worth mentioning: 
• The number of docked compounds is a critical parameter for computational chemists. 
In only 37 days of effective computing, 41.27 million of number compounds were 
docked. As stated above, FlexX is significantly faster than Autodock and the FlexX 
phase allowed the computing of three times more compounds than the Autodock one.  
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• The number of docked compounds per hour is not a factor 3 larger for the FlexX phase 
compared to the Autodock phase because the number of FlexX licenses was limited to 
1,000 while the number of CPU used during the Autodock phase reached more than 
1,500 nodes. 
• The average crunching factor is 662, and reached 1,031 during the Autodock phase. 
 
Measures Total FlexX phase 
Autodock 
phase 
Cumulated number of docked compounds (in 
millions) 41.27 31.41 9.87 
Effective duration 37 days 22 days 15 days 
Number of docked compounds / hour 46,475 59,488 27,417 
Crunching factor 662 411 1,031 
Number of jobs submitted 72,751 41,520 31,231 
Number of grid Computing Elements used 58 56 57 
Number of Resource Brokers used 12 12 11 
Maximum number of jobs running in parallel 
on the grid 1,643 1,008 1,643 
Volume of output data 946 GB 506 GB 440 GB 
Total CPU time 80 years 29.5 years 50.5 years 
Effective CPU time used by successful jobs 67.2 years 24.8 years 42.4 years 
Overhead time 77.1 years 25.9 years 51.2 years 
Table 5: Performance measures of the WISDOM deployment. 
 
The percentage of CPU time provided by each EGEE computing resource is presented in 
figure 37. Half of the CPU time was consumed by only 7 of 58 sites. The WISDOM 
application did not use each site equally (ponderated by the computing capacity of the site), 
but distributed the tasks to the most important and robust sites. 
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Figure 37: Relative CPU time provided by EGEE computing resources. Some sites have been 
grouped to improve readability (groups “others”) 
 
In the next section the inefficiencies that generated the overhead time are detailed. 
5.3.2.  Grid node performances 
Figure 38 illustrates the different delays introduced by the grid deployment on three 
among the 58 sites of the biomedical Virtual Organization used for WISDOM. As already 
explained in chapter 2.5.1, jobs undergo different states when submitted to a grid Computing 
Element: 
• “Submitted” corresponds to jobs submitted by the user through the User Interface and 
not yet handled by the Resource Broker. It corresponds also to jobs failed and 
automatically resubmitted by the Resource Broker.  
• “Waiting” corresponds to jobs accepted by the Resource Broker but which are not yet 
allocated to a Computing Element 
• “Ready” corresponds to jobs for which the matching resources are found and which 
are submitted to a Computing Element 
• “Scheduled” corresponds to jobs accepted by a Computing Element and which are 
queuing for execution 
• “Running” corresponds to jobs executed on a Worker Node. 
Grid node performance depends on several parameters like scheduling policies, Worker 
Node configuration and system failures. Figure 38 shows the average time spent in the 
different states by the jobs submitted to the three sites. 
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Figure 38: Average time for the different status of a job on three Computing Elements. 
 
Delays introduced by the grid have different explanations for the three sites presented on 
these figures: 
• Scotgrid.ac.uk is a node with about 200 Worker Nodes that did not experience 
breakdown during the data challenge. The short time spent as “scheduled” shows that 
this node was not busy with concurrent jobs during the data challenge. The time spent 
at submission, corresponding to the time needed to access the Resource Broker, is 
more important.  
• The second grid node located in Marseille hosts 30 Worker Nodes. Additional time 
spent as “submitted” can be attributed to the fact that the node limited the number of 
scheduled jobs to 30. This limitation was ignored by the Resource Broker and 
therefore, the extra jobs submitted to this site were discarded immediately. This 
example shows how a node can have a special configuration not taken into account by 
the middleware. 
• The last node shown on the figure is unile.it with only a few Worker Nodes. Such a 
small node should not receive a large number of jobs. But a failure of the grid 
Information System directed almost 100 jobs to the node which increased very 
significantly the scheduled time.  
5.3.3.  Analysis of the job success rate 
The success rate definition used in this section is also used by EGEE Activity JRA2 in 
charge of Quality of Service. The formula is as follows:  
 
success rate = successful jobs / (submitted jobs – cancelled jobs) 
 
where successful jobs are jobs which have been executed successfully, submitted jobs are 
the jobs launched by the user from the User Interface, cancelled jobs are jobs cancelled by the 
user.  
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The proposed definition of the success rate is not completely relevant from a user point of 
view as a successful job as seen from the grid can be unsuccessful from a user perspective if it 
did not produce the expected output data. Finally, some of the jobs have to be cancelled for 
reasons external to the grid, for instance failures of the WISDOM execution environment or 
break downs of the FlexX license server.  
Table 6 shows the success rates during the data challenge and more specifically in its two 
specific phases. An analysis of the origin of failures is summarized in table 7 with their 
corresponding rates. 
 
Measures Total FlexX phase 
Autodock 
phase 
EGEE success rate 77 % 80.4 % 71.9 % 
Success rate after checking output data  46.2 % 33.8 % 64.4 % 
Success rate after checking output data and 
subtracting WISDOM and server license 
failures 
63 % 61.6 % 65 % 
Table 6: Efficiency measures of the WISDOM deployment. 
 
During the FlexX phase, the dominant source of failures was the license server which was 
distributing tokens to all the jobs running on the grid. This bottleneck can be overcome by 
having several license servers available. 
The second major source of failure was workload management and site failures, including 
overload, disk failure, node mis-configuration, disk space problems, air-conditioning and 
power cuts. To improve the job submission process, an automatic resubmission of jobs was 
included in the WISDOM execution environment. However, the consequence of automatic 
resubmission was the creation of several “sink-hole” effects where all the jobs are attracted to 
a single node. These sink-hole effects were observed when the status of a Computing Element 
was not correctly described in the Information System. If a Computing Element already 
loaded is still viewed as completely free by the Information System, it keeps receiving jobs 
from the Resource Broker. If the Computing Element goes down, all jobs are aborted. If the 
Computing Element can support the excessive number of jobs, the processing time is going to 
be very long. 
Most of the Data Management System failures were circumvented by the back-up system. 
Finally, unclassified failures account for 4% inefficiency. This illustrates the work which is 
still needed to improve grid monitoring.  
Other large scale deployments on EGEE report similar success rates [458] although the 
reported causes of job failures are partially different. 
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 Rate Reasons 
Success rate after checking output 
data 
46 %  
Workload Management failure 10 % Overload, disk failure 
Mis-configuration, disk space problem 
Air-conditioning, power cut 
Data Management failure 4 % Network / connection 
Power cut 
Other unknown causes 
Sites failure 9 % Mis-configuration, tar command, disk 
space 
Information system update 
Job number limitation in the waiting 
queue 
Air-conditioning, power cut 
Unclassified 4 % Lost jobs 
Other unknown causes 
Server license failure 23 % Server failure 
Power cut 
Server stop 
WISDOM failure 4 % Job distribution 
Human error 
Script failure 
Table 7: Origin of failures during the WISDOM deployment with their corresponding rates. 
 
5.3.4.  Analysis of grid services 
The WISDOM data challenge was the opportunity to test the different grid components 
within the framework of a large scale deployment. Each service has an important role in the 
process. In this section, the main issues encountered with the different grid services are 
described.   
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Information System 
To process a job, a Resource Broker chooses the best Computing Element using the 
information provided by the Information System. The following issues in relation to EGEE 
Information System were identified:  
• a Computing Element can have a policy unknown to the Information System like a 
limitation on the number of authorized biomedical jobs.  
• When the Grid Information Index Service of a Computing Element is down or very 
slow, it provides obsolete information on its status. This is misleading for the 
Resource Broker which may keep allocating jobs to this Computing Element although 
it is saturated.   
• The Information System is updated every 2 minutes. This has to be compared to the 
normal submission time to a Resource Broker which is 7 seconds. As a consequence, 
when jobs are simultaneously submitted to several Resource Brokers, these services 
have exactly the same image of the system and therefore distribute jobs in a very 
similar manner. This generates overload of the best ranked sites. 
In summary, our experience shows that detailed information on Computing Element 
configuration must be known to the Information System in order to manage large scale 
submission of jobs. Because of the limitations identified, a strategy was adopted not to submit 
jobs in bursts but rather to have a constant submission flow to limit the impact of missing 
information and sink-hole effects. 
Workload Management System 
The Resource Broker allocates jobs to a Computing Element depending on the job 
attributes described using the Job Description Language. Ranking of the Computing Elements 
depends on several criteria including the number of free Worker Nodes or the number of 
scheduled or running jobs.  
Resource Brokers turn out to be significant bottlenecks in the system. Several failures of 
the most used Resource Brokers were observed including disk crashes or overloaded services. 
As a consequence, hundreds of jobs were lost or retrieved with difficulty. In practice, the 
measured time for job submission was closer to 30 seconds than 7 seconds. WISDOM users 
had to change regularly Resource Brokers to limit their workload and instability. They were 
often left with the task of manually allocating jobs to Computing Elements.  
Our experience shows that there is a real need for synchronization between Resource 
Brokers to be able to send a job through a given Resource Broker and check its status or 
retrieve results via another one. This means that job databases should not be stored on the 
Resource Brokers but somewhere on the grid where they can be reached by any Resource 
Broker and possibly replicated. The idea would be to have a job management similar to the 
data management, with the notion of a Logical File Name for a job. 
On such large scale experiments, bulk submission, grouped monitoring, and partial error 
mechanisms are critical. On the EGEE infrastructure, bulk submission and grouped 
monitoring are implemented to some extent, although the application needs to limit the 
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stressing level on the workload management services. Partial error recovery is still handled at 
the level of the WISDOM environment. 
The Data Management System 
The Data Management System certifies data copy, registration and replication. This 
service is also a potential bottleneck, because there is only one file catalogue per Virtual 
Organization. As it was the main cause of failure for the previous ATLAS Rome Production 
Experiment [394], the EGEE Data Management System was significantly improved for the 
WISDOM data challenge. In case of breakdown of the Data Management System, the back-up 
solution for data transfer was to use GridFTP retry system for the input copy from a Storage 
Element to a Computing Element and for the output copy, registration and replication from a 
Computing Element on two Storage Elements. But failures like a power cut of the Computing 
Center of Lyon, IN2P3, hosting the unique file catalogue, proved the limitations of the 
system. 
The Data Management System could be improved by replicating the service and file 
information in several places. An automatic retry after checking the size and the integrity of 
the copied data could be developed similar to the retry system for job failures. 
Resource centers 
The resource centers, i.e. the Computing Elements, the Worker Nodes and the Storage 
Elements, were essential to the success of the data challenge. The 3 Storage Elements storing 
the output data on disk or tape worked very well despite the concurrent accesses. Difficulties 
encountered in using the Computing Elements have been discussed previously.  
The need for regularly testing all the resources of the biomedical Virtual Organization 
emerged during the preparation of the large scale deployment. Today, automatic testing is 
only performed on the EGEE infrastructure for a special test Virtual Organization. These tests 
allow the automatic extraction failing resources from the production grid.   
User Interface 
The User Interface is the entry door where the user is authenticated and authorized to 
submit jobs and manage data. Its disk capacity must be sufficient to receive all the 
information during and after execution. Preliminary tests are needed on each User Interface to 
evaluate its capacity to control a large number of jobs with EGEE APIs. Java and Perl are also 
required.  
License server 
The license server aims at authorizing the use of commercial software for a large number 
of jobs. Only a few institutes were not able to open the necessary ports for security reasons. 
They did not participate in the FlexX part of the data challenge. The server failed a few times 
because of a limited number of file descriptors on the system which prevented new socket 
connections. It was necessary to increase this number to allow new jobs to get a license (the 
number of possible socket connections must be at least equal to the number of available 
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licenses). In the future, an interesting improvement would be to integrate the server into the 
grid, so that it can check the certificates of the users requiring a license.   
Error messages 
When a job is aborted, a status message is sent to help to understand and solve the 
problem. There is a list of possible reasons for job abortion, but the message is often not clear 
and not sufficient to know exactly what has happened and what the source of the error is. The 
help from user support and site administrators is therefore crucial.  
5.4. Perspectives 
The experiment demonstrated how grid infrastructures have a tremendous capacity to 
mobilize very large CPU resources for well targeted goals during a significant period of time. 
But beyond successful large scale deployment, the produced outputs need to be analyzed, 
post-processed and shared in a collaborative environment. This section summarizes the 
biological outputs and presents the next steps of the grid-enabled virtual screening against 
malaria. 
5.4.1.  Biological results 
Post-processing of the huge amount of data generated was a very demanding task as 
millions of docking scores had to be compared. At the end of the large scale docking 
deployment, the best 1000 compounds based on scoring were selected thanks to post-
processing ranking jobs deployed on the grid. They were inspected individually. Several 
strategies were employed to reduce the number of false positives. A further 100 compounds 
were selected for post processing. These compounds had been selected based on the docking 
score, the binding mode of the compound inside the binding pocket and the interactions of the 
compounds to key residues of the protein.  
There are several scaffolds in the 100 compounds selected for post processing. The 
scaffolds diphenyl urea, thiourea, and guanidino analogues are most repeatedly identified in 
the top 1000 compounds. Some of the compounds identified were similar to already known 
plasmepsin inhibitors, like the diphenyl urea analogues which were already established as 
micro molar inhibitors for plasmepsins (Walter Reed compounds) [467]. This indicates that 
the overall approach is sensible and large scale docking on computational grids has potential 
to identify new inhibitors. Figure 39 represents a diphenyl urea analogue with a good score, 
well inside the binding pocket of plasmepsin, and interacting with key protein residues. The 
guanidino analogues can become a novel class of plasmepsin inhibitors.  
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Figure 39: Presentation of a Urea analogue inside the binding pocket of plasmepsin 
 
Before in vitro testing, the selected compounds need to be checked using molecular 
dynamics. 
5.4.2.  Next step: virtual screening by molecular dynamics 
While docking methods have been significantly improved in the last years by including 
more thorough ligand orientation searches, additional energy contributions and/or refined 
parameters in the force field, general opinion suggests that docking results need to be post-
processed with more accurate modeling tools before biological tests are undertaken. 
Molecular dynamics has great potential at this stage, as explained in chapter 1. One of the 
aims is to re-rank molecules based on more accurate scoring functions.  
For the same number of compounds, molecular dynamics analysis requires much heavier 
computing than docking. As a consequence, molecular dynamics can only be applied to a 
restricted number of compounds, usually the best hits coming out of the docking stage. 
Molecular Dynamics and subsequent free-energy analysis most often changes significantly 
the scoring of the best compounds and it is therefore very important to apply it to as many 
compounds as possible. As a consequence, grids appear very promising in the improvement of 
the virtual screening process by increasing the number of compounds that can be processed 
using molecular dynamics. 
For instance, running molecular dynamics analysis with Amber software version 8 [468] 
on one protein target and 10,000 compounds requires about 50 CPU years for a model with a 
few thousand atoms and a few tens of thousands of steps. This process produces only tens of 
gigabytes of data. One run with only one compound takes 44 hours (the computing time 
heavily depends on the choice of conditions, like explicit water simulations, or generalized 
born simulations). 
Both grids of clusters such as EGEE and grids of supercomputers such as DEISA [245] 
are relevant for molecular dynamics computing. Molecular dynamics computations of large 
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molecules are significantly faster on a supercomputer. Within the framework of the 
BioinfoGRID European project [384], focus will be put on the reranking of the best scoring 
ligands coming out of WISDOM. The goal will be to deploy on at least one of the European 
grid infrastructures a molecular dynamics software to re-rank the best compounds before in 
vitro testing.  
A molecular dynamics software deployment on the EGEE infrastructure to analyze the 
docking hits against plasmepsin is in progress. At the same time, a second data challenge 
against neglected diseases is being prepared. 
5.4.3.  Next data challenge against neglected diseases: 
WISDOM-II 
The impact of the first WISDOM computing challenge has significantly raised the 
interest of the research community on neglected diseases so that several laboratories all 
around the world have expressed an interest in proposing targets for a second computing 
challenge. One of the interests for such deployment is the access to high throughput in silico 
virtual screening thanks to large scale computing resources that majority of life science 
laboratories can not use, particularly in the research for neglected diseases or in least 
developed countries. The cost for high throughput experimental screening of millions 
compounds is estimated to millions euros. 
This next WISDOM data challenge called WISDOM-II will take place in autumn 2006. 
Contacts have been established with research groups from Italy, the United Kingdom, 
Venezuela and South Africa and a list of targets to be docked against malaria and leishmania 
has been established.  
Also, several grid projects have expressed interest in contributing to the WISDOM 
initiative by providing computing resources: AuverGrid, South East Asia Grid [388], South 
America grid EELA [382], SwissBiogrid [432]) or by contributing to the development of the 
virtual screening pipeline (Embrace [469], BioinfoGRID). A rough estimation of the needed 
resources is about 500 CPU years and about 4 terabytes storage 
5.5. Conclusion 
This fifth chapter has described how this application allowed the testing of the grid 
operation and services for a CPU consuming application generating large data flows. 
The WISDOM data challenge is the first large deployment of a biomedical application on 
a grid infrastructure. From 11 July 2005 until 19 August 2005, up to 1,700 computers were 
simultaneously used in 15 countries around the world to dock over 41 million compounds. On 
the biological side, the aim of the application was to identify new inhibitors for a family of 
proteins produced by Plasmodium falciparum through in silico virtual docking on a grid 
infrastructure.  
The data challenge has been a very useful experience in identifying the limitations and 
bottlenecks of the EGEE infrastructure. The WISDOM production system developed to 
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submit the jobs on the grid accounted for a small fraction of the failures, along with the grid 
management system. On the other hand, the resource brokers significantly limited the rate at 
which the jobs could be submitted. Another significant source of inefficiency came from the 
difficulty for the grid Information System to provide all the relevant information to the 
resource brokers for the distribution of the jobs on the grid. As a consequence, job scheduling 
was a time-consuming task for the WISDOM users during the data challenge due to the 
encountered limitations of the Information System, the Computing Elements and the resource 
brokers. Finally, the necessity to deploy licensed software during one of the deployment 
phases has generated a single point of failure ignored by the Information System. The 
development of a grid component to manage license software is under way in the EGEE 
project to address this limitation.  
The experiment demonstrated how grid infrastructures have a tremendous capacity to 
mobilize very large CPU resources for well targeted goals during a significant period of time. 
As a consequence of this challenge, middleware developers of the EGEE project are 
incorporating features required by the biomedical community.  
On the bioinformatics side, the WISDOM data challenge has demonstrated that 
collaborative production grids can be used for steps in the drug discovery process. Grid-
enabled high throughput structure-based virtual screening by docking is the first step to enable 
the virtual screening pipeline on a grid environment. The next step is the deployment of 
molecular dynamics simulations in grid environments. A second data challenge against 
neglected diseases, called WISDOM-II, is being prepared. A rough estimation of the required 
resources is about 500 CPU years and about 4 terabytes storage.  
On the biological side, the data challenge produced a large amount of output for analysis. 
Results extracted 10% of the compounds with key interactions and good scoring. Top scoring 
compounds possess basic chemical groups like thiourea, guanidino or diphenyl urea core 
structure. These compounds are currently under further analysis thanks to grid-enabled 
molecular dynamics. This large docking analysis is the initial proof of the concept: biologists 
need to come up with challenges that exploit the resources now available. The cost of the 
discovery of new inhibitors against neglected diseases would thus be lower. 
The final development of drug candidates could be awarded to a laboratory based on 
competitive bids. The drug itself would go into the public domain, for generic manufacturers 
to produce. This would achieve the goal of getting new medicines to those who need them at 
the lowest possible price. This model is currently supported by various United Nations 
programs and involves several commercial organizations, including large pharmaceutical 
companies. 
The first large scale docking experiment focused on virtual screening for neglected 
diseases but new perspectives appear also for using grids to address emerging infectious 
diseases. The next chapter will present a new data challenge dedicated to in silico docking 
against avian influenza deployed on the EGEE, AuverGrid and TWGrid infrastructures during 
the spring of 2006.  
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Chapter 6. First large scale deployment against 
avian influenza 
6.1. Introduction 
Large scale grids for in silico drug discovery open opportunities of particular interest to 
neglected and emerging infectious diseases. The first large scale docking experiment 
described in chapter 5 focused on virtual screening for neglected diseases, but new 
perspectives appear also for using grids to address emerging infectious diseases. While grid 
added value for neglected diseases is related to their cost effectiveness as compared to in vitro 
testing, grids are also extremely relevant when time becomes a critical factor. 
In April and May 2006, the second biomedical data challenge of the EGEE project was 
kicked off to tackle the computational challenge of screening about 300,000 compounds 
against the avian influenza virus H5N1. The goal was to find potential compounds that can 
inhibit the activities of an enzyme on the surface of the influenza virus, the so-called 
neuraminidase, subtype N1. Using the grid to identify the most promising leads for biological 
tests could speed up the development process for drugs against the influenza virus. 
This new deployment required a much shorter preparation, about a month, and took 
advantage of the experience acquired with WISDOM. In order to compress the overhead so 
that biomedical chemists could have the best responses to instant threads while the mutation 
of the virus happened, more than 1600 CPUs in the EGEE, AuverGrid and TWGrid grid 
infrastructures were mobilized to perform large scale distributed virtual screening during 6 
weeks. About 750 Gigabytes of output data were produced and archived on the grid with one 
additional backup. In addition to re-exercising the same framework used for the first 
WISDOM deployment, a light-weight framework, DIANE, also took part in this second large 
scale deployment. The purpose was to investigate the performances of DIANE’s special 
scheduling and failure recovery mechanisms under the pressure of handling jobs on a large 
scale.  
The aim of this chapter is to report the effects of the deployment and the monitoring of 
improvements of the WISDOM production system concerning deployment stability and to 
compare it with the DIANE framework, another production system framework. Docking 
experiment preparation and output analysis were leaded by Genomics Research Center from 
Academia Sinica of Taiwan and Institute for Biomedical Technologies from CNR, Italy. 
The chapter content is as follows: 
• After the introduction, the second section presents in detail the three objectives of the 
data challenge. 
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• The second section describes deployment strategy improvements for the WISDOM 
production system and presents the DIANE framework. 
• Then an analysis of the large scale deployment is proposed, followed by a description 
of achievements in term of scale, focused on the comparisons of the WISDOM and 
DIANE production systems. 
• Perspectives about the biological results from the deployment and a grid-enabled 
virtual screening service will be presented in the last section. 
6.2. Objectives of the deployments 
6.2.1.  Grid objective 
There were two grid technology objectives for this activity: one was to improve the 
performance of the in silico high throughput screening environment based on what was learnt 
in the previous challenge against malaria; the other was to test another environment which 
enables users to have efficient and interactive control of the massive molecular dockings on 
the grid. 
Therefore, two grid tools were used in parallel in the second data challenge. An enhanced 
version of WISDOM high throughput workflow was designed to achieve the first goal and a 
light-weight framework called DIANE [470,471] was introduced to carry a significant portion 
of the deployment for implementing and testing the new scenario. Grid performance measures 
will be compared between the first and the second data challenge. 
Compared to the first WISDOM deployment which used only the EGEE infrastructure, 
the avian influenza computing challenge used three infrastructures which are share the same 
middleware (LCG2) and also common services: AuverGrid, EGEE and TWGrid.  
6.2.2.  Bioinformatics objective 
The first WISDOM data challenge demonstrated the large scale deployment of virtual 
screening by docking. The bioinformatics objectives of this second deployment were to 
validate such a successful acceleration of the discovery of novel potent inhibitors and to 
improve the efficiency of high throughput structure-based screening.  
The docking tool used in this project was Autodock [434]. Only one parameter set was 
defined, but it had a strong impact on the computing time. Using AutoDock to evaluate one 
compound structure for 50 poses within the target enzyme would take 300 kilobytes storage 
and 30 minutes on an average PC. 
200,000 compounds from the ZINC database [461] and 100,000 compounds from a 
chemical combinatorial library were selected. Filters used were the presence of a benzyl, a six 
or five member-ring as the compound core, the presence of at least one acid group, and drug-
like consideration. These criteria were defined according to the natural inhibitor and known 
drugs of the target. For instance, in figure 40 presented below, the zanamivir and oseltamivir 
core is composed of a benzyl. 
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6.2.3.  Biological objective 
The potential for reemergence of influenza pandemics has been a great threat since the 
report that avian influenza A virus (H5N1) could acquire the ability to be transmitted to 
humans. Indeed, an increase of transmission incidents suggests the risk of human-to-human 
transmission. Moreover, the report of development of drug resistance variants is another 
potential concern. 
Two of the present drugs, oseltamivir and zanamivir, were discovered through structure-
based drug design targeting influenza neuraminidase (NA). Viral neuraminidase is an enzyme 
that helps the release of new virions by cleaving human host receptors (terminal sialic acid 
residues from glycoconjugates), whose action is essential for virus proliferation and 
infectivity (see figure 5). Therefore, blocking its activity generates antivirus effects. Figure 40 
presents the neuraminidase binding pocket and the structures of oseltamivir and zanamivir. 
 
Zanamivir 
R=guanidine
Oseltamivir
R’=amine
R’
Binding pocket
 
Figure 40: Neuraminidase binding pocket and structures of oseltamivir and zanamivir  
 
The development of drug resistance variants is one of the potential concerns of influenza 
pandemics. Moreover, to date, there is no NA subtype one (the N1 of H5N1 virus) available 
for structural study. To minimize non-productive trial-and-error approaches and to accelerate 
the discovery of novel potent inhibitors, medical chemists take advantage of modeled NA 
variant structures and structure-based design. 
The biological goal of the grid deployment was to evaluate the impact of mutations on the 
efficiency of the existing drug and to find potential compounds that can inhibit the activities 
of influenza A neuraminidase N1 subtype variants. The idea was to compile the results from 
in silico screening to know the kinds of compounds and chemical groups (fragments) 
equipped for blocking the active neuraminidases if mutations are to occur at some specific 
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sites. 4 amino acids are expected from literature and the analysis within the range of binding 
pocket to possibly mutate. 8 structures from the same target protein (from PDB) were 
prepared by considering each with one amino acid mutated only. For validation, these 
preparations were compared with crystal structures of other subtypes, except N1, available in 
PDB. Figure 41 shows reported and predicted mutation sites in the binding pocket of N1. One 
example is E119, a glutamic acid at the position 119 in the amino-acid sequence. It is reported 
in [60,61], that the substitution of the residue 119 can affect the efficiency of oseltamivir. 
 
: Predicted mutation site
: Reported mutation site
 
Figure 41: Reported and predicted mutation sites in the binding pocket of the neuraminidase 
N1 subtype 
 
The grid helps to reduce the time and the cost of the initial investment on structure-based 
drug design. Table 8 summarizes the experimental setup for the avian influenza data 
challenge. 
 
Parameter Value for Autodock assay 
Number of structures 8 
Number of assay conditions 1 
Number of docked compounds 308,585 
Table 8: Experimental setup for the avian influenza data challenge 
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The next section details the two production systems taking advantage of the EGEE, 
AuverGrid and TWGrid infrastructures. 
6.3. Docking production environments on EGEE, 
AuverGrid and TWGrid 
Taking advantage of the experience acquired in the previous WISDOM data challenge on 
malaria, the grid-enabled in silico process was implemented in less than a month on three 
different grid infrastructures: AuverGrid, EGEE, and TWGrid, paving the way for a virtual 
drug screening service at a large scale. The majority of computing was conducted on the 
WISDOM platform; in addition, a light-weight application framework called DIANE was also 
adopted in this challenge and used to perform a sizeable portion of the total activity to enable 
efficient computing resource integration and usage.  
6.3.1.  WISDOM execution improvement 
The environment was improved to address limitations and bottlenecks identified during 
the first data challenge against malaria deployed in the summer of 2005 on the EGEE 
infrastructure. The main requirement was the improvement of the stability to increase the 
success rate, even if the grid performance could be lower. 
• The number of resource broker machines and the rate at which the jobs were 
submitted on them was extended to avoid or limit their overloading. Consequently, the 
time to saturate the grid resources would probably be longer, but the constant 
submission flow would limit the impact of missing information and sink-hole effects. 
• The resubmission process after a job failure was redesigned to avoid a “sink-hole” 
effect on a failing grid computing node. Automatic resubmission was replaced by the 
manual intervention of the WISDOM production user. A perl script module was 
developed to automate the resubmission.  
• During the first data challenge, docking process information produced during the job, 
such as process time, output size or failure messages, retrieved from the User Interface 
thank to the job Output Sandbox could be lost due to Resource Brokers crashes. Such 
an output file was now directly stored and registered on two Storage Elements and 
downloaded on the User Interface at the end of the job.  
• An instance is a job set submitted and monitored on the grid by the production system. 
The different jobs of a given instance have the same target input and docking software. 
They only differ by the molecules of the compound library which are docked. The 
number of instances was reduced for the avian influenza data challenge in order to 
decrease the needed manpower time to manage them and consequently the human 
failure rate.  
As Autodock is an open-source software, there is no license server.  
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6.3.2.  DIANE 
DIANE [470,471] is a lightweight distributed framework for parallel scientific 
applications in a master-worker model. It assumes that a job may be split into a number of 
independent tasks which is a typical case in many scientific applications. It has been applied 
in a number of applications ranging from image rendering to data analysis in high-energy 
physics. 
As opposed to standard message passing libraries such as MPI [472], the DIANE 
framework takes care of all synchronization, communication and workflow management 
details on behalf of the application. The execution of a job is fully controlled by the 
framework which decides when and where the tasks are executed. Thus the application is very 
simple to program and contains only the essential code directly related to the application itself 
without the need for networking details. 
Aiming to efficiently link underlying distributed computing environments and application 
centric User Interface as illustrated in figure 42, DIANE itself is a thin software layer which 
can easily work on top of more fundamental middleware such as LSF, PBS or the grid 
Resource Brokers. It may also work in a standalone mode and does not require any complex 
underlying software. DIANE hides the scheduling details of application distribution. 
 
DIANE Framework
Application Adapter Task Scheduler
AutoDock
Geant4
BLAST
ATHENA
Computing Workers
Application Oriented User Interface
Command Line Tools Web Portal Graphic User Interface
Personal Desktop Computing Cluster Computing Grid
Backend Handler Adapter
GANGA Build-in
 
Figure 42: The DIANE framework 
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As a framework, DIANE provides an adapter for applications. Figure 43 shows the 
template of DIANE application plug-ins. A complete DIANE application plug-in should 
implement three major Python objects: the Planner and the Integrator objects implement the 
job splitting and result merging, respectively; while the logic of the Worker object 
concentrates on the execution of the individual task. When a DIANE job is started by a user, 
both the Planner and the Integrator objects are invoked by a master agent usually executed on 
the user's desktop, and typically the worker agents are submitted to run on distributed CPUs 
such as the grid worker nodes. 
 
+__init__()
+env_createPlan()
Planner
+__init__()
+env_init()
+env_addPartialOutput()
Integrator
The DIANE task queue
based on the execution plan
Generate task queue
DIANE Master
+__init__()
+env_init()
+env_performWork()
Worker
Request new task Return task result
DIANE Worker
 
Figure 43: The template of DIANE application plug-ins as well as the cooperation model 
between the three major objects: Planner, Worker and Integrator. 
 
The deployment process described in this paragraph is based on the EGEE middleware. 
Once the worker agent is launched from a User Interface on a Worker Node of a Computing 
Element thanks to a Resource Broker, first it registers itself with the master agent. In the 
second step, a channel is established for extracting the tasks from the queue held by the 
master agent. When the individual task is completed by the worker agent, the result is 
returned and merged on the master. The extracting-executing- returning cycle will continue 
until all the tasks are completed. A DIANE job is thus longer than a WISDOM job, in which 
the execution time is calculated to be inferior to 20 hours. The same channel is also used to 
profile the worker agent's health and to support user interaction with the task. The whole 
DIANE framework is written in Python and the communication between the master agent and 
the worker agents is based on the CORBA protocol. The Data Management System of EGEE 
is thus used only to store the concatenated output files from the User Interface. 
Chapter 6. First large scale deployment against avian influenza 
 
  148 
Since the DIANE framework takes care of the control of the communication and the 
workflow on behalf of the application, implementing an AutoDock adaptor for DIANE costs 
approximately 3 days and the effort is less than 500 lines of Python codes. 
6.3.3.  Preparation of the deployment for the DIANE and 
WISDOM production systems 
The WISDOM production system is a workflow of grid job handling: automated job 
submission, status check and report, error recovery. It is a push model job scheduling and a 
batch mode job handling. The DIANE framework has a master-worker model. It is a pull 
mode job scheduling and an interactive mode job handling with flexible failure recovery 
features.  
Based on what was learnt in the previous data challenge, the deployment work including 
the prediction of the N1 variants took about 1 month. Before data challenge kick-off, the 
compounds were pre-staged on three Storage Elements, and the Autodock executable was 
widely deployed on most of the available Computing Elements. The centralized LCG File 
Catalog system was used to index all the files distributed on the grid. DIANE’s workflow and 
WISDOM production system’s workflow were synchronized for the policy of job taking and 
result archiving, the job execution statistics and the job submission agenda.  
Input for the avian influenza data challenge consists of 8 protein targets predicted from 
the N1 to simulate the possible mutations of the H5N1 virus and 308,585 chemical 
compounds selected from ZINC and a chemical combinatorial library. By dividing the 
308,585 chemical compounds into 2 subsets, the whole data challenge activity was broken 
down into 16 instances; each instance corresponded to the dockings of an N1 variant against 
the compounds in one of the 2 subsets. To avoid the concurrent executions of all the instances 
overloading the grid system and reducing the grid efficiency, the initialization time of each 
instance was well scheduled.  
The majority of the data challenge instances were executed using the WISDOM 
production environment since its scalability had been demonstrated already in the first data 
challenge. Taking into account the approximation that the computing time of each single 
docking is about 30 minutes (The measurement was done on a PC with one Xeon 2.8 GHz 
CPU and 2 Gigabytes physical memory), each WISDOM job was prepared to run on 40 
dockings. Thus each instance represented 7715 grid jobs of about 20 hours long. Two 
instances were deployed using the AuverGrid infrastructure with the AuverGrid Virtual 
Organization. 
In parallel with the WISDOM activity, DIANE was used to run as many dockings as it 
could handle during the data challenge activity. As the estimated elapsed time of each docking 
is significantly longer than the startup overhead of the task, each DIANE task was defined to 
correspond to the docking of one compound. As a master-worker model, DIANE submitted 
worker agents instead of docking tasks to the grid. Due to the fact that the CPU wall time of 
most of the grid Computing Elements is restricted to 24 hours, more worker agents need to be 
submitted once the limitation is reached. During the data challenge, a DIANE master was 
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maintained on the User Interface to hold a queue of the waiting docking jobs and a separate 
process for submitting DIANE worker agents was manually triggered. This strategy allowed 
the use of more CPU power to ramp up the docking throughput without interfering with the 
running master. The result of each docking was interactively returned back to the User 
Interface once the task was successfully completed. All the results were also concatenated and 
archived into the grid. DIANE jobs were submitted on the EGEE and TWGrid infrastructures 
at the same time. 
6.4. Second large scale deployment 
The deployment took place in April and May 2006. For 6 weeks, 9 users launched jobs 
from 7 User Interfaces, monitoring the process with the help of the WISDOM and DIANE 
environments and interacting with the user support of the EGEE project and the nodes 
administrators. 74,850 jobs were launched for a total of 105 CPU years, producing 752 GB of 
data (376 GB, doubled for the back-up). 69 grid sites from 22 countries were available for this 
second large scale deployment in the biomedical Virtual Organization. Figure 44 shows the 
distribution of jobs on the AuverGrid (7%), TWGrid (4%) and EGEE (89%) infrastructures.  
 
EGEE UK 23%
TWGrid 4%
AuverGrid 7%
EGEE France 19%EGEE SouthWestern 
Europe 15%
EGEE SouthEastern 
Europe 14%
EGEE Italy 6%
EGEE NorthernEurope 
4%
EGEE CentralEurope 
2%
EGEE 
GermanySwitzerland 2%
EGEE Russia 4%
 
Figure 44: Job distribution rate for AuverGrid, TWGrid and EGEE infrastructures 
 
In the next section, the deployment is further documented. Firstly, achievements in terms 
of scale are described, and then the grid performances measured during the deployment are 
discussed. Finally, the performances of the different grid services are also discussed.  
6.4.1.  Achieved deployment for the second data challenge 
For a sake of simplicity, the WISDOM deployment has been split into 4 phases:  
• Phase n°1’ corresponds to a first submission of Autodock jobs. The first problems due 
to the grid (sites) and to WISDOM users (an user certificate change, User Interface 
overload) were discovered during this early period. Moreover, the job submission 
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frequency was slower to control the grid stability (2 minutes between 2 submissions, 
then 1 minute). 
• Phase n°2’ corresponds to an intensive job submission phase. The job submission 
frequency was increased (30 seconds between 2 submissions). No failures were 
reported 
• Phase n°3’ corresponds to a limited job submission phase due to grid problems (sites, 
Resource Broker). 
• Phase n°4’ corresponds to the last resubmissions of failed jobs. 
Figure 45 shows the number of docked compounds over time during the months of April 
and May 2006. Figure 46 shows the number of running and waiting jobs vs. time.  
The different phases show different patterns: 
• Phase 4’ is a resubmission phase where the number of jobs submitted is significantly 
lower than in the high throughput docking phases 1’, 2’ and 3’. 
• Phase 1’ corresponds to a ramp-up phase where many bugs were identified and 
resolved 
• Docking throughput was highest in phase 2’ of production. 
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Figure 45: Number of docked compounds vs time. 
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Figure 46: Number of running and waiting jobs vs. time. 
 
A comparison of the achieved deployment phases between the first and the second large 
scale deployment shows differences: 
• The number of docked compounds increases more regularly than during the first 
WISDOM deployment. This more regular production demonstrates the lower number 
of failures. 
• The instances were submitted continually without resubmission interruption. The 
single resubmission phase is thus more important than the three resubmission phases 
of the first WISDOM deployment.  
• The gradient degree of phases 1’ and 3’ are similar to the gradient degree of phase 5 of 
the first deployment, the Autodock production phase, whereas phase 2’ is the highest. 
The production efficiency was thus better during the second deployment. 
• The gradient degree of phase 3 of the first deployment, the best FlexX production 
phase, is significantly higher than phase 2’. FlexX is faster than Autodock; its docked 
compound production phase is thus more efficient.  
Table 9 presents several parameters relevant to evaluate WISDOM and DIANE 
deployment scale. The following points are worth mentioning: 
• The number of docked compounds of the second deployment, 2.47 million, is lower 
than the number of docked compounds during the first deployment. As stated above, 
FlexX is significantly faster than Autodock. Moreover, Autodock parameters for the 
second deployment increased by a factor of 10 the execution time of Autodock jobs by 
comparison to the execution time with the Autodock parameters of the first 
deployment.  
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• The average crunching factor for WISDOM deployment is 767, whereas the average 
crunching factor for DIANE is 203. This can be explained by the lower maximum 
number of jobs running in parallel on the grid for DIANE: 240.  
• The overall crunching factor of the second deployment is higher than that of the first 
deployment (912 > 662). But this can be explained by the low crunching factor of the 
FlexX phases during the first deployment due to the low success rate. The crunching 
factor of the Autodock phase (1031) is slightly better than the crunching factor of the 
second deployment, but it was measured only during 2 weeks (the Autodock phase). 
The two crunching factors can be considered as equal. 
 
 Total WISDOM DIANE 
Cumulated number of docked compounds (in 
millions) 2.47 2.16 0.31 
Effective duration 42 days 42 days 30 days 
Number of docked compounds / hour 2,450 2,143 431 
Crunching factor 912 767 203 
Number of jobs submitted 74,850 72,000 2,850 
Number of grid Computing Elements used  69 69 36 
Number of Resource Brokers used 20 19 1 
Maximum number of jobs running in parallel on the 
grid 1,839 1,639 240 
Volume of output data 752 700 52 
Total CPU time 105 years 88.3 years 16.7 years 
Table 9: Statistical summary of the WISDOM and DIANE deployment 
 
In the next section, the performance of the two deployment tools is compared. 
6.4.2.  Performance comparison of WISDOM and DIANE 
production systems 
The WISDOM and DIANE production system performance can be compared thanks to 
two parameters: the approximated distribution efficiency and the docking throughput.  
Approximated distribution efficiency 
The approximated distribution efficiency is defined as the ratio between the crunching 
factor and the maximum number of jobs running in parallel on the grid. This parameter is 
based on the approximation that the maximum number of jobs running in parallel on the grid 
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corresponds to the number of available processors during the overall period of the 
deployment, and the crunching factor is the constant number of running jobs. 
The distribution efficiency was estimated at 47% for the WISDOM deployment. The low 
ratio for the WISDOM deployment is due to the overhead time in the current EGEE 
production system. The task pull model adopted by DIANE allows the isolation of the 
scheduling overhead of the grid jobs and is therefore expected to achieve a better distribution 
efficiency. During the data challenge, DIANE was able to push the efficiency to higher than 
80% within the scope of handling the intermediate scale of distributed docking. Figure 47 
presents the resource utilization by the DIANE framework for a period of 15 days. 
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Figure 47: The resource utilization of a DIANE job 
 
But a fair comparison with WISDOM could only be made if the improvement of the 
DIANE framework is tested in a large scale as with the WISDOM exercise. 
Docking throughput 
In this section, the docking throughput is the number of docked compounds by second. It 
depends on the execution time of the software and for this reason the docking throughput of 
the first and second deployments cannot be compared. 
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Figure 48: Cumulative plot of the completed dockings by the DIANE framework 
 
Because of the highly scalable nature of the WISDOM framework, high throughput 
docking could be achieved at a rate of 1.7 seconds per docking. As DIANE was handling not 
more than a few hundred concurrent jobs, its throughput was limited to about one docking 
every 8.4 seconds. The cumulative plot of the completed dockings by the DIANE framework 
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in figure 48 also demonstrates that a constant throughput can be effortlessly maintained for a 
few weeks using the task pull model.  
In the next section, the job success rate of each deployment is reported. 
6.4.3.  Analysis of the job success rate 
Table 10 shows the success rates during the data challenge and more specifically for the 
WISDOM and DIANE activities.  
 
Measures Total WISDOM DIANE 
EGEE success rate 83.1 % 83 % 85 % 
Success rate after checking output data  70.1 % 70 % 71 % 
Success rate after checking output data and 
subtracting WISDOM and/or DIANE failures 80.3 % 80 % 83 % 
Table 10: Efficiency measures of the WISDOM and DIANE deployment. 
 
In the WISDOM activity, about 83% of the jobs were reported as successfully finished 
according to the status logged in the grid Logging and Bookkeeping system. The observed 
failures were mainly due to errors of Resource Brokers (overload, disk crashes, change of a 
Resource Broker name), of sites (mis-configuration of Computing Elements) and of 
WISDOM users. The WISDOM user failures were the change of a user certificate during the 
data challenge leading to the loss of submitted jobs for two instances. Another WISDOM user 
source of failure was the overload for an unidentified reason of a User Interface due to the 
Java job submission tool. 
The success rate went down to 70% after checking the content of the data output file. The 
main causes for these failures were frequent errors in the transfer of results to the Storage 
Elements and failures of the Computing Elements to access Autodock stored and registered in 
the Computing Element software repository (NFS and configuration failures). The success 
rate after checking output data and subtracting WISDOM failures is about 80%. 
Compared to the previous data challenge, improvement is significant as the observed 
success rate was 63% for the success rate after checking output data and subtracting 
WISDOM and server license failures. Moreover, the WISDOM job success rate has reached 
the level of typical EGEE grid success rate. Several parameters explain this improvement: 
• In order to balance the load on the Workload Management System, WISDOM 
submitted the jobs to 19 resource brokers in a round-robin order. An average of 10 
Resource Brokers was used simultaneously. 
• Because of the limitations identified during the first deployment, a strategy was 
adopted not to submit jobs in bursts but rather to have a constant submission flow to 
limit the impact of missing information and sink-hole effects. 
Chapter 6. First large scale deployment against avian influenza 
 
 
155 
• Resubmission by hand allows the process to be checked precisely and limits any sink-
hole effect. 
• The measured time for job submission was between 30 seconds and 2 minutes to limit 
Resource Broker overload. 
• Several failures of the most used Resource Brokers were observed including disk 
crashes or overloaded services. As a consequence, hundreds of jobs were lost or 
retrieved with difficulty. But the problem was limited thanks to the save on grid of the 
job process information and the non automatic resubmission. 
In the DIANE activity, a similar job failure rate was also observed; nevertheless, the 
failure recovery mechanism in DIANE automated the re-submission and guaranteed a finally 
fully complete job. The feature of interactively returning part of the computing efforts during 
the runtime (e.g. the output of each docking) introduces a more economical way of using the 
grid resources.  
The scalability issue of the DIANE framework is due to the fact that the DIANE master 
needs to keep the connections with the distributed DIANE workers for task dispatching and 
worker health checking. Performance evaluation during the data challenge showed that the 
current implementation of the DIANE master is restricted to handling a few hundred DIANE 
workers at the same time. The main reason for this restriction is still under investigation. An 
alternative solution is to adopt stateless protocols (e.g. web services or stateless CORBA); 
however, this will introduce an overhead for establishing every connection and a tradeoff 
should be made between the performance and scalability. 
For instance, to give users more flexible control over their DIANE jobs, the master of 
DIANE is usually executed on the User Interface. This feature will turn into a performance 
issue when the payload of result integration is high. The heavily loaded integration process 
will affect the performance of the User Interface. A possible approach to address this issue is 
to run the DIANE master as a Grid job on a Worker Node; however, one should make sure 
that the master is always started before the workers and the network connectivity between two 
Worker Nodes becomes yet another problem.  
6.4.4.  Issues related to the Grid middleware 
The different grid components within the framework of a large scale deployment were 
tested again during this large scale deployment. Improvements were noticed, as was reported 
in the previous section. But there was no significant change in the problems surrounding the 
services of LCG-2 middleware since the last deployment because the new gLite middleware 
was still under development. The only new middleware service was the LCG File Catalogue 
which replaced the Replica Location Service of the EGEE biomedical Virtual Organization 
during the spring of 2006 for the second deployment. The LCG File Catalogue has the same 
functionalities as the Replica Location Service. It certifies data copy, registration and 
replication. This service was again a potential bottleneck, because there is only one file 
catalogue per Virtual Organization.  
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The output data transfer process was described in chapter 5. A first output copy 
registration is done and two replications are executed. The output storage is then controlled by 
a LCG File Catalogue command line. More than 100,000 files were stored on the grid, 
meaning that the commands were executed more than 400 000 times. 
Failures have been observed regularly with the LCG File Catalogue for the preliminary 
installation of the compound database subsets and during the data challenge itself. The failure 
ratio was measured at about 1/20 during the database installation step and the data challenge 
deployment. The error can occur on any occasion, for no particular reason, and seems quite 
random. Most of the time, the command line must be rerun once more to be successful. 
Failure was reported to the EGEE grid user support. 
However, thanks to the back-up solution for data transfers by the GridFTP retry system, 
outputs were saved despite the instability of the LCG File Catalogue system. 
Among the new gLite services soon to be deployed on the EGEE infrastructure, the gLite 
Workload Management System is supposed to overcome several of the middleware 
limitations highlighted by the two WISDOM data challenges. 
It will be possible to submit several jobs in bulk mode i.e. in a single interaction. This 
will avoid the overhead of the authentication step per single interaction and will speed up the 
submission process. In addition, the Logging and Bookkeeping information will be collected 
by dedicated services (the gLite Information Service) to avoid overloaded systems. 
Preliminary tests of the gLite Workload Management System have shown an improvement in 
the job submission speed of a factor of 5 to 10 with respect to the LCG Resource Broker. 
The gLite middleware is currently deployed on the EGEE infrastructure but not 
sufficiently for the next data challenge WISDOM-II scheduled for autumn 2006. 
6.5. Perspectives 
The experiment demonstrated how grid infrastructures have a tremendous capacity to 
mobilize very large CPU resources for well targeted goals during a significant period of time. 
But beyond successful large scale deployment, the produced outputs need to be analyzed, 
post-processed and shared in a collaborative environment. This section summarizes the 
biological outputs and presents a grid-enabled high throughput virtual screening. 
6.5.1.  Biological results 
About 120,000 files in total were archived in Taiwan and in France. The most interesting 
docked compounds were identified and selected by ranking binding free energies of resulted 
docked models obtained from this data challenge. The example presented below shows how 
the mutation of only one amino acid can affect the energy of docked complexes. 
Figure 49 presents the energy distribution of docked complexes with the wild-type 
neuraminidase, one of the studied structures during the data challenge. The compound GNA, 
the core compound of the zanamivir drug, is docked with an energy located in the top 5% 
database compounds. The compound 4AM, the core compound of the oseltamivir drug, is 
Chapter 6. First large scale deployment against avian influenza 
 
 
157 
docked with an energy located in the 15%. These results are an argument to validate the 
overall docking process. 
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Figure 49: Energy distribution of docked complexes with the wild-type neuraminidase 
 
Figure 50 presents the energy distribution of docked complexes with a substitution 
E119A in the active site of neuraminidase. E119A signifies that the glutamic acid amino-acid 
in position 119 is substituted by an alanine. The mutation affects the energy of the docking 
complexes: GNA is no longer in the top 5% and 4AM is now a similar very bad docking 
energy. 
This example is an argument to validate the docking experiment: the docking conditions 
allow selection of a drug core. They also allow the retrieval of the mutation effect on the 
docking complex.  
Two sets of re-ranked data for each target were made (QM-MM method and selection by 
the study of the interactions between the compound and the target active site). The top 15% is 
about 45,000 compounds for each target. This set will be publicly available for the scientific 
community working on the avian influenza neuraminidase. The top 5% is about 2,250 
compounds for each target. This set will be refined by different methods (molecular modeling, 
molecular dynamics…). The analysis will indicate which residue mutation is critical, which 
chemical fragments are preferred in the mutation sub sites and other information for lead 
optimization to chemists. Finally, at least 25 compounds will be assayed experimentally at the 
Genomic Research Center from Academia Sinica. 
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Figure 50: Energy distribution of docked complexes with the E119A mutated neuraminidase 
 
6.5.2.  High throughput virtual screening service 
Improvements in the WISDOM environment during the second deployment demonstrate 
that a high throughput virtual screening service could be deployed for academic laboratories, 
and in the long-term for companies. Through a user-friendly interface, this service could 
register the customer data, applications and parameters, automate the grid deployment 
(installation, submission, monitoring, output retrieval), and provide the ranked outputs stored 
on the grid. 
The automatic resubmission applied during the first data challenge was a cause of failure 
and consequently a time-consuming correction task for the job supervisor. The removal of this 
process during the second deployment increased the success rate, but it is a limit to the 
building of an automatic pipeline of grid-enabled virtual screening. An issue for the future 
will be to improve the WISDOM production environment to manage efficient automatic 
resubmission with only the relevant resource brokers and grid computing nodes. Other issues 
for a successful service deployment are cost and time reduction for scientists, security and 
data protection, fault tolerant and robust services and infrastructure, resource access policy 
and transparent and easy use of the interfaces. 
Such a service could be progressively enriched by other services integrated in a grid 
infrastructure. Figure 51 illustrates a grid-enabled drug discovery pipeline. Grid service 
providers would deploy their drug discovery services on a grid infrastructure such as docking 
or molecular dynamics services. Grid service customers would access these drug discovery 
services through grid-enabled high throughput services such as that described in the previous 
paragraph. 
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Such service requires check points with easy data access. This is the main next issue for 
the WISDOM production system. The aim is to improve output data collections and post-
docking analysis in order to reduce as much as possible the time needed for experts to analyze 
the results. Real-time storage of job output in a relational database is under way for the 
WISDOM-II data challenge.  
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Figure 51: Grid-enabled in silico drug discovery pipeline 
 
This model would be relevant for competence and resource sharing between developed 
and least developed countries. Services would be available routinely and in an emergency, in 
order to compress the overhead so that biomedical chemists can have the best response to 
instant threads, for instance while the mutation of a virus happens. 
6.6. Conclusion 
This sixth chapter has demonstrated that reliability of the improved WISDOM 
environment which reached the average EGEE grid success rate despite the deployment of 
tens of thousands jobs and consummation of almost 90 CPU years in the same time period.  
This second data challenge is the first large deployment for an emerging infectious 
disease on three grid infrastructures. In April and May 2006, almost 1700 computers were 
simultaneously used in 22 countries around the world to dock over 2 million compounds. This 
new deployment required a much shorter preparation, about a month, and took advantage of 
the experience acquired with the first WISDOM deployment against malaria. On the 
biological side, the goal was to find potential compounds that can inhibit the activities of an 
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enzyme on the surface of the influenza virus, the so-called neuraminidase, subtype N1 
through in silico virtual docking on a grid infrastructure.  
Compared to the first WISDOM deployment, the deployment scale and the grid 
performance were similar. But the job success rate was greatly improved even if middleware 
issues reported in chapter 5 did not change between the two deployments. The rate is now at 
the level of the average EGEE grid success rate for lower scale grid applications. The main 
reasons for this improvement are a constant and slower job submission flow and a manual 
control of re-submission process. Compared to the DIANE deployment, the WISDOM 
production system allows a higher throughput for a similar job success rate. The DIANE 
light-weight framework offers better distribution efficiency and saves progressively the 
outputs during the job instead of at the end of the job as does the WISDOM system. The 
development of a new system merging functionalities from both WISDOM and DIANE 
frameworks is being considered. The next development steps of the WISDOM production 
system will be a migration to gLite middleware framework and the improvement of output 
data collection and post-docking analysis. 
The results are now under analysis and the outcome will help biomedical chemists to 
reduce the cost of the first investment in the process of structure-based drug design. A 
permanent high throughput virtual screening service could offer a shared space for 
collaboration between developed and least developed countries. It could also be integrated 
into the in silico drug discovery pipeline. Moreover, the much shorter preparation time for this 
large scale deployment opens interesting perspective in the use of the large scale EGEE grid 
for urgent needs for disaster management like emerging infectious disease pandemic.  
These achievements demonstrated the relevance of grids for the drug discovery process 
against neglected and emerging infectious diseases and in enabling world-wide and 
multidisciplinary collaboration. 
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General conclusion 
Neglected and emerging infectious diseases are major public health concerns in the 
beginning of the 21Pst P century. Neglected diseases are one of the main reasons of deaths in least 
developed countries. They affect hundreds of millions of people world-wide, but they 
continue to suffer from a lack of research and development. Emerging infectious diseases 
have the potential to cause a large-scale pandemic and the question is how long would be 
required to develop a vaccine or a drug should such a pandemic occur. 
Grids offer great perspectives to foster international collaboration in order to reduce costs 
and time for in silico drug discovery for neglected and emerging infectious diseases. This 
document describes innovative approaches to protein structure prediction and virtual 
screening taking advantage of grid technologies: 
• a grid-enabled service to deploy protein structure prediction software and database on 
the RUGBI grid.  
• a grid-enabled service to update protein structure prediction database on the RUGBI 
grid 
•  a grid-enabled deployment of high throughput structure-based virtual screening by 
docking against malaria 
• a second grid-enabled deployment of high throughput structure-based virtual screening 
by docking against avian influenza 
 
The deployment service aims to ease the use of software and databases for non-grid 
expert users on a grid environment. It allows registration, download and installation thanks to 
interfaces generated by the Information System describing software and databases. 
Developments are still needed to improve interfaces and enrich functionalities. 
The Database Update Service aims to provide the grid users with the most up to date 
version of any biological flat file database, to do it transparently and without disturbing any 
running jobs. This service ensures that the user’s analysis on grid will be carried out with the 
last available version of the database. It is installed for a precise database by its administrator 
but runs autonomously and periodically for small updates and for large new versions. 
Developments are still needed to interconnect the service with an execution service to 
parallelize recurrent time-consuming tasks such as indexing. There is a plan to migrate the 
service onto other grid environments like EGEE.  
These two services are deployed on the RUGBI grid, which is available for commercial 
users, such as companies of the Biopôle Clermont-Limagne, and for academic users. Services 
are also proposed by Communication & Systems in the framework of grid solution for small 
and medium enterprises. The Database Update Service will be improved in the framework of 
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the Embrace network of excellence in collaboration with developers of the CONStanza 
system. 
 
The deployments of computing and data intensive tasks against malaria and avian 
influenza are the first attempt to deploy large scale in silico docking on a public grid 
infrastructure. They allowed the testing of the grid operation and services for a CPU 
consuming application generating large data flows. Issues related to the deployment and the 
monitoring of the in silico docking experiment were reported. 
The data challenges have been a very useful experience in identifying the limitations and 
bottlenecks of the EGEE infrastructure. The WISDOM production system developed to 
submit the jobs on the grid accounted for a small fraction of the failures, along with the grid 
management system. The current success rate of the WISDOM production system is now at 
the level of the average EGEE grid success rate for lower scale grid applications. 
Compared to the DIANE deployment, the WISDOM production system allows a higher 
throughput for a similar job success rate. The DIANE light-weight framework offers better 
distribution efficiency and saves progressively the outputs during the job instead of at the end 
of the job as does the WISDOM system. The development of a new system merging 
functionalities from both WISDOM and DIANE frameworks is being considered. The next 
development steps of the WISDOM production system will be a migration to gLite 
middleware framework and the improvement of output data collection and post-docking 
analysis. The goal is to reduce as much as possible the time needed for experts to analyze the 
results. 
On the bioinformatics side, the WISDOM data challenge has demonstrated that 
collaborative production grids can be used for steps in the drug discovery process. Grid-
enabled high throughput structure-based virtual screening by docking is the first step to enable 
the virtual screening pipeline on a grid environment. The next step is the deployment of 
molecular dynamics simulations. The deployment against avian influenza required a short 
preparation period, about a month, and took advantage of the experience acquired with the 
first WISDOM deployment against malaria. Less than three months were required between 
the first contacts and the achievement for all the required virtual screening. A second data 
challenge against neglected diseases, called WISDOM-II, is currently running. 
On the biological side, the data challenges produced a large amount of output for 
analysis. Results extracted compounds with key interactions and good scoring. These 
compounds are currently under further analysis thanks to grid-enabled molecular dynamics in 
the framework of BioinfoGRID project. The outcome will help biomedical chemists to reduce 
the cost of the first investment in the process of structure-based drug design. This large 
docking analysis is the initial proof of the concept: biologists need to come up with challenges 
that exploit the resources now available. 
The experiments demonstrated how grid infrastructures have a tremendous capacity to 
mobilize very large CPU resources for well targeted goals during a significant period of time 
and in enabling world-wide and multidisciplinary collaboration. 
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The results described in this document demonstrate the relevance of grids in addressing 
neglected and emerging infectious diseases. It is however a first step and much work still 
needs to be done before in silico drug discovery on grids is adopted by the research 
community. Nonetheless, our results open important perspectives. 
 
A permanent high throughput virtual screening service could offer a shared space for 
collaboration between developed and least developed countries. It could also be integrated 
with the grid-enabled service for deployment and update. The cost of the discovery of new 
inhibitors against neglected diseases would thus be lower. The final development of drug 
candidates could be awarded to a laboratory based on competitive bids. The drug itself would 
go into the public domain, for generic manufacturers to produce. This would achieve the goal 
of getting new medicines to those who need them at the lowest possible price. This model is 
currently supported by various United Nations programs and involves several commercial 
organizations, including large pharmaceutical companies. 
 
Emerging infectious diseases can evolve into a crisis situation. In case of a pandemic, 
public authorities, like governments, have to take urgent decisions. Various resources such as 
health-care centers and infrastructures can be requisitioned. Industries can be solicited to 
produce on a large scale drugs or vaccines.  
A grid infrastructure providing easily and quickly thousands of processors could be used 
with the same approach for urgent needs. Such a grid infrastructure could contribute to an 
international drug or vaccine discovery effort by large computing power access. Mission 
critical applications (e.g. disease diagnosis, drug discovery, etc.) running on a grid require a 
high level of Quality of Service. Taking the example of the data challenge, the throughput is 
one of the key Quality of Service parameters as time may become a critical factor to address 
emerging infectious diseases. The avian influenza virus might spread at an unexpected speed 
once the variant with the ability of human-to-human transmission comes out. 
According to the definition of the Quality of Service taxonomy [249], the Quality of 
Service in the current EGEE middleware is implemented in a software way based only on the 
ranking and match-making mechanism provided by the Workload Management System. The 
Workload Management System relying highly on the Information System has no way to 
guarantee that its resource selection will meet the user’s Quality of Service requirement. Thus 
how to ensure the Quality of Service within the current grid middleware is still an open 
question. 
 
Beyond virtual screening, grid technology provides the collaborative Information 
Technology environment to enable the combining of molecular biology research and goal-
oriented field work. The long term vision of the WISDOM initiative is to build a grid for 
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malaria. The aim would be to provide services to research laboratories working on malaria. 
One of these services could be to collect and analyze epidemiological data from least 
developed countries. 
It proposes a new paradigm for the collection and analysis of distributed information 
where data are no longer centralized in one single repository. On a grid, data can be stored 
anywhere and still be transparently accessed by any authorized user. The computing resources 
of a grid are also shared and can be mobilized on demand so as to enable very large scale 
genomics comparative analysis and virtual screening. 
A web site would allow chemists and biologists to volunteer their expertise on certain 
areas of the disease. They would examine and annotate shared databases and perform 
experiments. The results would be fully transparent and discussed in chat rooms. The research 
would be initially mainly computational, based on resources provided by grid infrastructures, 
and not carried out in “wet” laboratories. Scientists would collaborate on the data and the 
software. 
 
An environment supported by the grid-enabled facilities proposed in this 
document can contribute to the fostering of international collaborations in the 
fight against neglected and emerging infectious diseases.  The very real hope is 
that this can accelerate the discovery of new drugs and therefore save lives. 
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